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Establishing patterns of differentiation is an important theme in developmental biology.  A key 
mechanism involved in creating these patterns of differentiation is the establishment and 
interpretation of transcription factor gradients.  The Drosophila transcriptional repressor Brinker 
(Brk) is expressed in lateral-to-medial gradients across the anterioposterior axis of the wing 
imaginal disc where it negatively regulates the spatial patterns of expression of genes including 
spalt (sal) and optomotor-blind (omb); the precise pattern of expression of these targets is 
determined by their sensitivity to repression by Brk so that the sal domain is narrower than that 
of omb largely because it is repressed by lower levels of Brk than omb.  The brk gradient is 
established by an inverse gradient of BMP signaling through the secreted BMP homolog 
Decapentaplegic (Dpp): the intracellular Smad effectors of Dpp signaling, pMad and Medea, 
bind together with the repressor protein Schnurri (Shn) to silencer elements at the brk locus and 
repress the activity of a constitutive enhancer.  My studies have revealed that the generation of 
the brk gradient is not simply a precise negative read-out of the dpp gradient; Brk must also 
negatively autoregulate its own expression by interacting with the pMad/Medea/Shn repressor 
complex.  Additionally, I have demonstrated that this Brk/pMad/Medea/Shn repressor complex 
alone cannot establish the graded profile of brk but that an additional positive cis-regulatory 
element that is activated by pMad is required.  This may provide the first example of a 
transcription factor both activating and repressing the same gene, brk, in the same cells at the 
same time via two different response elements.  In conclusion, generating the brk gradient 
 iii 
requires at least two positive and two negative inputs: constitutive activation by an activator, Brk 
negative autoregulation, and both activation and repression by pMad.  Generating a stable 
expression gradient appears to be much more complex than previously thought and may reflect 
the importance of multiple inputs in generating intermediate levels of gene expression rather than 
a simple on/off threshold response.  
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1.0  INTRODUCTION 
Developmental biologists have long asked the question: How does a single, undifferentiated cell, 
the fertilized egg, undergo changes to produce millions of cells that give rise to various tissues, 
organs, appendages, and ultimately an entire organism?  What must become different between 
these cells, allowing them to differentiate and become specialized, carry out different functions, 
and interact with other cells to form complex patterns within tissues?  To understand 
development, we must understand the steps that lead to the correct development of tissues and 
higher order structures that create a properly formed organism.  I am interested in how spatial 
patterns of gene expression are established and how these establish patterns of differentiation in 
developing organisms. 
1.1 DEVELOPMENT IN EUKARYOTES IS REGULATED BY DIFFERENTIAL 
GENE EXPRESSION 
An important feature of all eukaryotic cells is their ability to transcribe only a portion of the 
genes present in their genomes.  This differential gene expression is what allows cells to become 
different from each other and is controlled by the spatial and temporal cues cells receive from 
their environment.   The cues in the environment are predominantly different types of secreted 
signaling polypeptides, which control gene expression through signaling pathways that regulate 
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the activity of transcription factors.  Thus, transcription factors ultimately regulate cell 
differentiation. 
1.2 REGULATION OF EUKARYOTIC GENE EXPRESSION 
The regulation of transcription is essential for the establishment of proper patterns of gene 
expression.  The transcription of eukaryotic protein-coding genes is dependent upon the 
positioning of RNA polymerase II at the correct initiation sites.  One of the factors involved in 
this proper placement is the core promoter.  Core promoters are found at the transcription start 
site and position the trans-acting basal transcriptional machinery to initiate transcription (Smale 
and Kadonaga, 2003).  These regions typically include DNA elements that can extend about 35 
basepairs upstream and/or downstream of the transcription initiation site (Juven-Gershon et al., 
2006).   
Spatial and temporal patterns of gene expression are controlled by a variety of cis-acting 
DNA elements at response elements (also known as proximal promoters).  While core promoter 
elements are largely the same for all genes, response elements are unique for practically every 
gene. Because RNA polymerase II is incapable of promoter recognition and accurate 
transcription initiation on its own, its interactions with basal transcription factors at the core 
promoter as well as the interactions of sequence specific transcription factors at response 
elements are all required for proper gene expression. 
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1.2.1 Core promoter elements 
RNA polymerase II interacts at the core promoter with basal transcription factors.  Core 
promoter elements include the TATA box, TFIIB recognition element (BRE), initiator (Inr), 
downstream promoter element (DPE), and a more recently identified Motif Ten Element (MTE) 
(reviewed by Smale and Kadonaga, 2003).  The TATA box was the first eukaryotic core 
promoter motif to be identified and is recognized by the TATA-binding protein (TBP) subunit of 
the TFIID complex (Smale and Kadonaga, 2003).  Putative TATA box motifs are A/T rich, 
located about 30 nucleotides upstream of the transcription start site, and are found in ~43% of 
Drosophila core promoters and ~32% of human core promoters (Kutach and Kadonaga, 2000; 
Suzuki et al., 2001).  The BRE is found upstream of about 12% of TATA box containing 
promoters where it serves to augment the binding of TFIIB to the core promoter (Lagrange et al., 
1998).   
TATA boxes are not the only core promoter elements; TFIID interacts at the Inr element, 
a discrete core promoter element with the ability to function in Drosophila independently of the 
TATA box often by functioning together with the DPE. The DPE is conserved from Drosophila 
through vertebrates and is found approximately 30 nucleotides downstream of the transcription 
start site where it associates with the TBP-associated factor (TAF) subunits of TFIID (Smale and 
Kadonaga, 2003). DPE-containing promoters often have both Inr and DPE motifs but lack a 
TATA box motif; in Drosophila, the DPE-driven promoter is utilized as frequently as the 
TATA-driven promoter (Willy et al., 2000).  DNaseI footprinting studies revealed that TFIID 
binds cooperatively to the Inr and DPE motifs with a precise spacing required for maximal 
transcriptional stimulation by the Inr and DPE elements (Burke and Kadonaga, 1996; Smale and 
Kadonaga, 2003).  In Drosophila, computer predictions suggest that approximately 14% of 
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promoters contain both TATA and DPE elements while approximately 31% do not appear to 
contain either motif suggesting that other motifs may remain to be identified (Kutach and 
Kadonaga, 2000).   
The MTE is a relatively newly identified element found in promoters that, for the most 
part, do not contain a TATA box.  The MTE promotes transcription by RNA polymerase II in 
conjunction with the Inr and synergistically with the DPE by contributing to the binding of 
TFIID to the core promoter (Lim et al., 2004).  The MTE was demonstrated to be functional in 
vitro in human promoters, indicating that all of these core promoter elements function not only in 
Drosophila transcription but are conserved all the way to humans (Lim et al., 2004). 
1.2.2 Response elements 
Response elements (also known generically as cis-regulatory elements) function to regulate 
levels of gene activity through their contained binding sites for sequence-specific transcriptional 
activators and repressors (Arnosti, 2003).  Response elements can be utilized to drive reporter 
gene expression in patterns identical to those of the gene they regulate. The decision to 
transcriptionally activate or repress a specific promoter is dependent on the particular regulatory 
transcription factors that bind in a sequence-specific manner to the cis-regulatory response 
elements associated with each specific gene.  Once bound to these elements, regulatory 
transcription factors function specifically to either activate/enhance or repress/silence 
transcription from a given promoter.   
Most response elements are characterized by one or more enhancer and silencer elements, 
though the distinction between the silencer and enhancer portions of the response element is 
often not possible as many response elements do not have clearly separable enhancer and 
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silencer elements.  Activator proteins bind to enhancer elements to activate transcription whereas 
transcriptional repressors bind to silencer elements to direct transcriptional repression.  Both 
positively and negatively acting transcription factors often bind to overlapping binding sites 
contained within the same response elements and the sites are often redundant as most regulatory 
mutations involve the removal of multiple, not individual, transcription factor binding sites 
(Arnosti, 2003).  
1.2.2.1 Response element function 
Response elements have been suggested to function by several different pathways that are 
differentiated by the transcription factors recruited.  First, enzymatic modifications of histones 
modulate repression by nucleosomes to either enhance or interfere with the binding of the basal 
transcriptional machinery or activators.  In addition to the basal transcriptional machinery, 
response elements are necessary for the transcription of genes because the eukaryotic genome is 
packaged into chromatin. Covalent modifications of histones include post-translational 
modifications such as methylation, acetylation, ubiquitination, and sumoylation; these 
modifications affect higher-order complex assembly as well as the binding of other factors 
(Bhaumik et al., 2007).  Gene activation is thus thought of as relief of repression by 
nucleosomes, often through the histone acetyltransferase activities of coactivators whereas 
corepressors often utilize deacetylation to re-establish repression (Kornberg, 1999). This notion 
was supported by the observation that in the absence of nucleosomes, transcriptional activators 
are not necessary for gene activation and that nucleosome reassembly is required for gene 
repression following active transcription (Adkins and Tyler, 2006).   
Second, response elements can function through direct interactions with the general 
transcription machinery (reviewed by Blackwood and Kadonaga, 1998).  Some coactivators 
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function at response elements to bind transcription factors, recruit RNA polymerase II, and 
interact with the general transcriptional apparatus in order to regulate levels of transcription 
(Spiegelman and Heinrich, 2004).   
Third, response elements can function through the recruitment of chromatin remodeling 
proteins.  Chromatin remodeling is ATP-dependent and disrupts the histone-DNA contacts thus 
altering the position of histone octamers on DNA to create either a dense cluster of nucleosomes 
or a region of DNA containing no nucleosomes (Kokavec et al., 2008).  All of the mechanisms 
described above function in vivo and can regulate levels of transcription or switch gene 
expression on or off (Arnosti, 2003).   
1.3 APPROACHES TO IDENTIFYING REGULATORY ELEMENTS 
Regulatory elements were initially identified through genetic approaches; a good example 
includes the mutations that altered expression of HOX genes in the bithorax complex (reviewed 
by Lewis, 1998).  Transgenic technology in model organisms like Drosophila has allowed 
promoter/response element testing experiments to identify regulatory elements through 
functional studies (Arnosti, 2003).  Specifically, portions of regulatory elements or putative 
candidate sequences thought to make up response elements are cloned into P-element 
transformation vectors that use reporter genes like lacZ or GFP to monitor gene expression 
driven by the regulatory element (Barolo et al., 2000).  Transgenic animals are created and 
reporter gene expression is analyzed in multiple transgenic lines.  This allows transcriptional 
output to be assessed based on the level as well as the spatial and temporal pattern of reporter 
gene expression.  
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 Bioinformatic approaches are often used to identify evolutionarily conserved clusters of 
transcription factor binding sites that may constitute putative response elements (Arnosti, 2003).  
Binding sites contained within regulatory elements can be altered to analyze the difference in 
reporter gene expression compared to normal expression domain of the element thus determining 
the importance of these sites for regulation of gene expression.   
The “minimal” enhancer or response element is the smallest portion of a gene’s 
regulatory region which, when used to drive a reporter gene, is sufficient to exhibit expression in 
a pattern that is a reasonable approximation to the endogenous gene.  It is important to consider 
that in order to truly understand how gene expression is being controlled, all of the response 
elements necessary for its function must be analyzed.  Often, single response elements or 
regulatory regions are tested in reporter constructs; these often do not exactly recapitulate gene 
expression because proper gene expression often requires multiple response elements that are not 
always near one another in the genomic context; this is often overlooked deliberately in order to 
characterize a new element or perhaps to make studies of a particular regulatory element more 
manageable. 
1.4 MORPHOGENS AS SECRECTED SIGNALING MOLECULES 
Secreted signaling pathways control gene expression via a limited number of signaling pathway 
molecules or proteins that regulate the activity of transcription factors, ultimately directing a cell 
in a developing organism to become different from other nearby cells.  Because secreted 
signaling molecule pathways control most gene expression during development through a limited 
number of signaling proteins, their observed complexity in output must be built by alternative 
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mechanisms, for example, combinatorially, through differences in timing of expression, or 
through quantitative outputs that depend on the level of activity of the pathway (Ashe and 
Briscoe, 2006).  Some secreted signaling molecules function as morphogens in order to generate 
these quantitative outputs.  Morphogens, originally characterized as “form-giving molecules”, 
are signaling molecules secreted by a group of cells; the morphogen moves away from the cells 
in which it was originally expressed resulting in the formation of a gradient of the secreted 
signaling molecule (Vincent and Perrimon, 2001).  Cells can detect their position in the gradient 
with respect to the source of the morphogen because the activity of the morphogen is a function 
of its concentration and distance from the source of secretion (Vincent and Briscoe, 2001).  
Pattern formation primarily depends on gradients of morphogens and their subsequent 
organization in discrete locations in developing tissues (Lawrence and Struhl, 1996).   
The key feature of morphogen gradients is the ability of cells to respond to the 
morphogen in a concentration dependent manner, detecting threshold levels of the morphogen 
and responding in different ways to high, intermediate, and low levels (Fig. 1-1 A-D) (Gurdon 
and Bourillot, 2001; Wolpert, 1969).  These responses include the transcriptional activation or 
repression of gene expression based on threshold levels of morphogen signaling detected.  This 
is important and will be discussed in more detail in Chapter 4.  Genes responsive to low levels of 
morphogen signaling are expressed by cells at a greater distance from the source of the secreted 
polypeptide than those requiring higher levels of activity, which are expressed more closely to 
the cells secreting the signal (Strigini and Cohen, 1999).  Through this mechanism, the 
intracellular signal transduction pathway receiving the signal identifies the concentration of the 
morphogen it is receiving and subsequently activates target genes only above the appropriate 
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threshold level allowing cells to take on different fates depending on their position in the cellular 
field (Ashe and Briscoe, 2006). 
1.5 TRANSCRIPTIONAL REGULATORS 
The regulation of transcription of specific nuclear target genes in response to the binding of a 
secreted signaling ligand to the pathway’s receptor and the subsequent stimulation of an 
intracellular signal transduction cascade is a conserved method of function for all major facets of 
developmental biology.  The transcriptional control exhibited by the pathway is facilitated by 
one or more transcription factors that interact at specific response elements in the upstream 
regulatory regions of target genes (Barolo and Posakony, 2002).  
Regulatory transcription factors interact at response elements that, as described above, 
contain binding sites for these regulatory proteins; transcription of a gene can then be activated 
or repressed by these transcription factors and their associated co-factors (Hanna-Rose and 
Hansen, 1996; Johnson, 1995).  Eukaryotic genes contain very complex response elements that 
are capable of binding different regulatory transcription factors thus allowing for differential 
gene expression. Regulatory transcription factors can act in two different manners: to activate or 
repress transcription. 
1.5.1 Transcriptional activation 
Transcriptional activator proteins facilitate transcriptional activation; they are modular and 
contain DNA-binding (DBD) domains to recognize regulatory sequences as well as activation 
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domains to interact with additional transcription factors or transcriptional machinery to initiate 
transcription (Kornberg, 1999).  Activator proteins typically interact with another group of 
proteins known as co-activators; these proteins interact with transcription factors and often 
contain (or recruit other secondary co-activator proteins that contain) the enzymatic ability to 
modify chromatin allowing effective transcription to take place (Spiegelman and Heinrich, 
2004).  Mediator is a multiprotein complex that acts as a transcriptional co-activator and is 
required for the successful transcription of almost all protein-coding eukaryotic genes (Kornberg, 
2005).  It functions by binding the C-terminal domain of RNA polymerase II and acts as a bridge 
between this enzyme and other transcription factors thus linking transcriptional control at 
response elements with the promoter (Kornberg, 2005).  Additionally, many other co-activators 
exist including TBP-associated factors (TAFs) that associate with TATA-box-binding protein 
(TBP) to form the TFIID portion of the RNA polymerase core promoter where they direct 
transcriptional activation (Burley and Roeder, 1996). 
1.5.2 Transcriptional repression 
Transcription factors that function as repressors bind to specific sequences in the regulatory 
regions of genes thereby preventing the initiation of transcription by RNA polymerase II (Barolo 
and Posakony, 2002).  There are several ways in which the cell-specific regulation of gene 
expression might occur.  One way would be for the organism to control where the activators 
were located.  In this situation, transcriptional repressors would never be necessary.  A second 
mechanism would be for activators to be widely expressed while the expression of repressors 
would be tightly controlled such that cell-specific gene expression would be regulated largely by 
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where the repressors were located.  In many, if not most systems, it is the second mechanism that 
is important for spatial cues to control different gene expression.   
In much the same manner as transcriptional activators associate with co-activators, 
transcriptional repressors often recruit co-repressors that assist in the inhibition of transcription at 
a given locus (Gray and Levine, 1996). The methods of repression utilized by transcriptional 
repressors include passive and active mechanisms as well as long and short-range repression. 
1.5.2.1 Passive and active repression 
Passive repression is not often used in eukaryotes, but can result from competition between a 
repressor and an activator for a DNA binding site or other site necessary for transcriptional 
initiation.  In situations where the repressor is found at higher concentrations than the activator, 
the repressor will either compete away the activator or bind the target DNA binding site with a 
higher affinity than the activator (Cowell, 1994; Johnson, 1995).   
Active repression is a characteristic of repressors that contain particular protein domains 
or motifs in addition to a DNA-binding domain (Hanna-Rose and Hansen, 1996).  These 
domains or motifs can either function alone or can recruit additional co-repressors to mediate 
repression, often by altering chromatin structure, blocking the activity of an activator, or by 
interfering with activity of the basal transcriptional machinery at the promoter (Hanna-Rose and 
Hansen, 1996; Johnson, 1995).  Active repression utilizing co-repressors can act over both long 
and short ranges. 
1.5.2.2 Long and short range repression 
Long-range repressor proteins often inactivate entire chromosomal loci by making a response 
element resistant to activation from all enhancers including those found thousands of basepairs 
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away from the repressor binding site (Courey and Jia, 2001).  A familiar example of long-range 
repression is the co-repressor Groucho (Gro), a protein that mediates repression over as much as 
1 kb of DNA in Drosophila and functions with repressors to silence transcription of promoters in 
a global manner (Chen and Courey, 2000).  Groucho orthologs are found in all metazoan 
organisms and are often recruited to the WRPW tetrapeptide motif of the DNA-binding 
transcriptional repressor proteins to which they are recruited (Courey and Jia, 2001).  Groucho 
protein molecules appear to oligomerize with each other creating higher order, condensed 
complexes that organize chromosomal domains into transcriptionally silent states through 
interactions with co-repressors that possess histone deacetyltransferase activity as well as by 
causing inhibitory interactions with the basal transcriptional machinery and/or preventing 
activator binding (Courey and Jia, 2001; Sekiya and Zaret, 2007). 
Short-range repressors, on the other hand, do not interfere with all transcription but 
instead inhibit the activity of only DNA-bound activators located close to a particular locus 
(Courey and Jia, 2001). A popular example of a short-range repressor is C-terminal Binding 
Protein (CtBP), a co-repressor found in Drosophila as well as vertebrates including humans that 
is recruited to DNA by a repressor containing the PXDLS motif and mediates repression over a 
distance not exceeding 150 basepairs (Chinnadurai, 2007; Gray and Levine, 1996).  Studies 
suggest that CtBP may function by interacting with a nearby DNA-bound activator protein to 
obstruct interactions of the activator and the general transcriptional machinery (Courey and Jia, 
2001).  Additionally, the CtBP co-repressor complex contains enzymatic constituents that 
mediate histone modification by deacetylation as well as other mechanisms (Chinnadurai, 2007; 
Courey and Jia, 2001; Shi et al., 2003).  In Drosophila, several short range repressors such as 
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Snail, Knirps, and Kruppel exert their transcriptional activity during embryonic development 
primarily by recruiting CtBP (Chinnadurai, 2007). 
1.5.3 Proteins can function as transcriptional activators or repressors 
Notable, studies of gene repression originally performed in bacteria revealed that a single protein 
can function as either a transcriptional repressor or as an activator protein depending on the 
arrangement of its binding sites with respect to the promoter and the other gene regulatory 
proteins with which it is in complex (Johnson, 1995).  In some cases, a repressor may bind 
cooperatively with an activator while in other situations the repressor instead recognizes other 
DNA-bound proteins.  Smads, intracellular signal-transducers in the TGF-ß signaling pathway, 
target specific genes for either transcriptional induction or inhibition by directly recruiting co-
activators or co-repressors to Smad-targeted promoters (Massague et al., 2005). Suppressor of 
Hairless, Su(H), is a transcription factor that functions as an activator of gene expression during 
Notch pathway signaling; however, in the absence of signaling, it represses target genes through 
its interactions with Hairless (H), a Drosophila protein that antagonizes Notch signaling by 
inhibiting DNA binding by Su(H), and through the recruitment of two co-repressor proteins, 
CtBP and Gro (Barolo et al., 2002).  Another example conserved from Drosophila to mammals 
includes the Tcf/Lef family of transcription factors important for transcriptional activation upon 
association with ß-catenin in the nucleus of cells signaled by the Wnt/Wingless signaling cascade 
(Llimargas, 2000).  The Tcf/Lef molecules can also function as transcriptional repressors in the 
absence of a Wnt/Wingless signal by binding with different transcriptional co-repressors 
including CtBP (Drosophila) or Gro (vertebrates) (Brantjes et al., 2001).  In both of the 
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situations described above, the same response element sequence is bound by Su(H) or Tcf/Lef 
when these transcription factors function to both activate and repress transcription.   
1.5.4 Transcription factor gradients 
A common feature of many morphogen gradients is their ability to establish transcription factor 
gradients; these gradients can specify positional information by either transcriptionally activating 
or repressing target genes that possess differential sensitivities to the signaling protein of the 
morphogen gradient (Hewitt et al., 1999).  An inverse gradient of a transcriptional repressor that 
is reciprocal to the transcriptional effector or activator protein that has been activated by the 
morphogen signal is a common phenomenon of morphogen gradients (Fig. 1-1 E-F) (Ashe and 
Briscoe, 2006). Different target genes of secreted signaling molecules are differentially 
expressed because they respond in a concentration dependent manner to the gradients of 
transcription factors set up by the signaling pathway (Ashe and Briscoe, 2006). 
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 Figure 1-1: Morphogen and transcription factor gradient model. 
(A) A cellular field.  (B) The morphogen is a localized source of a signaling molecule with high levels near the 
source (left side of page), shown in red.  (C) Following secretion and diffusion, the morphogen is present in a 
gradient with highest levels near the source (red cells) and lowest levels farthest from the source (pink cells).  (D) 
Target genes are activated above distinct threshold levels of morphogen to which they are exposed, with gene X 
being activated by the highest levels, gene Y by intermediate levels, and gene Z by the lowest levels.  (E) 
Morphogen gradients (as shown in panel C) can induce inverse/complimentary transcription factor activity gradients 
where the highest levels of transcription factor may be found where the concentration of the morphogen is lowest 
(dark purple cells) and lowest concentrations where the amount of morphogen is the greatest (light violet circles).  
(F) Target genes can be repressed differentially by the concentration of the transcriptional repressor protein present 
where gene X is repressed by low levels of the transcriptional repressor, gene Y by intermediate levels, and gene Z 
by high levels. 
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1.6 DROSOPHILA MELANOGASTER AS A MODEL SYSTEM IN 
DEVELOPMENTAL BIOLOGY 
Drosophila is often considered the experimental model organism of choice for examining a 
number of important developmental biological processes (Roberts, 1998).  Gradients of 
transcription factors can be generated by diffusion from localized sources of transcription or 
maternal message found within the early embryo because it develops as a syncytium.  The role of 
these gradients in patterning the early embryo is described below.  Later in embryonic 
development, organized pockets of tissue called imaginal discs are set-aside to later become 
adult structures including the appendages; this tissue is largely patterned during larval life before 
the adult structures develop during the pupal period. 
 I am interested in understanding the regulation of pattern formation during animal 
development and how these patterns of differentiated tissue create functional structures like 
appendages.  The developing Drosophila provides many opportunities to study pattern formation 
due to the vast knowledge of the regulation of the function of many genes as well as the 
numerous molecular and genetic techniques available to researchers. 
1.7 PATTERNING THE DROSOPHILA EMBRYO BY TRANSCRIPTION FACTOR 
GRADIENTS 
In the early Drosophila embryo, gradients of transcription factors are established along the A/P 
axis from a localized source of RNA because the embryo develops as a syncytium.  The factors 
diffuse easily through the cytoplasm allowing the formation of transcription factor concentration 
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gradients forms along axes where target genes are differentially sensitive to the levels of the 
graded transcription factor.  This single factor can provide the information necessary to establish 
spatial patterns of gene expression along much of a given body axis.  In the Drosophila egg, the 
activity of the Bicoid (Bcd) transcription factor was the first identified example of how 
quantitative information contained in a morphogen gradient is transformed into precise patterns 
of target gene expression.  The bcd mRNA is produced during oogenesis and deposited into the 
anterior pole of the embryo; following translation, the Bcd protein, a homeodomain-containing 
transcription factor, can diffuse along the A/P axis giving rise to a concentration gradient with its 
highest point at the anterior pole (Dreiver, 1988) (Fig. 1-2). High levels of Bcd pattern the 
anterior most region of the embryo and promote the expression of genes including buttonhead 
whereas lower levels of protein expression in the posterior of the embryo regulate the expression 
of hunchback (Burz et al., 1998; Crauk and Dostatni, 2005).  
In other situations (aside from syncitially developing Drosophila embryos), gradients of 
activated transcription factors are also established along developing axes, as demonstrated for 
Dorsal (Dl), which is the second critical transcription factor gradient responsible for patterning 
the major body plan axes of the Drosophila embryo.  However, this the gradient of activated Dl 
cannot be established in the same manner as described for the A/P axis in the embryo as there are 
membranes between the cells, so gradients, like that of activated Dl, are typically established by 
a gradient of an extracellular signal.  The Dl protein is uniformly distributed in the egg and 
initially restricted to the cytoplasm.  Dorsoventral (D/V) patterning by Dl occurs because a Dl 
activity gradient is produced by a processed form of the Spatzle protein, which is present in the 
perivitelline space surrounding the embryo but is processed in the ventral region resulting in a 
ventral to lateral Dl gradient (Papatsenko and Levine, 2005).  The graded nuclear localization of 
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Dl is promoted by the activation of the Toll receptor by Spatzle (Papatsenko and Levine, 2005).  
This nuclear Dl concentration gradient is responsible for early patterning of the D/V axis and 
specifies three basic regions/germ layers: the mesoderm, neuroectoderm, and dorsal ectoderm 
(Fig. 1-2) (Jiang et al., 1992; St Johnston, 1992). The expression patterns of genes along the D/V 
axis such as decapentaplegic and twist are determined by their sensitivity to either activation 
(twist) or repression (decapentaplegic) by the Dl protein (Papatsenko and Levine, 2005; 
Stathopoulos and Levine, 2005). 
 In the developing Drosophila wing, gradients of extracellular signaling proteins result in 
a similar gradient of activated transcription factor.  The signaling protein Decapentaplegic (Dpp) 
is a TGF- homolog whose gradient controls patterning and development along the A/P axis of 
the wing. 
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 Figure 1-2: Gradients of transcription factors pattern the Drosophila embryo. 
(A) The bcd mRNA is produced during oogenesis and deposited into the anterior pole of the embryo.  Following 
translation and diffusion, the Bcd protein gradient is established with highest concentrations of Bcd in the anterior 
and lowest levels in the posterior.  High levels of Bcd promote the expression of genes like buttonhead while lower 
levels allow the expression of genes like hunchback in the posterior.  (B) Spatzle protein is processed in the ventral 
region of the embryo producing a ventral to lateral cytoplasmic Dorsal protein gradient.  Activation of the Toll 
receptor by Spatzle promotes the nuclear accumulation of Dorsal establishing a nuclear Dorsal protein gradient with 
peak levels ventrally and progressively lower levels laterally and dorsally.  Target genes like dpp are repressed by 
lower levels of nuclear Dorsal protein while others like twist are activated by higher levels of nuclear Dorsal protein.  
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1.8 IMAGINAL DISCS DEVELOP INTO ADULT WINGS 
In Drosophila, the appendages of the adult fly develop from larval imaginal discs (Blair, 1995).  
Discs are set aside during embryonic development as small clusters of 10-40 cells that divide 
during larval life to form large epithelial sacs of tissue (Blair, 1995).  The developing Drosophila 
embryo contains parasegments that ultimately give rise to the segments of the larva and adult 
(Wolpert, 2002).  Primordial wing imaginal disc cells originate in response to a positional cue 
from the Wingless protein in the embryonic ectoderm on opposite sides of the parasegment 
boundary (Brook et al., 1996).  Because of this, founder cells that comprise the disc primordium 
are made up of cells from two adjacent parasegments; those in the posterior compartment inherit 
engrailed expression from the embryonic segment, which is important later for patterning the 
appendage along the A/P axis (Brook et al., 1996).   
Extensive studies on the transplantation of imaginal disc fragments has demonstrated that 
the majority of the patterning information necessary for the generation of adult appendages is not 
present in early larval stages, but becomes defined in the discs by the end of the third larval 
instar (Cohen, 1993).  During metamorphosis, various regions of the wing disc epithelium 
differentiate into the epidermal tissues of the wing to form two fused sheets of cuticle secreted by 
epithelial cells as well as characteristic patterns of bristles and veins (Fig. 1-3 A-B) (Blair, 1995).   
1.9 WING DEVELOPMENT IS REGULATED BY DPP 
Decapentaplegic (Dpp) is a protein in the TGF- family that regulates both growth and 
patterning across the A/P axis of wing imaginal discs through its activity as a morphogen.  In the 
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wing disc, the identity of cells in the posterior compartment is dictated by the expression of the 
engrailed gene, as described above.  As a result, cells in the posterior secrete Hedgehog (Hh), 
which acts as a morphogen signaling to anterior compartment cells and patterns the central 
region of the wing blade primordium while also inducing dpp mRNA expression in a stripe of 
cells just anterior to the A/P compartment boundary (Zecca et al., 1995).  Following protein 
synthesis and secretion, the Dpp protein is located in a symmetrical medial-to-lateral gradient in 
the anterior and posterior compartments (Fig. 1-3 C-D) (Teleman and Cohen, 2000).   
Dpp is essential for the growth of wing cells and is responsible for pattering the wing via 
a concentration-dependent mechanism utilized to induce the expression of target genes such as 
spalt (sal) and optomotorblind (omb) at varied distances from the A/P compartment border (Fig. 
1-4) (Nellen et al., 1996; Tabata, 2001).  Characteristic nested patterns of target gene expression 
are generated by Dpp where genes requiring high levels of Dpp for activation are expressed 
closest to the source of Dpp whereas genes requiring lower amounts of activity are transcribed in 
more broad expression domains (Zecca et al., 1995).  For example, sal and omb are regulated by 
different levels of Dpp signaling: the sal expression domain is more narrow than that of omb 
indicating that sal is transcribed in regions of the disc where Dpp levels are high while omb is 
transcribed in a wider domain corresponding to the notion that lower levels of Dpp are necessary 
for the activation of omb expression (Fig. 1-3 C-D). 
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 Figure 1-3: Fate map and gene expression in wing imaginal disc projected onto adult wing. 
(A) Wing imaginal disc illustrating regions that correspond to adult wing.  The wing disc is divided into anterior 
(A), posterior (P), dorsal (D), and ventral (V) compartments.  (B) The adult wing is comprised of dorsal and ventral 
sheets of epithelial tissue fused at the margin (red).  (C) Wing imaginal disc illustrating stripe of Dpp mRNA 
expression (purple line) as well as the diffused Dpp morphogen gradient (purple gradient).  Regions corresponding 
to target gene expression are shown for sal (pink) and omb (green).  (D) Projection of regions of the adult wing 
patterned by Dpp targets sal and omb (colors as in C). 
 
 
 
1.9.1 Transforming growth factor-beta signaling pathway 
The transforming growth factor- (TGF-) family members include TGF-s, activins, and bone 
morphogenetic proteins (BMPs); this morphogen superfamily is utilized throughout animal 
development to control the transcription of target genes involved in the regulation of many 
different biological processes including the control of cell growth and proliferation (both 
positively and negatively), fate determination, cell motility, cell adhesion, cell death, and cell 
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cycle regulation as well as a number of other developmental processes (Gelbart, 1989; Padgett, 
1998; Yamamoto and Oelgeschlager, 2004). More than 20 members of the TGF- signaling 
family have been studied in a variety of species ranging from corals to mammals (Yamamoto 
and Oelgeschlager, 2004).  The ineffective regulation of TGF- family signaling has been linked 
to human diseases including cancer, nonfamilial pulmonary hypertension, fibrosis, and 
autoimmune diseases indicating that the proper regulation of this pathway is vital for 
development (ten Dijke et al., 2000; Yamamoto and Oelgeschlager, 2004). 
1.9.2 Receptor complexes 
Both biochemical and genetic analysis has demonstrated that two classes of membrane 
associated molecules are the primary effectors of TGF- signaling: the type I and II receptors.  
Type I receptors are transmembrane serine-threonine kinases that contain a glycine-serine (GS 
domain) rich region; signaling of these receptors requires the phosphorylation of the GS domain 
(Padgett, 1998).  Type II receptors are constitutively active kinases that activate type I receptors 
by directly phosphorylating them (Padgett, 1998).  Following BMP ligand binding to the type II 
receptor, the type I and II receptors dimerize forming a heteromeric complex where the type II 
receptor phosphorylates the type I receptor on its GS domain thus allowing the type I receptor to 
relay the signal to downstream effectors (Smad proteins) via phosphorylation events dictated by 
its kinase domain (Padgett, 1998; ten Dijke et al., 2000). 
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1.9.3 Intracellular signal transducers 
Smad proteins are the nuclear effectors/intracellular signal transducers of the TGF- superfamily 
that function to transmit ligand signaling into the nucleus of cells where they interact with other 
proteins to direct transcriptional responses such as activation or repression of target gene 
expression (ten Dijke et al., 2000).  Smad proteins are conserved between Drosophila and 
vertebrates and can be classified into three groups: receptor-regulated Smads (R-Smads), 
common-partner Smads (Co-Smads), and inhibitory Smads (I-Smads). 
R-Smads are differentially phosphorylated by activated type I receptor kinases and can 
form heteromeric complexes with Co-Smads (Padgett, 1998; ten Dijke et al., 2000).  Upon 
complex formation, the R-Smad/Co-Smad complexes move into the nucleus where they bind 
DNA sequences and are involved in the transcriptional regulation of target genes (Padgett, 1998; 
ten Dijke et al., 2000). 
R-Smads and Co-Smads contain two domains of high sequence similarity at their N- and 
C-termini, called the Mad-homology domains, or MH1 and MH2, respectively (ten Dijke et al., 
2000).  While the MH1 domain has intrinsic DNA-binding activity, the MH2 domain is where 
phosphorylation of the C-terminal serine residues of R-Smads occurs and is also important for 
homo- and heteromeric complex formation between multiple R- and Co-Smads (ten Dijke et al., 
2000).  The MH1 and MH2 domains are separated by a proline-rich linker region that has the 
ability to associate with other transcription factors (Massague et al., 2005; ten Dijke et al., 2000). 
The I-Smads act antagonistically to BMP signaling in Drosophila by acting as negative 
regulators of R-Smad signaling via interactions with activated type I receptors to block the 
phosphorylation/activation of R-Smad signaling (Schmierer and Hill, 2007; ten Dijke et al., 
2000). 
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1.10 BMPs REGULATE DEVELOPMENT VIA ACTIVITY GRADIENTS 
The establishment of a BMP activity gradient is important not only in Drosophila but also in 
vertebrate systems where it controls multiple developmental processes including skeletal 
development, stem cell regulation, neurogenesis, and embryonic D/V axis patterning (Gazzerro 
and Canalis, 2006; Yanagita, 2005).  Due to the multitude of dose-dependent processes regulated 
by BMP signaling, a requirement exists for the tight regulation of BMP activity.  BMP signaling 
is regulated via several mechanisms including: (1) tissue-specific BMP expression, (2) the tissue-
specific localization of cell-surface receptors, and (3) antagonists (Yanagita, 2005).  While the 
tissue-specific localization of BMPs and their receptors can provide the primary mechanism to 
regulate activity of the signaling pathway, this is not always the case and the specific control of 
activity is often achieved through the use of extracellular BMP antagonists whose expression is 
precisely regulated, as discussed in the next section (Yanagita, 2005). 
1.10.1 Extracellular antagonists of BMP activity gradients 
A number of differentially expressed, extracellular, secreted proteins known as antagonists have 
been identified that negatively regulate the interaction of BMPs with their receptors by binding 
BMPs in the extracellular space thus inhibiting downstream signaling (Gazzerro and Canalis, 
2006; Yamamoto and Oelgeschlager, 2004).  Based on sequence alignment, vertebrate 
antagonists have been categorized into four subgroups including: noggin, the chordin family, 
twisted gastrulation, and the differential screening-selected gene aberrative in Neuroblastoma 
(DAN) family.  BMPs are widely expressed during Xenopus embryogenesis, but a gradient of 
BMP signaling activity important for patterning the presumptive D/V axis is achieved by the 
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graded distribution of extracellular antagonists including Chordin and Noggin, which are largely 
redundant and expressed in the Spemann’s organizer.  Among other roles in skeletal 
development, Noggin is a secreted by the Spemann’s organizer in Xenopus embryos where it 
antagonizes BMPs in order to induce neuronal tissue by binding BMP-2, 4, and 7 (Yanagita, 
2005).  Chordin binds to BMP-2 and 4 in order to prevent the interactions of these signaling 
molecules with the receptors in its functions at the Spemann’s organizer (Yamamoto and 
Oelgeschlager, 2004).  Twisted gastrulation (Tsg) is another glycoprotein antagonist that forms 
stable complexes with Chordin and BMPs; it is thought that Tsg acts as a BMP-4 antagonist 
during the formation of the vertebrate skeleton and T-cells (Yanagita, 2005).  DAN is a family of 
secreted antagonists of BMP signaling; most members are expressed during embryonic 
development where they antagonize BMP signaling, particularly in the regulation of skeletal 
formation (Gazzerro and Canalis, 2006).  It appears that the primary mechanism utilized to 
control BMP activity gradients in vertebrates is through negative regulation by secreted 
antagonists of BMP signaling. 
1.10.1.1 Antagonists of BMP activity in Drosophila 
Two of the above described secreted antagonists that function to regulate BMP signaling 
throughout vertebrate development also have Drosophila homologs. Short gastrulation (Sog) is 
the Drosophila Chordin homolog that antagonizes Dpp signaling in embryonic D/V axis 
development (Carneiro et al., 2006).  Drosophila also have their own Tsg protein BMP 
antagonist also important for D/V axis formation (Gazzerro and Canalis, 2006).  An extracellular 
antagonist functioning to regulate BMP signaling during larval wing imaginal disc development 
has not been identified leading to the possibility that BMP activity is regulated via a mechanism 
other than secreted antagonists to Dpp signaling. 
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1.11 DECAPENTAPLEGIC SIGNALING PATHWAY 
Dpp acts as a morphogen by providing positional information required to pattern Drosophila 
tissues including the embryonic ectoderm and the wing imaginal disc (Gelbart, 1989; Padgett, 
1998).  The pathway that transduces the Dpp signal utilizes combination of type I and II 
receptors where Thickveins (Tkv) and Saxophone (Sax) are the type I receptors and Punt (Put) is 
the type II receptor (Tabata, 2001).  Tkv is crucial for wing development as its constitutively 
active form, when ectopically expressed, is capable of inducing the expression of the target genes 
sal and omb (Tabata, 2001).  Put phosphorylates Tkv, which in turn recruits and subsequently 
phosphorylates the founding R-Smad member of the Smad family, Mothers against Dpp (Mad) 
(Sekelsky et al., 1995).  Phosphorylated Mad (pMad) then interacts with its Co-Smad, Medea 
(Med); this heteromeric complex translocates from the cytoplasm to the nucleus where it binds 
the regulatory elements of target genes and directs transcriptional activation or repression (Xu et 
al., 1998).  A Dpp target, Daughters against Dpp (Dad), has been shown to regulate the Dpp 
activity gradient.  Dad, an I-Smad, competes with Mad for binding to the Tkv receptor thereby 
antagonizing the phosphorylation of Mad to create a negative-feedback loop that limits the 
domain of pMad (Tabata, 2001). 
Evidence demonstrating that Dpp acts in a concentration-dependent manner and directly 
on cells, rather than through a signal relay mechanism, came from experiments that used a 
constitutively active form of the Dpp receptor, Tkv (Lecuit et al., 1996; Nellen et al., 1996).  
Ectopically expressed constitutively active Tkv induces the expression of the Dpp target genes 
sal and omb (Lecuit et al., 1996).  The key to demonstrating that Dpp acts directly on cells was 
based on the determination of whether or not the effect of expressing activated Tkv was cell-
autonomous—if Dpp functions as a morphogen, the effects of activated Tkv would be cell-
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autonomous because a second signal would not be secreted from the constitutively active Tkv-
expressing cells.  The cell-autonomous effects observed for the induction of sal and omb by 
activated Tkv demonstrated that Dpp functions directly on target cells as a morphogen (Lecuit et 
al., 1996; Nellen et al., 1996).  
The Dpp signaling system becomes more complicated when the contributions of Glass 
bottom boat (Gbb), the other BMP ligand responsible for patterning the wing imaginal disc along 
its A/P axis, are considered.  gbb is expressed in a considerably broader domain than dpp; while 
Dpp primarily signals to cells relatively close to its expression domain, Gbb acts over a longer 
distance in order to establish boundaries of target gene expression at the low points of the BMP 
signaling gradient in both the anterior and posterior compartments of wing discs (Bangi and 
Wharton, 2006).  Therefore, the wing patterning BMP activity gradient is not comprised of a 
single graded molecule but rather by the contributions of two BMPs that exhibit different 
effective ranges in the wing imaginal disc.  Because both ligands signal through the Tkv type I 
receptor in the activation of the same downstream effector, Mad, the difference in their effective 
ranges is probably based on how the ligands interact with other molecules (Bangi and Wharton, 
2006).  While I refer to the Drosophila TGF-ß signaling pathway as primarily functioning 
through the Dpp ligand, it is important to keep in mind that Gbb also appears to play a role 
laterally in the patterning of the A/P axis of the wing imaginal disc.  
1.11.1 Dpp can direct both transcriptional activation and repression 
Dpp is a signaling system with the ability to either activate or repress transcription upon pathway 
activation.  As members of the Dpp signaling pathways, the R-Smad (Mad) and Co-Smad (Med) 
bind to the cis-regulatory elements of Dpp target genes in a variety of tissues throughout 
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Drosophila development in order to alter the transcription of target genes.  Smad complexes 
target specific genes for transcriptional activation or repression via their direct recruitment of 
transcriptional co-activators or co-repressors to the regulatory regions of target genes.   
Smads activate transcription often through the recruitment of general co-activators 
thought to be important for chromatin remodeling (Massague et al., 2005).  One instance where 
Smads activate gene expression is in Drosophila embryonic development where they are critical 
for mesodermal tinman induction.  A second example includes the wing where Mad binds to and 
is required for the activation of an enhancer within the vestigal gene used for pattern generation 
across the entire developing wing blade (Kim et al., 1997; Xu et al., 1998).    
Due to the fact that DNA binding site context can discriminate between transcriptional 
induction or inhibition, Mad and Med have also been shown to transcriptionally repress Dpp 
target gene expression in Drosophila through their recruitment of the zinc finger-containing 
repressor protein Schnurri (Pyrowolakis et al., 2004).  The determination of whether Mad and 
Med activate or repress transcription is based on the sequence and spacing between their binding 
sites, as discussed below.  One such target repressed by Dpp signaling in the developing wing 
imaginal disc is brinker (brk). 
1.12 DPP SIGNALING REGULATES BRINKER 
The brk gene was independently characterized as a modifier of Dpp signaling in three 
laboratories where it was found to function as a regulator of Dpp target genes (Campbell and 
Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 1999).  In the Drosophila wing 
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imaginal disc, the medial-to-lateral Dpp gradient present along the A/P axis was found to be 
complemented by a lateral-to-medial gradient of Brk (Campbell and Tomlinson, 1999).   
Several studies confirmed that Dpp signaling regulates brk.  High levels of brk are 
expressed by clones of mutant cells lacking the Dpp receptor Tkv; this is not dependent upon 
their location along the A/P axis indicating that in the absence of a Dpp expression gradient, brk 
expression would occur ubiquitously throughout the wing pouch (Jazwinska et al., 1999a).  
Consistent with the notion that brk is negatively regulated by Dpp, expression of an enhancer 
trap near the brk gene (with a reporter gene expression pattern identical to brk) was lost in wing 
discs ubiquitously expressing Dpp while dpp mutant discs demonstrated ubiquitous expression of 
the reporter (Campbell and Tomlinson, 1999). 
1.13 DPP REGULATES TARGETS INDIRECTLY THROUGH BRK REPRESSION 
In the Drosophila wing, Brk functions to repress the expression of Dpp target genes including sal 
and omb.  In brk mutants, the sal and omb expression domains are expanded laterally (Fig. 1-4).  
Ectopic expression of brk in the central region of the wing disc (where it is not normally 
expressed) results in a loss of both sal and omb expression (Campbell and Tomlinson, 1999; 
Jazwinska et al., 1999a; Muller et al., 2003).  These results indicate that the Brk protein must be 
either absent or expressed only at reduced levels for the expression of sal and omb.  This is 
indeed the situation in the middle of the wing disc where high levels of Dpp repress brk.  
Furthermore, the ectopic expression of Dpp target genes was induced when a brk mutation was 
combined with mutations that prevented the transduction of Dpp signaling suggesting that Brk 
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functions to inhibit the Dpp target genes directly (Bray, 1999; Campbell and Tomlinson, 1999; 
Jazwinska et al., 1999a).   
While Dpp seems to act via an indirect mechanism of target gene regulation (repressing 
brk that in turn represses targets), studies have also indicated that Dpp directly regulates (through 
Mad) some of its targets.  The sal gene encodes a zinc-finger protein that is involved in vein 
patterning and the growth of the adult wing (Kuhnlein et al., 1997).   While Dpp signaling 
appears to not be required for sal expression, brk mutant clones in lateral regions of wing discs 
exhibit lower levels of sal expression than those in the central region and a loss of both brk and 
mad in the central region results in a reduction in the expression level of sal (Campbell and 
Tomlinson, 1999).  Thus, maximal sal expression levels may require Dpp signaling.  Another 
target of Dpp signaling is the omb gene, which encodes a member of the T-box family of 
transcription factors and is repressed by Brk binding within its regulatory regions (Sivasankaran 
et al., 2000).  However, omb is also most likely directly activated by pMad, a component of the 
Dpp signaling pathway; upregulation of pMad expression antagonizes the ability of ectopic Brk 
to repress omb, lending support to the notion that pMad may activate omb while Brk is at the 
same time repressing it (Moser and Campbell, 2005). 
 31 
 Figure 1-4: Dpp target gene expression in wildtype and brk mutant discs. 
Figure adapted from Campbell and Tomlinson (1999).  Wildtype wing discs compared to those of a brkXA mutant.  
Note that brkXA mutant discs demonstrate an overgrowth phenotype along the A/P axis associated with the de-
regulation of Dpp target gene expression.  (A) sal expression (anti-sal) in a wildtype disc is confined to the medial 
portion of the disc.  (B) The sal expression domain is widened into the expanding wing pouch in the brkXA mutant 
disc.  (C) omb expression (UAS-GFP; omb-Gal4) in a wildtype disc is confined to the medial portion of the disc.  
(D) The omb expression domain is widened into the expanding wing pouch in the brkXA mutant disc.   
 
 
 
1.14 SENSITIVITY OF DPP TARGETS TO BRK 
While Dpp signaling induces the expression of its targets sal and omb, the brk expression 
gradient is necessary to organize the nested patterns of gene expression of these targets.  The sal 
expression domain is narrower than that of omb.  It appears that sal has a lower threshold than 
omb to repression by Brk leading to the differences in widths of the genes’ expression domains 
along the A/P axis of the wing imaginal disc (Fig. 1-5) (Campbell and Tomlinson, 1999; 
Jazwinska et al., 1999a; Minami et al., 1999).   
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Some mis-expression studies have supported the notion that sal and omb are differentially 
sensitive to Brk in that different levels of Brk can elicit distinct outputs of Dpp target gene 
expression (Moser and Campbell, 2005; Muller et al., 2003).  Some of the most likely 
mechanisms to explain differences in sensitivity of threshold responses to a transcription factor 
gradient relate to the number and affinity of binding sites in the response elements of target 
genes as well as the position of binding sites relative to a promoter (Hewitt et al., 1999; Ochoa-
Espinosa et al., 2005; Papatsenko and Levine, 2005). 
It is important to remember that brk is not the only gene or gene product that controls the 
expression of Dpp targets; they are themselves often activated or influenced by Dpp signaling 
through Smad complexes, as described in detail above. Therefore, Brk is not the only protein 
involved in their expression, although it appears to be the primary factor responsible for properly 
positioning their expression domains.   
The establishment of a brk expression gradient is significant in that Brk is required to 
repress Dpp target genes above distinct threshold levels of signaling.  Without exact gradient 
placement, sal and omb would not be expressed in their characteristic nested patterns of gene 
expression where more Brk is required to repress omb than is required to repress sal.  Without 
the proper regulation of expression domain placement of sal and omb, wing veins II and V are 
not properly developed thereby making the regulation of the brk expression gradient crucial for 
the establishment of target gene expression and thus adult wing structure and function (Campbell 
and Tomlinson, 1999).  While no brk gene has been identified in animals other than arthropods, 
there also does not appear to be an extracellular antagonist functioning to regulate BMP 
signaling during larval wing imaginal disc development in Drosophila.  These observations raise 
the possibility that brk may be important for wing patterning because it functions to regulate Dpp 
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signaling in the absence of a secreted antagonist.  The study of the brk expression gradient is 
significant in terms of all developmental biology in that it provides a model for the 
understanding of the establishment and usage of transcription factor gradients and BMP 
signaling to regulate spatial patterns of gene expression. 
 
 
 
 
Figure 1-5: Differential gene expression in the Drosophila wing by Dpp and Brk. 
dpp RNA is expressed in the center of the A/P axis of the wing disc.  Following secretion and diffusion of the 
protein, Dpp becomes distributed in a mediolateral gradient.  pMad is expressed in a complementary gradient.  Brk 
is expressed at high levels in the lateral-most regions of the disc and shows graded expression toward the center of 
the disc.  Dpp directly regulates this expression through pMad.  The Dpp target genes sal and omb are differentially 
expressed in a nested pattern where sal requires higher levels of Dpp than omb.  This model suggests that sal and 
omb are repressed by Brk and are differentially sensitive to it such that sal is repressed by lower levels of Brk than 
omb.   
 
 
 
1.15 MECHANISMS OF BRK REPRESSION 
The brk gene encodes a nuclear, 704 amino acid protein with a sequence-specific N-terminal 
helix-turn-helix (HTH) DNA binding motif (Fig. 1-6) (Campbell and Tomlinson, 1999).  It uses 
this domain to interact directly with the cis-regulatory elements of a number of Dpp target genes 
in order to repress their expression (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and 
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Bienz, 2001; Sivasankaran et al., 2000; Zhang et al., 2001).  DNA binding site selection and 
footprinting studies identified that Brk binds to multiple Dpp target genes via the sequence 
GGCGYY and helps to repress them in the absence of Dpp signaling, thus acting as a default 
repressor (Sivasankaran et al., 2000; Zhang et al., 2001).   
Target gene repression by Brk requires its DNA-binding domain (DBD) as well as a 
repression domain/motif that is responsible for recruiting co-repressor proteins (Winter and 
Campbell, 2004).  Different Brk target genes may be transcriptionally repressed by different 
mechanisms.  The cis-regulatory elements of the embryonic Brk targets zen and UbxB contain 
Brk binding sites that overlap with sites where Mad binds and functions to activate transcription 
(Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and Bienz, 2001; Winter and Campbell, 
2004).  While in vitro binding experiments demonstrated that Mad and Brk can compete for 
binding to those overlapping sequences, recent studies in the Campbell lab have indicated that 
Brk proteins containing only the DBD are insufficient for the repression of targets containing 
overlapping Brk and Mad binding sites (Winter and Campbell, 2004). 
There are at least three non-equivalent repression domains/motifs in Brk through which it 
exerts transcriptional repression: the Gro interaction motif (GiM), CtBP interaction motif (CiM), 
and 3R (Fig. 1-6) (Winter and Campbell, 2004).  The CiM and GiM recruit the corepressor 
proteins CtBP and Gro; loss of the CiM or GiM results in derepression of some Brk targets but 
not others, indicating that Brk might use different mechanisms and different domains/motifs to 
repress a variety of target genes (Hasson et al., 2001).  Repressive activity in the absence of 
CtBP and Gro is provided by 3R, a domain of the Brk protein located near the DBD (Winter and 
Campbell, 2004).  Experimental evidence suggests that all the domains/motifs contained within 
Brk are not equivalent.  For example, the cofactors CtBP and Gro are differentially required by 
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Brk to repress a subset of targets including sal while they are dispensable for the regulation of 
other genes like omb as indicated by the observation that 3R is sufficient for the repression of 
omb but not sal (Hasson et al., 2001; Winter and Campbell, 2004).  While it still remains unclear 
if Gro alone is sufficient for the repression of target genes by Brk, Brk may contain multiple 
domains/motifs so that it can repress different Dpp-responsive genes based on their response 
element context for both qualitative and quantitative purposes (Winter and Campbell, 2004). 
 
 
 
 
Figure 1-6: Schematic of the domains/motifs of the Brk protein. 
Figure adapted from Winter and Campbell (2004).  Domains/motifs in the 704 amino acid Brk protein included the 
DNA-binding domain (DBD) (green), the 3R repression motif (3R) (orange), the CtBP interaction motif (CiM) 
(purple), and the Groucho interaction motif (GiM) (red). 
 
 
 
1.16 THE BRK REGULATORY REGION HAS SEPARABLE ENHANCER AND 
REPRESSOR ACTIVITIES 
To understand the role played by Dpp in the generation of the brk expression gradient, the 
regulatory elements of the brk gene important for the regulation of its expression were analyzed 
by the Basler lab.  Putative brk regulatory fragments from genomic lambda phages were cloned 
into a lacZ reporter P-element vector and transgenic flies were evaluated to determine which 
regulatory regions were responsible for brk expression.  It was reported that a fragment, B14, 
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drives reporter gene expression in a pattern that recapitulates all aspects of late embryonic and 
larval brk expression (Muller et al., 2003).  B14 is a 4.7 kb response element fragment located 
about 5 kb upstream of the start of brk transcription and was found to be divisible into two 
separable elements: a ubiquitously active, constitutive enhancer portion and a regulated 
repression element (Muller et al., 2003). Creating an extensive collection of truncated reporter 
constructs narrowed down both the repressive and activating properties of the B14 response 
element.  The constitutive enhancer portion (for which the identity of the activator is not yet 
known) drives reporter gene expression ubiquitously in the wing disc while systematic point 
mutations throughout the repression element identified the basepairs essential for repressive 
activity leading to the conclusion that the repressive region, termed the brk silencer (S) element, 
is the minimal fragment necessary to direct repressive activity (Muller et al., 2003). 
The brk S can operate independently of the brk enhancer in that it can impose repression 
on heterologous enhancers active in wing discs; this activity is strictly dependent upon Dpp 
signaling as demonstrated in tkv mutant cells which autonomously lose repression activity and by 
the ability of the S to regulate embryonic enhancers as well as ß-gal reporter assays in 
Drosophila S2 cells (Muller et al., 2003; Pyrowolakis et al., 2004). It was also demonstrated that 
brk expression could be altered at any level of Dpp signaling by altering the copy number of 
silencers and enhancers; increasing the number of silencers results in a lateral shift of reporter 
gene expression while adding multiple copies of the constitutively active brk enhancer leads to 
more medial reporter gene expression (Muller et al., 2003).  
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1.17 A REPRESSIVE PROTEIN COMPLEX IS ASSEMBLED ON THE BRK 
SILENCER 
In Drosophila, Schnurri (Shn) is a large zinc-finger containing protein that interacts with pMad 
and Med in response to Dpp signaling (Muller et al., 2003; Pyrowolakis et al., 2004; Yao et al., 
2006).  The brk S assembles a pMad/Med/Shn (MMS) complex, where pMad and Med bind 
directly to the silencer element and then recruit Shn; this complex functions in vivo in a single 
copy (Fig. 1-7) (Muller et al., 2003; Pyrowolakis et al., 2004).  Evidence for this observation 
consisted of electrophoretic mobility shift assays (EMSAs) of the brk S DNA using S2 cells 
lysates transfected with Mad, Med, and/or Shn containing plasmids.  TkvQD, a constitutively 
active receptor in the Dpp signaling pathway, was also expressed in the cells in order to activate 
the Dpp signaling pathway (Raftery and Sutherland, 1999).  A protein/DNA complex was 
formed upon transfection of Mad alone, however, a more prominent complex was observed upon 
co-transfection of Mad and Med (Muller et al., 2003).  When Shn was transfected alone or with 
only Mad or Med, no protein/DNA complex was formed; however, when Shn was transfected 
with Mad and Med, a protein/DNA complex of slower mobility than either Mad or Med alone 
was established indicating that Mad and Med recruited Shn to the brk S (Muller et al., 2003).  
The molecular composition of the complexes was confirmed by supershift analysis with 
antibodies directed against the tags on the co-transfected MMS complex members. 
The DNA sequence and spacing between binding sites necessary for the establishment of 
the MMS complex on the brk S has been well characterized through EMSA probe sequence 
mutation and subsequent binding studies with MMS complex members to be 
GRCGNCN(5)GTCTG (Gao and Laughon, 2006; Pyrowolakis et al., 2004). The brk S is bound 
by a heterotrimeric complex containing two Mad subunits (which bind to the GRCGNC 
 38 
sequence) and one Med subunit (which binds to the GTCTG sequence) where all three subunits 
contributed directly to sequence-specific DNA contact through their MH1 domains (Fig 1-8) 
(Gao et al., 2005). Strikingly, Shn was found to need any five basepairs of sequence between the 
Mad and Med binding sites; any alteration (i.e. addition or removal of a base) results in a loss of 
Shn recruitment to the complex and a loss of repression when transgenes are analyzed in wing 
discs (Fig. 1-8) (Muller et al., 2003; Pyrowolakis et al., 2004). This indicates that the spacing 
between the Mad and Med sites is crucial for Shn recruitment and subsequent repression by the 
MMS complex as was confirmed by experiments that demonstrated minor alterations in 
sequence or spacing of binding sites can result in Dpp-responsive transcriptional activation 
instead of repression due to the failure of Shn recruitment to the MMS complex (Gao et al., 
2005).   
Shn confers transcriptional repressive activity to the MMS complex by acting as a co-
repressor mediating Dpp-dependent repression of brk (Gao et al., 2005; Muller et al., 2003).  The 
MMS complex is established in genes repressed, not activated, by Dpp signaling because Shn, 
which appears to act as a co-repressor, is only recruited to silencers in the presence of 
pMad/Med.   brk is not repressed when the brk S is missing or mutated, Dpp input is prevented, 
or when the C-terminal zinc fingers of Shn are deleted/mutated; similarly, the formation of the 
MMS complex is dependent upon these same requirements (Pyrowolakis et al., 2004).  It is 
believed that the brk S controls the establishment of the brk expression gradient by assembling 
the MMS multiprotein complex; however, it is unclear if the MMS complex is the only input 
necessary for the establishment of the Brk expression gradient; this will be a focus of my work in 
this dissertation.   
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In contrast to brk, shn-related genes have been identified in other animals and serve 
important roles in cell regulation; both Drosophila Shn and hShn1 from humans mediate Dpp-
dependent repression of Drosophila Dpp-responsive silencers (Yao et al., 2006).  In vertebrate 
cells, however, a BMP-responsive element is acted on in a positive manner by both Shn and 
hShn1 (Yao et al., 2006).  These results seem to indicate that complexes formed between Shn 
and Smads may function differently in vertebrates and Drosophila, perhaps in context-dependent 
manners through the recruitment of positively or negatively acting co-factors. 
 
 
 
 
Figure 1-7: Model of regulation of gene expression by Dpp and Brk in the Drosophila wing. 
(A) In the absence of Dpp signaling, the R-Smad, Mad, and the Co-Smad, Med remain in the cytoplasm allowing 
high-level expression of brk under the control of a yet unidentified activator, Act-B.  Brk protein binds at the 
response elements of Dpp target genes repressing their expression.  (B) In the presence of Dpp signaling, Mad is 
recruited to the activated receptors where it is phosphorylated and thus translocates to the nucleus with Med where it 
binds response elements in the brk gene and, in combination with Shn, represses the expression of brk.  The absence 
of Brk allows the transcriptional activation of Dpp targets by tissue specific transcriptional activators, sometimes 
Mad and Med themselves.  (C) In the absence of Dpp and Brk, Dpp targets are expressed due to the sufficiency of 
their tissue specific activators.  
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 Figure 1-8: Model of the MMS complex bound to the brk S. 
Figure adapted from Gao et. al (2005).  The Mad/Med heterotrimer appears to consist of two Mad MH1 domains 
contacting the brk S DNA at the GRCGNC sequence and one Med MH1 domain contacting DNA at the GTCT 
sequence.  The MH2 domains are thought to interact and contribute to the formation of the heterotrimer.  Shn is 
recruited to the five basepairs of DNA between the Mad and Med binding site and is shown to contact the Mad and 
Med MH1 domains because it is not recruited in the absence of these proteins.  
 
 
  
1.17.1 Key differences exist between activation and repression by pMad 
The key factor in the determination of whether the binding sites will activate or repress 
transcription is based on the binding site position—binding sites with five basepairs of sequence 
between them will recruit Shn while those spaced closer or further away will not (Muller et al., 
2003; Pyrowolakis et al., 2004).  Thus, it is important to distinguish the repressive MMS 
complex-forming Mad and Med binding sites from those where Mad and Med act as 
transcriptional activators.   Activating Mad binding sites are typically G/C rich and are difficult 
to identify because pMad is not a terribly efficient DNA-binding protein; nevertheless, the 
binding sites often contain a GCCGnCGC motif (Kim et al., 1997; Massague et al., 2005; Xu et 
al., 1998). Therefore, the Dpp signaling pathway appears to split into two major branches in the 
nucleus downstream of the activated nuclear pMad/Med complex: a branch involved in brk 
 41 
repression that is Shn-dependent and a Shn-independent branch involved in the activation of 
gene expression. 
1.18 DPP-RESPONSIVE SILENCER ELEMENTS 
When the consensus sequence for the MMS complex is used to scan the Drosophila genome, 
about 350 putative silencers can be identified (Pyrowolakis et al., 2004).  Functional MMS 
complex-dependent silencers can be found not only in brk, but also in other Drosophila genes 
repressed by Dpp signaling; thus, the brk repression element as well as these other silencers can 
be categorized as Dpp-responsive silencer elements (Pyrowolakis et al., 2004).  
One Dpp-responsive S identified by genome searches is located in the 5’untranslated 
region of bag of marbles (bam), a gene that encodes the key regulator determining asymmetric 
division of the Drosophila germline stem cell (Chen and McKearin, 2003a).  bam transcription is 
specifically repressed in germline stem cells by Dpp signaling through a transcriptional S 
element to which pMad and Med have previously been shown to bind (Chen and McKearin, 
2003a; Chen and McKearin, 2003b).  Sequence similarity between the bam S and brk S 
suggested both recruited Shn; this was confirmed by gel shift analysis conducted in the Basler 
lab (Muller et al., 2003).  Additionally, substitution of the brk S with the bam S along with the 
brk enhancer and lacZ resulted in a reporter gene expression pattern identical to that achieved 
when using the brk S (Muller et al., 2003).   Therefore, Dpp represses the transcription of genes 
other than brk directly by utilizing Shn and the formation of the MMS complex. 
When sequence alignments were conducted, all the conditions described above to be 
important for MMS complex formation and subsequent repression were shared between the brk 
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S and bam S.  The brk gene was found to contain a total of ten silencers, most likely because brk 
requires an S near each of the different enhancers required to drive expression in various tissues 
or because the interpretation of the Dpp gradient might require a combinatorial activity of several 
silencer elements (Pyrowolakis et al., 2004; Yao et al., 2008).   
1.19 THESIS AIMS 
The primary goal of my project was to understand how a brk expression gradient is established 
from a complementary gradient of BMP signaling and how it is then used to generate spatial 
patterns of gene expression.  The preceding introduction has illustrated the importance of 
transcription factor gradients due to the ability of these gradients to repress different targets 
above distinct thresholds, thereby allowing targets to be expressed at different positions along an 
axis to control differentiation of specific cell types in these positions.   
This project began from unpublished, preliminary studies that suggested Brk acts as a 
transcriptional repressor to negatively autoregulate its expression (see Chapter 2).  I set out to 
understand how this negative autoregulation occurs.  Does Brk repress its own expression by 
binding putative Brk binding sites in its own regulatory regions?  Does it work through the 
silencer or enhancer portion of its regulatory element?  Does it interact with other proteins 
previously described to control Brk (e.g. the MMS complex) to exert transcriptional repression 
upon itself?   
I also sought to determine what response elements contribute to (are necessary for) 
graded brk expression.  Initial studies published by the Basler lab, as discussed above, presented 
a response element that drove a reporter gene in a pattern similar to brk; however, its expression 
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could not exactly recapitulate endogenous brk expression (Muller et al., 2003).  I determined that 
this response element failed to rescue a brk mutant, thus confirming the imprecise nature of the 
reconstituted response element expression.  Therefore, I sought to determine what other response 
elements and recruited transcription factors were necessary to establish a proper brk expression 
gradient. 
The studies I have performed have added two additional requirements for the 
establishment of the brk expression gradient.  While it was previously thought that one positive 
input (activation by a yet unidentified activator at the enhancer) and one negative input 
(repression by the MMS complex on the brk S) created graded brk expression, my studies 
demonstrated that additional negative and positive influences are necessary.  This information 
greatly contributes to the understanding of how the brk expression gradient is established in the 
correct location so that it can properly generate spatial patterns of gene expression that are 
required for proper embryo/tissue morphogenesis. 
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2.0  GENERATION OF THE BRK EXPRESSION GRADIENT REQUIRES BRK TO 
NEGATIVELY AUTOREGULATE 
2.1 INTRODUCTION 
2.1.1 Comparison of brk expression to that of pMad and downstream targets sal and omb 
Previous studies demonstrated brk is expressed in lateral-to-medial gradients in the anterior and 
posterior halves of the wing pouch (Campbell and Tomlinson, 1999; Jazwinska et al., 1999b; 
Minami et al., 1999; Muller et al., 2003).  Initially we re-examined the brk expression gradient in 
more detail and compared it to that of pMad, which is directly responsible for its establishment 
(Muller et al., 2003), and to downstream targets sal and omb, which are directly regulated by Brk 
(Barrio and de Celis, 2004; Sivasankaran et al., 2000).  Brk expression was monitored using 
either a Brk-specific antibody (anti-brk), or with the enhancer trap, brkXA (with anti-ßgal); both 
demonstrated graded expression in the wing pouch (Fig. 2-1 A).  pMad expression was revealed 
using an antibody against the phosphorylated form and antibody staining was clearly graded 
from the medial peaks in the A and P compartments, but the gradient was fairly sharp and levels 
drop to background quite rapidly so that antibody staining appeared at this background level over 
most of the region where brk expression was graded (Fig. 2-1 Bii).  Note that this reflects the 
limits of our ability to detect physiological levels of pMad with the antibody because genetic 
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studies demonstrated that pMad is required to repress brk even in the regions where pMad levels 
detected with the antibody are at background levels (Campbell and Tomlinson, 1999).  However, 
this suggested that relatively low levels of pMad are sufficient to repress brk. 
Closer examination revealed a slight difference in the gradient profile of the anti-brk 
staining compared to that of the enhancer trap, with the latter gradient being shifted more medial 
than the former (Fig. 2-1 A).  This could be explained by a number of reasons: first, there may 
have been a real difference in brk RNA versus protein expression, second, the enhancer trap may 
not have faithfully reproduced brk expression, third, if the gradient was not static, perdurance of 
ß-gal protein may have accounted for this difference, or lastly, the most likely explanation, the 
ßgal antibody was simply more sensitive than the anti-brk antibody.  Whether these staining 
patterns actually reflected where brk is expressed can be judged by comparing them to where 
Brk is known to repress target genes, as described below.   
Two of the best-characterized targets of Brk are sal and omb, with the limits of sal 
expression being more medial than that of omb (Fig. 2-1 C) (Lecuit et al., 1996; Nellen et al., 
1996).  Loss of brk results in the expansion of both the sal and omb domains (Campbell and 
Tomlinson, 1999; Jazwinska et al., 1999a; Minami et al., 1999), so brk must be expressed in the 
cells immediately lateral to the sal expression domain.  Comparison of the brk enhancer trap 
staining with that of sal shows that in the anterior compartment, the edge of the sal expression 
domain coincides with the site at which ßgal expression is first detected (Fig. 2-1 C) and 
indicates this enhancer trap is probably a good reflection of where brk is actually expressed.  
Overall, these results strongly support the hypothesis that more Brk is required to repress omb 
than is required to repress sal (Moser and Campbell, 2005).   
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 Figure 2-1: Expression of brk and Brk target genes in wildtype wing discs. 
Figure published in Moser and Campbell (2005).  (A) Expression of brk revealed with a specific antibody (Ai; 
green) and a brk-lacZ enhancer trap (Aii; brkXA/+; red).  (Aiii) An intensity profile across the A/P axis (from left to 
right, averaging the region between the two horizontal lines in Aii centered on the dorsoventral boundary) shows the 
lateral-to-medial gradient of expression in the anterior and posterior halves of the wing pouch; there is a slight 
difference in the profile of the gradients revealed by the antibody and enhancer trap. (B) Comparison of brk 
expression (Bi; brkXA/+;  green) to that of pMad (Bii; red). (Biii) An intensity profile shows that although pMad was 
graded, at the levels of detection, this gradient does not extend significantly into the region where brk is graded.  (C) 
Comparison of brk-lacZ expression (Ci; brkXA/+; green) to that of Brk targets, sal (Cii, red) and omb (Ciii; blue).  
(Civ) Merge panel of (Ci), (Cii), and (Ciii).  The intensity profile (Cv) shows that there is little overlap between sal 
and brk in the anterior, but this is not the case in the posterior, suggesting sal is repressed above a higher threshold 
of Brk (indicated by the lines) in the posterior compared to the anterior.  (ßgal expression in brkXA, pMad, and sal 
expression were detected using specific antibodies; omb expression was detected using omb-Gal4; UAS-GFP). 
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2.1.2 Autoregulation by Brk is also important for brk expression 
The studies described above clearly demonstrated that a gradient of brk expression is essential 
for both maintaining the normal morphology of the wing disc and establishing nested patterns of 
gene expression along the A/P axis; they demonstrated that the extracellular Dpp protein gradient 
establishes the brk gradient by generating an intracellular gradient of pMad which, in 
combination with the co-Smad, Med, binds to silencer elements upstream of brk and recruits Shn 
to repress transcription (Muller et al., 2003; Pyrowolakis et al., 2004).  However, brk expression 
has also been suggested to be negatively regulated by Brk itself (Hasson et al., 2001) and the 
Campbell lab initially investigated the role Brk plays in establishing its own expression pattern 
by analyzing what happens to the brk expression gradient in the absence of Brk protein.  This 
was achieved initially by monitoring ßgal expression in the brkXA enhancer trap. 
The brk mutant, brkXA, has a lacZ P-element inserted just upstream of the transcription 
start site (Campbell and Tomlinson, 1999) and wing discs from brkXA mutant hemizygotes have a 
strong brk phenotype that is associated with markedly reduced levels of Brk protein (as described 
in Chapter 1).  In brkXA/+ heterozygous discs, ßgal expression is similar to that of Brk protein, 
showing a clear lateral-to-medial graded expression in the anterior and posterior halves of the 
wing pouch (Fig. 2-2A).  However, in brkXA mutant discs, although ßgal is still expressed, there 
is a dramatic alteration in both the level and pattern of expression compared to that in 
heterozygous discs; the general level of expression is increased (Fig. 2-2 D) (this was partly, but 
probably not entirely, due to dosage compensation as brk is located on the X chromosome).  
Although expression is still absent from the medial region of the wing disc, there is very little 
graded expression such that there is a fairly sharp boundary between cells expressing ßgal and 
those not (Fig. 2-2).  When compared to wildtype discs, it is apparent that the normal pattern of 
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no brk expression in the medial region, high levels in the lateral region, and graded levels in the 
mediolateral region is modified in the brk mutant discs to no expression in the medial region and 
high levels in both the mediolateral and lateral regions; in other words, the region that shows 
graded expression in wildtype discs has high levels of expression in the mutant (Fig. 2-2 C, F).  
One possible reason for this difference could be that pMad levels are modified in the mutant 
discs.  However, examination of pMad expression in the mutant discs revealed that there is no 
apparent difference compared to that in wildtype discs (Fig. 2-2 E, F).  This indicated that Brk is 
required to repress itself to generate the gradient of expression (Moser and Campbell, 2005). 
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Figure 2-2: The brk expression gradient is lost in a brk mutant. 
Figure adapted from Moser and Campbell (2005).  (A) Phenotypically wildtype disc from a brkXA/+ animal stained 
for ßgal expression.  (Bi) The same disc as (A) with the central region enlarged.  (Bii) The same disc as (Bi) stained 
for pMad expression.  (Biii) Merge of (Bi) and (Bii).  (C) Intensity profile of ßgal and pMad expression across the 
A/P axis in a brkXA/+ wildtype disc.  pMad is expressed in the central region of the disc and brk expression levels are 
high laterally while graded brk expression is found in the mediolateral region of the disc with expression absent 
medially.  (D) Hemizygous mutant brkXA disc stained for ßgal expression in parallel with the disc in (A) at the same 
magnification as the disc in (A).  The general levels of expression are clearly higher, expression extends more 
medially, and expression is not graded. (Ei) The same disc as (D) with the central region enlarged.  (Eii) The same 
disc as (Ei) stained for pMad expression.  (Eiii) Merge of (Ei) and (Eii).  (F) Intensity profile of ßgal and pMad 
expression across the A/P axis in brkXA mutant disc.  The graded brk expression demonstrated in (C) is lost in the 
mutant where there is a fairly sharp boundary between high levels of expression laterally/mediolaterally and no 
expression medially. 
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2.1.3 Aims of these studies 
This project began from preliminary studies that suggested Brk acts as a transcriptional repressor 
to negatively autoregulate its own expression (Hasson et al., 2001; Moser and Campbell, 2005).  
I set out to determine how this negative autoregulation occurs.  Did Brk repress its own 
expression by binding putative Brk binding sites in its own regulatory regions?  Did it work 
through the silencer or enhancer portion of its regulatory element?  Additionally, could it interact 
with other proteins previously described to control brk expression (e.g. the MMS complex) in 
order to exert transcriptional repression upon itself?   
2.2 MAD AND MED REGULATE BRK EXPRESSION 
Studies described above suggested that brk expression is dependent upon Brk autoregulation; a 
proper brk expression gradient is not formed in the absence of Brk repression (Moser and 
Campbell, 2005).  To test if pMad and Med are required to repress brk expression, pMad and 
Med mutant clones were generated and subsequent brk expression, as well as brk target gene 
expression, was analyzed.   
pMad and Med mutant clones were created in third instar wing discs (Fig. 2-3 Ai, Bi, Ci).  
When pMad and Med mutant clones were examined in the central and mediolateral portions of 
the wing disc (where both proteins are typically expressed), an upregulation of brk was observed 
(Fig. 2-3 Aii, Bii, Cii).  Therefore, pMad and Med are required to repress brk expression in the 
central and mediolateral regions of the wing disc.  pMad and Med mutant clones in lateral 
regions of the wing discs (where pMad and Med are typically not expressed) did not demonstrate 
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any effect on brk expression indicating that pMad and Med do not function to repress brk 
expression in the lateral most regions of the wing disc.  Further examination of brk mis-
expression in Med mutant clones in the central portion of the wing disc demonstrated that mis-
expression of Brk repressed sal and omb expression in the central portion of the wing disc where 
both sal and omb normally exhibit high levels of expression (Fig. 2-3 Biii, Ciii).   These results 
indicated that brk expression is dependent upon repression by pMad and Med in the mediolateral 
and medial regions of the wing disc. 
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Figure 2-3: Mad and Med are required to repress brk expression. 
(A) Mad mutant clones.  (Ai) Mad mutant clones are marked by a loss of GFP.  (Aii) brk expression is upregulated 
in mutant clones (anti-brk).  (Aiii) merge of (Ai) and (Aii).  (B) and (C) Med mutant clones.  (Bi) Med mutant 
clones are marked by a loss of GFP.  (Bii) brk expression is upregulated in mutant clones (anti-brk).  (Biii) sal 
expression (anti-sal) is absent in the medial region in mutant clones where Brk is mis-expressed.  (Biv) merge of 
(Bi), (Bii), and (Biii). (Ci) Med mutant clones are marked by a loss of GFP.  (Cii) brk expression is upregulated in 
mutant clones (anti-brk).  (Ciii) omb expression (omb-lacZ, anti-ßgal) is absent in the medial region in mutant clones 
where Brk is mis-expressed.  (Civ) merge of (Ci), (Cii), and (Ciii).   
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2.3 BRK AUTOREGULATES THE B14 & B315 RESPONSE ELEMENTS 
I previously presented evidence (in Section 2.1) that suggested Brk plays a role in establishing its 
own expression pattern by comparing ßgal expression of the brkXA enhancer trap in mutant 
hemizygotes and phenotypically wildtype heterozygotes.  Further evidence was obtained below 
through analyzing the expression of brk reporters in wing discs containing brk null mutant 
clones.  In this section, two previously published response elements, B14 and B315, were used to 
support the hypothesis (Muller et al., 2003). 
2.3.1 Brk autoregulates B14 in the wing disc 
The expression of the brk reporter B14X was examined in wing discs containing brk null mutant 
clones. Recall that the B14 genomic fragment possesses the Mad/Med/Shn (MMS) silencer 
element as well as an enhancer element and was demonstrated to drive lacZ expression in a 
pattern similar to that of the endogenous gene (Muller et al., 2003).  B14X is this B14 genomic 
fragment driving lacZ reporter gene expression and was obtained from the Basler lab (construct 
described in more detail in Chapter 3) (Muller et al., 2003). 
B14X expression was dramatically upregulated in brk null mutant clones located in the 
mediolateral and lateral regions of the wing disc, but B14X was not expressed in clones located 
in the medial regions (Fig. 2-4).  This indicated that Brk functions to repress B14X expression in 
the lateral and mediolateral regions of the wing disc but does not function in the medial region of 
the disc where pMad functions to repress brk expression.  Thus, the B14 response element is 
autoregulated by Brk (Moser and Campbell, 2005). 
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2.3.2 Brk represses B14 in the embryo 
To verify that the same autoregulation occurs in embryos, the B14 response element was utilized 
to drive a GFP reporter gene (B14B) and tested in embryos (construct described in more detail in 
Chapter 3).  B14B drove reporter gene expression in embryos ubiquitously, apart from the 
ventrolateral region where dpp is expressed; in this region, reporter gene expression was 
repressed (Fig. 2-4 E).  This expression is similar to that described previously for B14X and is 
expected based on what is known about dpp expression (Muller et al., 2003).  Our anti-brk 
antibody does not work on embryos, therefore, a UAS-Brk protein with a C-terminal HA tag 
(UAS-3PF3-HA) (Winter and Campbell, 2004) was driven with the engrailedGal4 (enG4) driver;  
this construct drove UAS-3PF3-HA in stripes consistent with enG4 expression (Fig. 2-4 F).  Upon 
examination of B14B expression in these embryos, ectopically expressed Brk was found to 
repress B14B expression (Fig. 2-4 G).  This result was also obtained for B14X (data not shown).  
These results indicated that Brk represses B14 in embryos, just as it does in wing imaginal discs 
(Section 2.3.1). 
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Figure 2-4: Brk represses/autoregulates the B14 response element. 
(Adapted from Moser and Campbell, 2005).  (A) Schematic diagram of the B14 response element located upstream 
of the start of brk transcription as well as the enhancer (E) and silencer (S) regions of which B14 is composed.  (B-
D) Brk loss of function clones demonstrate upregulation of B14X indicating Brk is required to repress B14X.  (Bi) 
brk null clones are marked by a loss of GFP.  (Bii) magnification of the region outlined in white in (Bi) where a 
lateral clone is marked in white, several mediolateral clones are marked in yellow, and a medial clone is marked in 
red.  (Ci) B14X expression demonstrates an upregulation of reporter gene expression in lateral brk null clones and in 
mediolateral clones but no upregulation of reporter gene expression in medial regions where pMad is sufficient for 
repression indicating that Brk autoregulates the B14X construct. (Cii) magnification of (Ci).  (Di) merge of panels 
(Bi) and (Ci).  (Dii) Magnification of (Di) where clones are marked as described in (Aii).  B14X expression is off in 
the medial clone but is upregulated in the mediolateral clone to levels similar to those laterally.  The lateral clones 
also demonstrate an upregulation of expression.  (E) Expression of the B14B reporter in wildtype embryo.  (F-H) 
Embryo where UAS-3PF3-HA (full-length wildtype Brk) is driven with the enG4 driver and B14B expression 
examined.  (F) UAS-3PF3-HA driven with the enG4 driver and detected with anti-HA.  (G) B14B expression 
(detected with GFP).  (Gi) B14B expression is repressed in the regions where UAS-3PF3-HA is driven (yellow 
arrowhead) indicating that Brk represses the B14B construct in the embryo, when compared to (E).  (Gii) 
Magnification of the region of (Fi) outlined in the box with repressed region indicated by yellow arrowhead.  (H) 
Merge panel of (F) and (Gi) where region repressed is marked with yellow arrowhead. 
 
 
 
2.3.3 Brk autoregulates B315 in the wing disc 
To examine if the B315 response element is also regulated by Brk (as is B14), B315X reporter 
gene expression was examined in brk null clones.  B315X is comprised of the S and E portions 
of the B14 genomic fragment driving lacZ reporter gene expression and was obtained from the 
Basler lab (construct described in more detail in Chapter 3) (Muller et al., 2003). 
B315X expression was dramatically upregulated in brk null mutant clones located in the 
lateral and portions of mediolateral clones of the wing disc (Fig. 2-5).  B315X was not 
upregulated in clones located in the medial regions (Fig. 2-5).  This indicated that Brk is 
functioning to repress B315X expression in the lateral and mediolateral regions of the wing disc 
but does not function in the medial region of the disc where pMad functions to repress brk 
expression.  B315X is not expressed in embryos most likely because it does not contain an 
embryonic enhancer element, so it was not tested for repression by Brk as described for B14 in 
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Section 2.3.2.  Altogether, these resulted indicated that the B315 response element is 
autoregulated by Brk. 
 
 
 
 
 
Figure 2-5: Brk represses/autoregulates the B315 response element. 
(A) Schematic diagram of the B14 and B315 response elements located upstream of the start of brk transcription.  
B315 consisted of two regions: 1) an enhancer (E) region and 2) the silencer (S) region.   (B-D) Brk loss of function 
clones demonstrate upregulation of B315X indicating Brk is required to repress B315X.  (Bi) brk null clones are 
marked by a loss of GFP.  (Bii) magnification of the region outlined in white in (Bi) where a lateral clone is marked 
in white, a mediolateral clone is marked in yellow, and a medial clone is marked in red.  (Ci) B315X expression 
demonstrates an upregulation of reporter gene expression in the lateral brk null clone and in portions of the 
mediolateral clone but no upregulation of reporter gene expression in medial regions where pMad is sufficient for 
repression indicating that Brk autoregulates the B315X construct.  (Cii) magnification of (Ci).  (Di) merge of panels 
(Bi) and (Ci).  (Dii) Magnification of (Di) where clones are marked as described in (Bii).  B315X expression is off 
in the medial clone but is upregulated in the lateral portion of the mediolateral clone to levels similar to that 
laterally.  The lateral clones also demonstrate an upregulation of expression. 
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2.4 BRK REQUIRES ITS DBD TO AUTOREGULATE 
As described earlier, the brk gene encodes a nuclear, 704 amino acid protein with a sequence-
specific N-terminal HTH DNA binding motif (Campbell and Tomlinson, 1999).  The DBD is 
used to interact directly with the cis-regulatory elements of a number of Dpp target genes, 
allowing Brk to repress their expression (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller 
and Bienz, 2001; Sivasankaran et al., 2000; Zhang et al., 2001).  DNA binding site selection and 
footprinting studies identified that Brk binds to many Dpp target genes via the sequence 
GGCGYY (Sivasankaran et al., 2000; Zhang et al., 2001).  Target gene repression by Brk 
requires its DBD as well as a repression domain/motif (Winter and Campbell, 2004). 
To begin to determine the mechanism utilized by Brk to autoregulate, we tested a brk 
DBD mutant for its ability to autoregulate.  brkF124 is an EMS point mutant with an amino acid 
substitution (R82W) in the recognition helix of its DNA binding domain; it was determined to 
have little or no repressive activity (Winter and Campbell, 2004).  brkF124 mutant clones were 
created in wing imaginal discs (Fig. 2-6).  The discs were stained with an anti-brk antibody that 
detected endogenous (wildtype) Brk as well as the mutant protein produced from the brkF124 
mutant.  Upon examination of anti-brk staining in brkF124 homozygous mutant clones, an 
upregulation of Brk was observed compared to the staining observed for nearby heterozygous 
tissue (Fig. 2-6 Aii).  This indicated that brkF124 homozygous mutant clones are not able to 
autoregulate Brk, thus leading to the over-expression detected with anti-brk compared to nearby 
heterozygous tissue.  This indicated that Brk needs its DBD to autoregulate. 
 59 
 
 
Figure 2-6: brkF124 homozygous mutant clones demonstrate Brk requires its DBD to autoregulate. 
(Ai) Anti-brk staining reveals staining from endogenous (wildtype) Brk as well as that of brkF124.  White box 
indicates region enlarged in (Aii) and (B).  (Aii) Mutant clone (outlined in white, white arrowhead) demonstrates an 
upregulation of Brk (detected with anti-brk) compared to the heterozygous tissue below it (yellow arrowhead) 
indicating that brkF124 fails to autoregulate in the mutant clones thereby indicating Brk requires its DBD for 
autoregulation.  (B) brkF124 homozygous mutant clones are marked by a loss of GFP. 
 
 
 
2.5 BRK MOST LIKELY DOES NOT INTERACT DIRECTLY WITH DNA TO 
AUTOREGULATE 
Because Brk appears to function as a transcriptional repressor that requires its DBD to 
autoregulate its own expression, several possibilities exist as to the mechanism(s) Brk may 
utilize to confer its autoregulatory inhibition.  One possibility is that Brk binds to cognate, well-
characterized Brk binding sites contained within its regulatory regions to repress its own 
expression.  A second possibility is that Brk utilizes its DBD to bind non-cognate sites on DNA 
to autoregulate.  A third possibility is that Brk interacts indirectly with DNA to autoregulate by 
associating with other proteins bound to DNA.  The ability of Brk to interact directly with DNA 
will be examined in this section. 
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2.5.1 Brk does not repress by binding cognate Brk binding sites 
Because Brk binds directly to the cis-regulatory elements of a number of Dpp target genes to 
repress their expression, it is possible that it uses its DBD to bind Brk binding sites in the brk 
regulatory regions to autoregulate (Kirkpatrick et al., 2001; Rushlow et al., 2001; Saller and 
Bienz, 2001; Sivasankaran et al., 2000; Zhang et al., 2001).  As mentioned previously, DNA 
binding site selection and footprinting studies identified that Brk binds to many Dpp target genes 
via the sequence GGCGYY in order to repress (Sivasankaran et al., 2000; Zhang et al., 2001).  
Therefore, the putative Brk binding sites consisting of the GGCGYY sequence were identified in 
the brk regulatory region and their positions indicated in or near the B14 and B315 response 
elements (Fig. 2-7).  The B14 response element possesses 15 cognate Brk binding sites between 
the silencer and enhancer (one of these sites is contained within the enhancer).  The B315 
response element consists of a 53bp silencer and an 860bp enhancer, which contains one Brk 
site. 
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Figure 2-7: Brk binding sites in the B14 and B315 response elements. 
Schematic diagram of the B14 (pink) and B315 (blue) response elements (Muller et al., 2003) and the nearby 
putative cognate Brk binding sites (blue lines above sequence) located upstream of the start of transcription.  B315 
consisted of two regions: 1) an enhancer (E) region, which alone drives reporter gene expression ubiquitously across 
the wing disc, and 2) the silencer (S) region, which, when combined with the E, drives reporter gene expression in a 
pattern very similar to B14.  B14B is the B14 response element that drives GFP reporter gene expression and B315X 
is the B315 response element that drives lacZ reporter gene expression. 
 
 
 
 Both the B14B and B315X constructs are autoregulated by Brk (Figs. 2-4 and 2-5).  Both 
constructs contain putative Brk binding sites.  B14B contains 15 sites where 7 are clustered.  
B315X contains one putative site that it shares with the 15th site in B14B.   
 To determine if Brk binds to one or more of the putative Brk binding sites contained 
within the B14B construct to autoregulate its expression, Brk mutant clones were created in the 
B14∆2M15B construct in wing discs.  The B14∆2M15B construct contains B14B, except its first 
14 Brk binding sites are removed and the 15th site is mutated (Fig. 2-8 A).  Therefore, an 
upregulation of B14∆2M15B reporter gene expression in brk mutant clones would indicate that 
the construct is autoregulated by Brk even though no cognate Brk binding sites are contained 
within the construct.  Upon examination of B14∆2M15B reporter gene expression in wing discs 
containing brk null mutant clones, an upregulation of reporter gene expression was observed 
indicating that Brk can autoregulate the B14∆2M15B construct in wing discs even though it 
contains no cognate Brk binding sites (Fig. 2-8 B).  
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Figure 2-8: B142M15B contains no cognate Brk binding sites but is autoregulated by Brk. 
 (A) Schematic of the brk genomic region and the B14∆2M15B construct.  Blue lines above the sequence indicate 
putative Brk binding sites.  (B) Brk autoregulates the B14∆2M15B construct in wing discs.  (Bi) Brk null mutant 
clones are marked by a loss of lacZ (anti-ßgal, red).  (Bii) B14∆2M15B (GFP) is upregulated in brk mutant clones 
indicating that the B14∆2M15B construct is regulated by Brk.  (Biii) Merge panel of (Bi) and (Bii). 
 
 
 
To determine if Brk binds the one putative Brk binding sites contained within the B315X 
construct to autoregulate its expression, Brk mutant clones were created in the B315M15X 
construct in wing discs.  The B315M15X construct contains B315X, except that its only putative 
Brk binding site is mutated (Fig. 2-9 A).  Therefore, an upregulation of B315M15X reporter gene 
expression in brk mutant clones would indicate that the construct is autoregulated by Brk.  Upon 
examination of B315M15X reporter gene expression in wing discs containing brk null mutant 
clones, an upregulation of reporter gene expression was observed indicating that Brk 
autoregulates the B315M15X construct in wing discs even though it contains no cognate Brk 
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binding sites (Fig. 2-9 B).  B315X and B315M15X are not expressed in embryos, so this study 
was not confirmed in embryonic assays. 
 
 
 
 
 
Figure 2-9: B315M15X contains no cognate Brk binding sites but is autoregulated by Brk. 
(A) Schematic of the brk genomic region and the B315M15X construct.  Blue lines above the sequence indicate 
putative Brk binding sites.  (B) Brk autoregulates the B315M15X construct in wing discs.  (Bi) Brk null mutant 
clones are marked by a loss of GFP( green).  (Bii) B315M15X (anti-ßgal, red) is upregulated in brk mutant clones 
indicating that the B315M15X construct is regulated by Brk.  (Biii) Merge panel of (Bi) and (Bii).   
 
 
 
Altogether, the results obtained for the B14∆2M15B and B315M15X constructs indicated 
that the while both of these constructs contain no cognate Brk binding sites, they are both 
autoregulated by Brk.  Therefore, Brk can autoregulate independently of binding its own cognate 
Brk binding sites on DNA. 
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2.6 BRK APPEARS TO FUNCTION AT THE SILENCER TO NEGATIVELY 
AUTOREGULATE     
For Brk to autoregulate the B14 and B315 response elements (Figs. 2-4 and 2-5), it must act on 
some portion of the response elements.  To determine if Brk functions to autoregulate through 
the S or E portions of the B14 and B315 response elements, a construct was created and its 
reporter gene expression analyzed in brk mutant clones (Fig. 2-10 A).  The expression of dpp 
within the wing disc is controlled by an enhancer, dpp E; therefore, combination of the dpp E 
with the brk S created the construct dppE-brkS.  This construct drove reporter gene expression in 
the lateral regions of the disc (Fig. 2-10 B) whereas the dppE alone drives ubiquitous expression 
in the wing pouch, much like the brk E alone (Muller et al., 2003).  It should be noted that the 
dppE, which drives expression throughout much of the wing disc, is not expressed like the 
endogenous dpp gene as the dppE is a minimal enhancer, not the entire collection of response 
elements necessary to drive dpp expression.  When brk homozygous mutant clones were created 
and dppE-brkS reporter gene expression analyzed, the dppE-brkS construct was upregulated in 
mutant clones indicating that it is autoregulated by Brk (Fig. 2-10 C).   
Both the brkS-brkE (B315X) construct as well as the dppE-brkS construct were shown to 
be autoregulated by Brk, even though they contained different enhancers (dppE and brkE).  The 
dppE contains no Brk binding sites and has no sequence similarity to the brkE.  Additionally, the 
brk S contains no Brk binding sites and the brk S in combination with the brk E (which contains 
one Brk site) is still autoregulated when its only Brk binding site is mutated (B315M15X) 
(Figure 2-9).  It appears that Brk autoregulates through the S; this autoregulation may occur by 
Brk binding to non-cognate sites on DNA (as the S contains no Brk sites) or by indirectly 
binding DNA.   
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Figure 2-10: Brk appears to autoregulate through the S. 
 (A) Schematic of the brk genomic region, the B14 and B315 response elements, and the constructs created.  Blue 
lines above the sequence indicate cognate Brk binding sites.  (B) dppE-brkS lacZ expression (anti-ßgal, red).  (C) 
brk null mutant clones in dppE-brkE indicate that dppE-brkS is autoregulated by Brk.  (Ci) brk homozygous mutant 
clones marked by a loss of GFP (green).  (Cii) dppE-brkS lacZ reporter gene expression (anti-ßgal, red).  White 
arrowhead indicates an upregulation of expression in a brk mutant clone.  (Ciii) Merge panel of (Ci) and (Cii).  (D) 
brkE-bamS lacZ expression (anti-ßgal, red).  (E) brk null mutant clones in brkE-bamS indicate that brkE-bamS is 
autoregulated by Brk.  (Ei) brk homozygous mutant clones marked by a loss of GFP (green).  (Eii) brkE-bamS lacZ 
reporter gene expression (anti-ßgal, red).  White arrowhead indicates an upregulation of expression in a brk mutant 
clone.  (Eiii) Merge panel of (Ei) and (Eii). 
 
 
 
2.7 BRK AUTOREGULATES BY INTERACTING WITH pMAD AS PART OF THE 
MMS COMPLEX 
The evidence I have presented above suggests that Brk autoregulates through the silencer.  
Several possibilities exist to describe how Brk autoregulates at the S.  One possibility is that Brk 
binds to the S even though this element contains no standard Brk binding sites.  Initial EMSA 
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studies with a bacterially expressed GST-fusion of the Brk N-terminus (first 101 amino acids, 
including the DNA binding domain) suggested that any binding is very weak, but the interaction 
is not well characterized and it is unclear if the Brk fusion protein containing the DNA binding 
domain would bind to any sequence non-specifically (data not shown).  Studies of this nature are 
typically conducted using enriched S2 cell lysates on EMSAs; therefore, this study awaits further 
evaluation.   
A second possibility, which cannot be ruled out, is that Brk represses an activator of 
another transcriptional repressor (that in turn represses Brk) in order to autoregulate.  This 
activator would have to act at the S (as Brk autoregulation occurs through this element) and 
interact with the MMS complex thus making it highly coincidental if this scenario is the true 
mechanism of Brk autoregulation.  Chromatin IP experiments (described in section 2.9) will 
address this possibility.  If ChIP indicates Brk is present at the S, then this possibility will be 
ruled out. 
A third more likely possibility is that Brk autoregulates at the S by interacting with other 
proteins known to function at the S, specifically members of the MMS complex. The MMS 
complex is formed when pMad and Med bind directly to the S of brk and then recruit Shn 
(Muller et al., 2003; Pyrowolakis et al., 2004). brk is not repressed when (1) the brk S is missing 
or mutated,  (2) Dpp input is prevented, or (3) when the C-terminal zinc fingers of Shn are 
deleted/mutated; the formation of the MMS complex is dependent upon these same requirements 
(Pyrowolakis et al., 2004).  
If Brk interacts with the MMS complex in order to autoregulate, several predictions can 
be made and tested about this interaction.  (1) Brk autoregulation should be pMad dependent.  If 
pMad cannot function as a transcriptional repressor with the MMS complex, no Brk should be 
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present at the S and autoregulation should cease.  (2) Brk should interact with one or more of the 
component proteins of the MMS complex.  These predictions are tested below. 
2.7.1 Autoregulation by Brk is dependent on pMad activity 
If Brk autoregulates by interacting with the MMS complex at the S, the first prediction to be 
tested is that Brk autoregulation should be pMad dependent.  To demonstrate that pMad is 
necessary to repress brk expression in embryos as it is in discs (Fig. 2-3), studies were performed 
with an inhibitory Smad, UAS-Dad, driven at high levels with the enG4 system.  Recall that Dad 
is an I-Smad that acts antagonistically to pMad and Med (Schmierer and Hill, 2007; ten Dijke et 
al., 2000). 
Upon examination, the B14X reporter gene expression was expressed in almost all of the 
ectoderm of stage 11 embryos apart from its exclusion from a ventrolateral stripe where dpp is 
expressed at this stage (Fig. 2-11 A).  When UAS-Dad was ectopically expressed in stripes (Fig. 
2-11 B) (thus removing or significantly reducing pMad from those regions) across the embryo, 
B14X reporter gene expression was no longer repressed; in the ventrolateral region, it now 
extended through the stripes of UAS-Dad expression.  This indicated that pMad activity is 
necessary to repress the B14 response element, and thus Brk, as was previously demonstrated in 
discs (Fig. 2-11 B-D).   
As shown above, ectopically driving UAS-3PF3-HA with enG4 in embryos repressed B14 
expression, indicating that ectopically driven Brk autoregulates the B14 response element (Fig. 
2-4 D-G).  To determine if pMad plays a role in this autoregulation of Brk, studies were carried 
out where UAS-Dad and UAS-3PF3-HA were driven with the enG4 system in combination.  If 
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Brk was no longer able to repress B14 when an I-Smad was over-expressed, it would indicate 
that Brk autoregulation is dependent upon pMad. 
Indeed when UAS-Dad and UAS-3PF3-HA were driven in the same embryo and B14X 
reporter gene expression assayed, it was determined that ectopically expressed Brk fails to 
repress B14 in the absence of pMad (Fig. 2-11 E-H).   This result is consistent with the notion 
that Brk on its own is not sufficient for autoregulation to occur and supports the hypothesis that 
Brk autoregulates by interacting with the MMS complex. 
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 Figure 2-11: Autoregulation by Brk is dependent upon pMad activity. 
 (A) Expression of B14X (anti-ßgal) in an embryo.  (B-D) The same embryo was utilized to show that pMad is 
necessary for brk repression. (B) UAS-Dad is driven with enG4UASGFP.  (Ci) B14X (anti-ßgal) expression extends 
into the stripes of expression where UAS-Dad is driven.  (Cii) Magnification of (Ci).  (D) Merge panel of (B) and 
(Ci).  (E-H) The same embryo was utilized to show that pMad is necessary for brk to autoregulate.  (E) UAS-Dad is 
driven with enG4UASGFP.  (F) UAS-3PF3-HA is driven with enG4UASGFP and detected with anti-HA (blue).  (Gi) 
B14X (anti-ßgal) expression extends into the stripes of expression where UAS-Dad is driven indicating ectopically 
expressed Brk cannot repress (as it did in the absence of the UAS-Dad transgene) without pMad.  (Gii) 
Magnification of (Gi).  (H) Merge panel of (E), (F), and (Gi). 
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2.7.2 Brk and pMad interact in vivo 
If Brk autoregulates by interacting with the MMS complex at the S, the second prediction to be 
tested is that Brk interacts with one or more of the components of the MMS complex. To test this 
hypothesis, I sought to: (1) confirm the expression of an in vitro translated Brk protein and (2) 
determine if pMad and Brk co-immunoprecipitate (co-IP) from enriched embryonic lysates. The 
embryonic lysates used in these studies were of the following genotype: .  
The UAS-3PF3-HA construct (Winter and Campbell, 2004) and the UAS-tkvQD construct were 
driven by enG4 and Myc-tagged Mad was ubiquitously expressed.  A constitutively active form 
of the tkv receptor (tkvQD) was also co-expressed because nuclear translocation of pMad and 
Med requires activation of the Dpp signal transduction cascade (Raftery and Sutherland, 1999).  
2.7.2.1 in vitro translated Brk protein immunoprecipitates with multiple antibodies 
To evaluate if the Brk protein could be immunoprecipitated, radiolabeled full-length Brk protein 
with a C-terminal HA tag (3PFT) was transcribed and translated in vitro using a rabbit 
reticulocyte system.  To confirm the later usage of multiple antibodies, this protein was then 
subjected to immunoprecipitation experiments using two anti-brk antibodies, two-anti-HA 
antibodies, one non-specific antibody control, and a no antibody control (Fig. 2-12).  3PFT was 
efficiently immunoprecipitated by both anti-brk antibodies as well as both anti-HA antibodies 
(Fig. 2-12 A).  As a control, radiolabeled Luciferase protein lysate was similarly treated.  
Luciferase was not immunoprecipitated by any of the antibodies (Fig. 2-12 B) indicating that the 
immunoprecipitations observed for 3PFT were specific to Brk. 
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 Figure 2-12: in vitro translated Brk immunoprecipitates with multiple antibodies. 
9% SDS-PAGE with radiolabeled full-length in vitro translated Brk with a C-terminal HA tag (3PFT).  (A) 3PFT 
immunoprecipitated with two anti-brk antibodies as well as with two anti-HA antibodies.  3PFT immunoprecipitated 
only very weakly with no antibody or with a non-specific (anti-MBP) antibody control.  (B) Luciferase control 
protein did not immunoprecipitate with either anti-brk antibody or with either anti-HA antibody. 
 
 
 
2.7.2.2 Western blot analysis of Brk with anti-HA and anti-brkR3 antibodies 
Experiments were conducted to test the ability of the anti-HA and anti-brk antibodies to detect 
Brk protein from embryonic lysates enriched for UAS-3PF3-HA protein.  Initially, the two anti-
HA antibodies were utilized as they are commercially available and quantities are not limiting.  
The anti-HA F-7 antibody was unable to detect Brk from 0.13 mg of Brk-enriched embryonic 
lysate while it was able to detect Slpr, a control HA-tagged protein, from only 30g of Slpr-
enriched embryonic lysate (Fig. 2-13 A).  Similar results were obtained for the anti-HA Y-11 
antibody (data not shown).  An anti-HA antibody detected Brk from an embryonic lysate 
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enriched for UAS-3PF3-HA when the sample was first enriched for UAS-3PF3-HA by 
immunoprecipitation, but even then, the band detected was very weak (Fig. 2-13 C).   
Because the anti-HA antibodies did not efficiently recognize the Brk protein in 
embryonic lysates, the anti-brk antibodies were examined by Western blot.  The anti-brkR3 
antibody recognized Brk protein at both wildtype levels as well as that enriched from the UAS-
3PF3-HA construct in embryos (Fig. 2-13 B).  The anti-brkM6 antibody failed to recognize the 
Brk protein on Western blot analysis (data not shown).  The anti-brkR3 antibody also recognized 
a large band above 250kDa that was thought to include a complex of the Brk protein with other 
proteins in the embryonic lysate that was not denatured (Dr. Jeffrey Brodsky, personal 
communication).   
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Figure 2-13: Western blot of Brk with anti-brkR3 and anti-HA. 
Embryonic lysate enriched for Brk is of the genotype: UAS-3PF3-HA/+; enG4/+; UAS-tkvQD/Ubiq-myc-Mad.  (A-B) 
Same blot stripped and re-probed.  (A) Western blot analysis of 30µg embryonic lysate enriched for a control HA-
tagged protein, Slpr (gift from Stronach lab) and 0.13mg embryonic lysate enriched for Brk with the anti-HA F-7 
antibody.  Slpr control protein is detected with this antibody but Brk protein is not.  (B) Same blot as (A). Western 
blot analysis with anti-brkR3.  Endogenous Brk is detected very weakly in the lane enriched (via the UAS-Gal4 
system) for Slpr control protein while an enrichment of UAS-3PF3-HA is detected in the lane enriched for Brk 
protein.  Upper band detected by the anti-brkR3 antibody is a complex of the Brk protein with other proteins in the 
lysate.  (C) Western blot with anti-HA F-7 of 0.13mg embryonic lysate enriched for Brk immunoprecipitated with 
the anti-HA F-7 antibody.  Input sample is very weakly recognized by the anti-HA F-7 antibody, but a faint band 
representing UAS-3PF3-HA is detected in the IP lane.  No band is detected for the mock IP (no antibody added). 
 
 
 
2.7.2.3 Western blot and IP analysis of Brk and Mad 
Molecular mass predictions for UAS-3PF3-HA predicted that the tagged protein should have a 
molecular mass of approximately 85kDa.  The endogenous protein and UAS-3FP3-HA protein 
from embryonic lysates as well as the 3PFT protein generated by in vitro transcription/translation 
all ran on SDS-PAGE at a molecular mass slightly above 100kDa.  This is consistent with other 
published results (Sivasankaran et al., 2000). 
To evaluate the ability of the anti-brkR3 and anti-mycHRP antibodies to 
immunoprecipitate Brk and myc-tagged Mad, embryonic lysates enriched for UAS-3PF3-HA 
and Ubiq-myc-Mad were prepared and boiled for 5 minutes in 1% SDS. The concentration of 
SDS was then reduced and the lysate immunoprecipitated and subsequently blotted with the anti-
brkR3 antibody or the anti-myc antibody.  Upon analysis, the UAS-3PF3-HA protein detected 
upon Western blot analysis of the immunoprecipitation reaction from embryonic lysates boiled in 
1% SDS indicated that the tagged Brk protein had a molecular mass slightly over 100kDa (Fig. 
2-14 A).  This result indicated that the anti-brkR3 antibody successfully immunoprecipitated and 
detected the Brk protein.   
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Molecular mass predictions for myc-tagged Mad predicted a protein of approximately 
60kDa and this was the mass of the protein detected upon Western blot analysis of 
immunoprecipitated myc-mad (Fig. 2-14 B).  This result indicated that the anti-mycHRP 
antibody successfully immunoprecipitated and detected the Brk protein. 
While only one band is recognized by the anti-brk antibody in input samples, three bands 
are recognized when the lysate is immunoprecipitated and blotted with the anti-brk antibody; one 
band is the same size as the input, while one band is slightly smaller and one band is slightly 
larger (Fig. 2-14 A).  One possible explanation could be that the protein in the IP that is slightly 
smaller than (un-tagged endogenous) Brk in the embryonic input lysate is a degradation product 
while the protein that is slightly larger in the IP than the protein observed in the embryonic input 
lysate is the HA-tagged version of Brk.  This could indicate that the protein most often found in 
the enriched embryonic lysate and detected with the anti-brk antibody is modified and does not 
contain its HA tag (the middle band).  This would explain the observation that the HA-tagged 
Brk protein is very difficult to blot with an anti-HA antibody.  If this were the case, it would be 
expected that any time HA-tagged Brk protein is recognized, it would be slightly larger on a blot 
than the endogenous protein recognized by the anti-brk antibody.  It appears that the small 
amount of HA-tagged Brk protein recognized upon IP and Western blotting with anti-HA is 
slightly larger than that observed when blotting with an anti-brk antibody (compare Fig. 2-13 B 
and C).  An alternative possible explanation for the three Brk protein bands could be that the Brk 
protein is post-translationally modified. 
Further experiments to confirm the identity of the Brk and myc-tagged Mad bands 
observed on Western blots would include performing IPs and Western blots on tissue from brk 
 76 
mutants (and blotting with anti-brk) and tissue not carrying the myc-tagged Mad construct (and 
blotting with anti-myc). 
 
 
 
 
Figure 2-14: Immunoprecipitation analysis of Brk and Mad from embryonic lysates treated with 1% SDS. 
9% SDS-PAGE.  Embryonic lysate was of the genotype: UAS-3PF3-HA/+; enG4/+; UAS-tkvQD/Ubiq-myc-Mad and 
was treated with 1% SDS before use (input and IP reactions). (A) Blot with anti-brkR3 of IP with anti-brkR3 
identifies Brk with a molecular mass just over 100kDa and that Brk immunoprecipitates with anti-brkR3.  Two 
volumes of IP reaction (10µL and 30µL) were run on the gel.  The three Brk proteins immunoprecipitated are 
labeled A, B, and C (see description Section 2.7.2.3).  Potentially un-denatured protein complex is as described in 
Fig. 2-13.  (B) Blot with anti-myc-HRP of IP with anti-myc identifies myc-tagged Mad with a molecular mass of 
approximately 60kDa and that Myc immunoprecipitates with anti-myc. Two volumes of IP reaction (10µL and 
30µL) were run on the gel.  Heavy and light chain antibodies are not recognized because the primary antibody is 
conjugate to HRP indicating no secondary antibody was utilized. 
 
 
 
2.7.2.4 Brk and Mad co-immunoprecipitate in vivo 
Because the studies described above support the hypothesis that Brk on its own is not sufficient 
for autoregulation and indicate that pMad activity is necessary for this repression, I sought to 
determine if Mad and Brk interact in vivo in embryonic lysates.  If so, immunoprecipitation with 
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an antibody directed against one of the proteins (or its tag) and subsequent Western blot analysis 
with an antibody directed against the other protein (or its tag) would result in a band on the blot. 
 Upon immunoprecipitation of the embryonic lysate with anti-myc, which recognized the 
myc-tagged Mad protein, and subsequent Western blot with anti-brkR3, a band was identified for 
Brk (Fig. 2-15).  This result indicated that Brk co-immunoprecipitates with myc-tagged Mad, 
thereby indicating that Mad and Brk interact in vivo. The complimentary experiment was then 
performed.  When the immunoprecipitations were performed to IP UAS-3PF3-HA with anti-
brkR3, anti-HA F-7, or anti- HA Y-11 and Western blot was then performed with anti-myc, no 
interaction was seen (data not shown).  This result does not necessarily indicate that the proteins 
do not interact, as it is most likely due to the poor/in-efficient ability of the anti-myc-HRP 
antibody to detect proteins on Western blot (as seen in Fig. 2-14 B).  In all, the ability of Brk and 
Mad to co-IP together indicates that the two proteins interact in vivo. 
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Figure 2-15: Brk and Mad co-IP in vivo. 
9% SDS-PAGE and subsequent Western blot analysis with anti-brkR3 antibody. Embryonic lysate is of the 
genotype: UAS-3PF3-HA/+; enG4/+; UAS-tkvQD/Ubiq-myc-Mad.  Anti-brkR3 detects the approximately 100kDa 
Brk protein (lane 1).  Immunoprecipitation with anti-myc and blot with anti-brkR3 detects the Brk protein indicating 
that Brk and myc-tagged Mad interact in vivo (lane 2).  Brk is not immunoprecipitated with a non-specific antibody 
(anti-MBP) (lane 3).  Brk protein is immunoprecipitated with anti-brkR3 (lane 4). 
 
 
 
2.7.3 MBP-pull down experiments indicated that Brk interacts in vitro directly with Mad 
and Med 
While the above described co-IP interactions confirm that Brk and Mad interacted in vivo, they 
do not indicate whether this interaction occurs directly or whether or not the interaction is 
dependent upon the presence of DNA.  To determine if Brk interacts directly with Mad and Med 
in vitro, Maltose binding protein pull-down (MBP-PD) experiments were performed.  
Radiolabeled, in vitro transcribed/translated, control protein (Luciferase) or full-length Brk 
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protein with a C-terminal HA tag (3PFT) were created and subjected to pull downs with MBP 
control protein, MBP-MadNL, or MBP-MedNL.  The MBP-Smad fusions consisted of the N-
terminal MH1 domain, which is believed to contact DNA, and the linker region, which is 
believed to interact with other proteins (Gao and Laughon, 2006). 
The results of the PD assay indicated that Brk interacts specifically with Mad and Med 
but not MBP alone (Fig. 2-16).  To determine which region of the Brk protein is responsible for 
its interactions with Mad and Med, a series of modified and C-terminally truncated Brk proteins 
were created (Fig. 2-16 A).  These proteins were radiolabeled, in vitro transcribed/translated, and 
subjected to MBP-PD analysis with the MBP, MBP-MadNL, and MBP-MedNL proteins. 
The first modified protein tested was RH2DT.  This modified Brk protein has the second 
recognition helix of its DNA binding domain deleted.  This construct was tested because 
evidence presented above suggests that Brk may require its DBD to autoregulate (Fig. 2-6).  It is 
possible that Brk requires its DBD to autoregulate because it utilizes this domain to interact with 
Mad.  Upon examination of the RH2DT protein in MBP-PD experiments, it was found to still 
interact with MBP-MadNL and MBP-MedNL indicating that Brk does not require its DBD for 
its interactions with Mad and Med.  This domain is most likely necessary for a different aspect of 
Brk autoregulation. 
To determine if the C-terminal region of Brk is responsible for its interactions with the 
Mad and Med proteins, C-terminal truncations of 3PFT were created and subjected to MBP-PD 
experiments.  Stop1T, Stop2T, and Stop3T were tested and seem to interact with MBP-MadNL 
and MBP-MedNL at levels comparable to those seen with Luciferase control protein.  These 
studies did not conclusively indicate whether or not the C-terminal region of Brk is required for 
its interactions with pMad and Med. 
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Because full-length Brk interacts with Mad and Med in the MBP-PD experiments, the 
interaction it possessed with each of these proteins appears to be direct.  It also appears that the 
interaction occurs independently of DNA in vitro (i.e. pMad does not need to bind DNA before it 
can bind to Brk).  Further modified Brk constructs would need to be examined to identify the 
domain/motif of Brk with which Mad and Med interact. 
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 Figure 2-16: Brk interacts directly with Mad and Med independently of DNA. 
Input run in each lane is 10% of the protein amount added to PD assay lanes.  (A) Schematic of the modified Brk 
proteins that were radiolabeled, in vitro transcribed/translated, and subjected to MBP-PD.  (B) Luciferase control 
protein does not interact with MBP and interacts only very weakly with MBP-MadNL and MBP-MedNL.  (C) 3PFT 
does not interact with MBP and interacts with both MBP-MadNL and MBP-MedNL.  (D) RH2DT does not interact 
with MBP and interacts with both MBP-MadNL and MBP-MedNL.  (E) Stop3T does not interact with MBP and 
interacts at low levels with both MBP-MadNL and MBP-MedNL.  (F) Stop2T does not interact with MBP and 
interacts at low levels with both MBP-MadNL and MBP-MedNL.  (G) Stop1T does not interact with MBP and 
interacts at low levels with both MBP-MadNL and MBP-MedNL. 
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2.8 CHIP STUDIES TO CONFIRM WHERE BRK ACTS ON B14 TO 
AUTOREGULATE 
To confirm that Brk autoregulates by acting at the S or to determine on what other response 
element region(s) of B14 Brk acts in order to autoregulate, chromatin immunoprecipitation 
(ChIP) experiments were carried out.  Because previous studies demonstrated that Brk 
autoregulates B14 in embryos (Fig. 2-4), ChIP studies were conducted utilizing chromatin from 
embryonic lysates of the following genotype:   Controls for the IP portion of 
the experiment included mock IPs (no antibody added) as well as IPs with embryonic lysates not 
enriched for the HA-tagged Brk protein (when IPs were conducted with anti-HA antibodies).  
Controls for the PCR portion of the experiment included negative control primers directed 
against DNA polymerase -180 and positive control primers directed against a portion of the 
UbxB regulatory region previously demonstrated to bind Brk in vitro (Saller and Bienz, 2001; 
Yamasaki and Nishida, 2006).  
2.8.1 Multiple HA and brk antibodies failed in ChIP studies 
Initially, antibodies directed against the C-terminal HA tag of the UAS-Brk construct were 
utilized in ChIP.  Both a mouse monoclonal and a rabbit polyclonal HA antibody were used in 
ChIP reactions with varied amounts of antibody and chromatin.  These experiments failed to 
indicate any enrichment of the tagged Brk protein at UbxB or brk (data not shown).   
 The experiment was then repeated with a third anti-HA antibody; however, this antibody 
was an IgG conjugate to a resin purchased from Santa Cruz Biotechnology.  The protocol 
followed for the ChIP was obtained from Marcie Warner in the Arndt lab and followed, but 
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again, these experiments failed to indicate any enrichment of the tagged Brk protein at UbxB or 
brk (data not shown). 
 Because the three anti-HA antibodies tested failed in ChIP experiments, I next attempted 
the experiments utilizing our anti-brk antibody.  The polyclonal rat anti-brkR3 antibody was 
tested in ChIP and failed to indicate an enrichment of tagged Brk; upon further analysis, the 
antibody was found to be contaminated with DNA; this result was confirmed by PCR using the 
antibody as a template.  Due to the lack of enough anti-brkR3 antibody for affinity purification, 
the anti-brkR3 antibody was then DNaseI treated in hopes of removing contaminating DNA.  
ChIP experiments with the DNaseI treated anti-brkR3 antibody failed to demonstrate any 
enrichment upon PCR analysis indicating that the dialysis conducted in attempts to remove the 
DNaseI enzyme from the antibody most likely failed (data not shown). 
2.8.2 Strategies for further ChIP experiments 
Based on the observations that the three anti-HA antibodies as well as the anti-brkR3 antibody 
failed to ChIP Brk, several strategies were attempted to create more reagents to use in the ChIP 
experiments in hopes of conducting a functional assay.   
(1) Two new UAS-Brk constructs were created: HA3PF3HAU contains both N- and C-
terminal HA tags while Flag3PF3HAU contains an N-terminal Flag tag and a C-terminal HA tag.  
Transformants were obtained for these constructs and enriched embryonic lysates will be created 
and tested. 
 (2) The same antigen used to create the anti-brkR3 antibody was injected into six animals 
in order to generate new anti-brk antibodies.  The purpose of these new antibodies was two-fold.  
First, they may function better for ChIP analysis than the previous anti-brk antibody.  Secondly, 
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enough antibody would be generated that I would be able to affinity purify the antibody in hopes 
of generating a cleaner antibody for ChIP experiments. 
 The six new anti-brk antibodies were tested via Western blot and anti-brkGP10 was 
determined to be the only antibody that could recognize the Brk protein in the enriched 
embryonic lysate (data not shown).  Therefore, this antibody was affinity purified (creating anti-
brkGP10AF) and then tested in ChIP experiments using varied amounts of chromatin as well as 
varied amounts of both anti-brkGP10 and anti-brkGP10AF.  The results of a representative 
experiment failed to indicate any enrichment of the Brk protein at UbxB or brk compared to a 
negative control region and to the mock (no antibody added) control (Fig. 2-17).  
 
 
 
 
Figure 2-17: Representative ChIP with anti-brk antibodies. 
Primer pairs utilized for PCR are indicated on the left.  Representative gel of PCR products obtained from ChIP with 
100L chromatin from enriched embryonic lysate.  Lane 1 is no DNA added PCR negative control. 1L purified 
chromatin was used in input PCR reaction.  For lanes 3-16, odd lanes had 1L purified chromatin added to PCR 
reaction whereas even lanes had 4L purified chromatin added to PCR reaction.  Indicated above the lanes is the 
antibody utilized as well as the volume of that antibody (1L, 3L, or 5L) utilized in the ChIP reaction. 
 85 
2.9 DISCUSSION 
When I joined the lab, preliminary studies suggested Brk acts as a transcriptional repressor to 
negatively autoregulate its own expression (Hasson et al., 2001; Moser and Campbell, 2005).  
The most convincing evidence in support of this hypothesis are the studies of the brkXA mutant.  
Wing discs from hemizoygotes have a strong brk phenotype that is associated with reduced 
levels of Brk protein.  Heterozygous brkXA discs have reporter gene expression in a pattern 
similar to that of Brk protein with a lateral-to-medial gradient of expression in the anterior and 
posterior halves of the wing pouch; however, brkXA mutant discs have a higher level of reporter 
gene expression that is still absent from the medial region of the disc but have very little graded 
expression such that there is as a sharp boundary between cells expressing the reporter versus 
non-expressing cells.  I was interested in determining how Brk negative autoregulation 
functioned in the generation of the brk expression gradient.  
2.9.1 Brk autoregulates through the S 
The ability of Brk to autoregulate the B14 and B315 response elements was evaluated through 
brk mutant clonal analysis.  It was determined that Brk autoregulates B14 and B315 in the wing 
disc and B14 in the embryo. These studies confirm that Brk represses its own response elements 
and therefore its own expression.  Brk does not bind its cognate Brk binding sites contained 
within the B14 and B315 response elements as the constructs B14∆2M15B and B315M15X 
contain no cognate Brk binding sites but are still autoregulated by Brk indicating that Brk most 
likely autoregulates by interacting indirectly with DNA. 
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I next sought to determine which portion of the B14 or B315 response elements were 
utilized by Brk for autoregulation.  To this end, I obtained several constructs from the Basler lab 
that combine different E and S elements and compared their reporter gene expression in brk 
mutant clones to B315, which consists of the brkE and brkS and is autoregulated by Brk 
(Pyrowolakis et al., 2004).  The dppE alone drives ubiquitous reporter gene expression in the 
wing pouch; upon combination with the brkS to create the construct dppE-brkS, expression is 
limited to the lateral regions of the disc (Pyrowolakis et al., 2004).  When brk mutant clones 
were created in the dppE-brkS construct and reporter gene expression analyzed, the construct 
was autoregulated by Brk.  The dppE and brkE share no common sequence similarity.  
Therefore, the common sequence element shared between dppE-brkS and B315 is the brkS 
indicating that Brk may autoregulate through the S.  Further experiments would be necessary to 
confirm this hypothesis—brk mutant clones would be created in the dppE and brkE alone to 
ensure that these constructs are not autoregulated by Brk.  While they share no common 
sequence similarity, it remains possible that they are repressed by Brk, perhaps in a situation 
where a yet-unknown activator requires Brk to repress at the E, though this possibility remains 
unlikely. 
2.9.2 Brk interacts in vivo with pMad to autoregulate  
Because the evidence described above suggested that Brk autoregulates through actions at the S, 
I sought to determine if Brk interacts with other proteins known to function as the S, specifically 
pMad, a member of the MMS complex recruited to the S and important for its function as a Dpp-
responsive silencer element.  If Brk autoregulates through members of the MMS complex, it 
 87 
would be expected that Brk autoregulation would be dependent upon pMad and that Brk should 
be able to interact with one or more components of the MMS complex. 
I demonstrated that autoregulation in embryos by Brk is dependent upon pMad activity.  
This result is consistent with the notion that Brk on its own is not sufficient for autoregulation 
and supports the hypothesis that it interacts with pMad in order to autoregulate.  In order to 
further test the hypothesis that Brk interacts with proteins found at the S, I first confirmed 
Western blot analysis of embryonic lysates enriched for UAS-3PF3-HA and Ubiq-myc-mad, 
then I sought to determine if the two proteins interact in vivo.  When the enriched embryonic 
lysate was subjected to immunoprecipitation with anti-myc and then blotted for anti-brk, it was 
determined that Brk and pMad interact in vivo in this embryonic lysate.  
2.9.3 Brk interacts in vitro with Mad and Med independently of DNA 
MBP-PD experiments were conducted to confirm that Brk and Mad interacted in vivo 
independently of DNA as well as in hopes of identifying the region of the Brk protein required 
for these interactions.  While Luciferase control protein interacts only very weakly with Mad and 
Med, full-length Brk interacts strongly with both Mad and Med.  We suspected the DBD was the 
region required for Brk to interact with pMad and Med as the brkF124 DBD mutant was unable to 
autoregulate in wing imaginal discs.  This was not the case, however, because the RH2DT 
construct interacts with Mad and Med even though the second recognition helix of the DBD was 
missing in this protein.  The DBD is most likely involved in an aspect of autoregulation outside 
of interactions with pMad and Med.  Additional N- and C-terminally truncated Brk constructs 
could be evaluated to determine the domain/motif of Brk responsible for its interactions with 
pMad and Med. 
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2.9.4 ChIP studies proved difficult in the identification of the region of B14 acted upon by 
Brk 
In order to determine what other portions of the brk B14 regulatory region Brk represses, ChIP 
experiments were commenced.  While these studies could not tell us if Brk acted directly on 
DNA to autoregulate or worked through binding partners, they would confirm where on B14 (or 
the entire brk upstream region) Brk acted.  A failure of these studies to identify a region could 
also indicate that Brk autoregulation occurs by Brk repressing an activator of another repressor 
that then acts on Brk.  This possibility, however, is unlikely as the unknown repressor would be 
predicted to function through the S.  Initial ChIP experiments were performed utilizing 
antibodies directed against the C-terminal HA tag carried by the Brk protein over-expressed in 
the embryonic lysates utilized in these studies.  Three different anti-HA antibodies failed to 
indicate Brk was bound more prevalently either at regions contained within B14 or the UbxB 
response element when compared to control PCR primer pairs.  This may be due to the fact that 
the anti-HA antibodies poorly recognize the tagged Brk protein via Western blot or may simply 
be due to the fact that the antibodies do not work well on ChIP.  An anti-brk antibody was 
attempted, but this also failed to indicate Brk was bound at regions contained within B14 or the 
Ubx B response element when compared to control PCR primer pairs.  
2.9.4.1 New constructs and antibodies generated for ChIP 
In attempts to successfully perform Brk ChIP analysis, (1) I created an N-terminally and C-
terminally HA tagged Brk protein and an N-terminally Flag and C-terminally HA tagged Brk 
protein to over-express in embryos utilized in ChIP studies, and  (2) I created six new antibodies 
and affinity purified one new anti-brk antibody generated in a guinea pig using the same antigen 
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as the anti-brk antibody (anti-brkR3) described above.  Because the C-terminal HA tag was not 
recognized on Western blot analysis and seemed to not be detected by the three anti-HA 
antibodies I tried on ChIP, I hoped that either the N-terminal HA or Flag tags would be more 
accessible and prove more useful for ChIP.   
The one new anti-brk antibody tested as well as the affinity-purified version of the same 
antibody failed to demonstrate an enrichment of Brk at B14.  While we generated six new 
antibodies, I only tested one.  The other five could also be tested in future ChIP experiments, 
though they were unable to detect Brk in embryonic lysates via Western blotting. 
2.9.4.2 A lack of controls contributed to ChIP failure 
Ultimately, I believe that many of the difficulties faced with the ChIP studies stemmed from the 
lack of a suitable positive control for use in the studies.  The failure of these experiments may 
indicate that the alternative mechanism of Brk autoregulation is functioning (Brk repressing an 
activator of an unknown transcriptional repressor of Brk); however, the ChIP experiments also 
failed to indicate an enrichment of Brk at UbxB, indicating that the controls for the experiment 
failed for reasons described below. 
We lacked a suitable region to utilize as a positive control for PCR.  zen and UbxB 
elements have been confirmed in vitro via EMSAs to be bound by Brk but never by ChIP.  While 
I utilized the UbxB response element as a positive control in my ChIP studies, UbxB is only 
expressed in a small proportion of cells in the embryo (Saller and Bienz, 2001).  Therefore, it is 
likely that it is difficult to detect Brk interactions at this element.  The only other control region 
Brk has been identified to repress was the zen promoter; Brk represses zen but zen is only 
expressed during hours 2-4 of embryonic development and attempts to obtain enough chromatin 
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from embryos in this early time point in development failed (Rushlow et al., 2001).  zen primers 
were not tested as control PCR primers for these reasons. 
2.9.4.3 Further ChIPs would utilize wing disc tissue in hopes of detecting interactions of 
Brk on B14 
The region of the embryo where UAS-3PF3-HA is driven with UAS-tkvQD and functions to 
repress B14 is only a very small proportion of the size of the entire embryo. We confirmed that 
Brk autoregulates in embryos (as in wing discs) in order to validate using enriched embryo 
extracts for ChIP and IP; indeed, IP experiments demonstrated that pMad and Brk interacted in 
vivo in embryos.  While attempts at ChIP were made with a large amount of chromatin to attempt 
to compensate for the fact that proportion of enG4 expressing cells was low and expression of 
UAS-Brk was driven at high levels, background signal remained too high.  These experiments 
could be repeated utilizing tissue from third-instar wing imaginal discs as the enG4 driver 
promotes high levels of expression in half of the wing disc.  Controls would include primers 
directed against regions of sal and omb previously characterized by our lab to be responsive to 
Brk repression (GC, unpublished results).  While large amounts of tissue would need to be 
dissected, it is possible that enough chromatin with the proper interactions may be isolated.   
Additionally, antibodies could be generated against a different antigen/region of the Brk protein 
in hopes that if the particular antigen we used is masked when Brk is bound to other proteins, 
other regions of Brk may be more accessible. 
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2.9.5 Brk negative autoregulation is key to establishing a gradient of brk expression 
I began these studies because I was interested in learning how the brk expression gradient is 
established.  Ultimately, the studies described above have demonstrated that the generation of the 
Brk expression gradient requires Brk to negatively autoregulate.  pMad and Med are also 
required to repress Brk, which does not seem to function by binding cognate Brk binding sites on 
DNA.  It appears likely that Brk functions to autoregulate by working at the S portion of the B14 
response element and may require its DBD for this autoregulation to occur.  Brk appears to 
autoregulate by functioning as a member of a protein complex with pMad.  
There are at least three reasons why brk negatively autoregulates, which will be discussed 
in more detail in Chapter 4.  First, Brk negative autoregulation may act as a feedback mechanism 
to ensure that the brk expression gradient is stable.  Second, pMad levels appear to be the same 
in the presence or absence of Brk, but mediolateral cells that are lacking Brk are unable to 
repress brk.  Brk may allow cells to repress brk and thereby respond to low levels of Dpp 
signaling.  Third, and most importantly, Brk negative autoregulation appears to be necessary in 
order to establish graded expression of brk from the pMad gradient, modulating the simple 
threshold response of brk to pMad (as demonstrated by examining the lacZ reporter gene 
expression in the brkXA mutant) to a continuous response creating a situation where the brk 
expression pattern is an equilibrium response to the amount of each input present at each position 
in the gradient.  Without Brk negative autoregulation, graded brk expression would not be 
achieved. 
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3.0  PROPER BRK GRADIENT PLACEMENT REQUIRES ACTIVATION BY pMAD 
AT A NEWLY-DEFINED SEQUENCE ELEMENT 
3.1 INTRODUCTION 
As described in detail above, the Basler lab set out to understand the role played by Dpp in the 
generation of the brk expression gradient by identifying the regulatory elements of the brk gene 
important for the regulation of its expression.  Recall that they identified B14 as a 4.7 kb 
response element fragment located about 5 kb upstream of the start of brk transcription (Muller 
et al., 2003).  Also as described in detail above, recall that B315 is a response element consisting 
only of the enhancer as well as a silencer from B14 (Muller et al., 2003). 
Also recall that pMad can function not only to repress the transcription of genes (as 
discussed above for its role at the brk S), but also to activate transcription of target genes based 
on its binding site context.  pMad can directly activate Dpp-dependent transcription of genes; the 
decision of activation or repression by pMad is determined by the Mad protein binding sites 
contained within the regulatory regions of Dpp-responsive genes where binding sites that are not 
oriented exactly five basepairs away from Med binding sites (and thus do not allow the 
recruitment of Shn and subsequent formation of the MMS complex) allow for activation of 
transcription (Certel et al., 2000; Kim et al., 1997). 
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3.1.1 Aims of these studies 
In addition to my goals of determining the mechanism by which Brk autoregulated (Chapter 2), I 
sought to determine what response elements contributed to defining the exact graded profile 
(both the position and slope) of brk expression.  This is important because Dpp target genes such 
as sal and omb are repressed by Brk and are differentially sensitive to the amount of Brk present 
in the gradient; without proper brk expression, target genes are not expressed properly.  Initial 
studies published by the Basler lab, as detailed in Chapter 1, presented a response element that 
drove a reporter gene in a pattern similar to brk; however, its expression could not recapitulate 
exactly brk expression (Muller et al., 2003).  Here I show that this response element fails to 
rescue a brk mutant therefore, I sought to and was successful in identifying other response 
elements and recruited transcription factors that are necessary to establish a proper brk 
expression gradient. 
3.2 B14 & B315 ARE NOT THE MINIMAL RESPONSE ELEMENTS REQUIRED 
FOR BRK EXPRESSION 
Initial studies published by the Basler lab utilized a series of enhancer-testing constructs 
composed of various upstream regions of brk to screen for response elements that drove a 
reporter gene in a pattern similar to brk (Muller et al., 2003).  However, our interpretation of the 
figures led us to believe that the reporters failed to recapitulate brk expression in two ways: 1) 
the reporter gene expression did not appear to extend as far medially across the A/P axis in the 
wing disc as our staining with an anti-brk antibody or enhancer trap and 2) the reporter gene 
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expression driven by the response elements was not graded like expression revealed with our 
anti-brk antibody or our enhancer trap, brkXA.  To test these observations, I obtained the 
previously published fly lines that consisted of B14, the minimal upstream response element 
published to drive reporter gene expression in a brk pattern, and B315, the fragments of B14 
containing only a short silencer and enhancer (Fig 3.1).   
 
 
 
 
Figure 3-1 : B14 and B315 response elements. 
Schematic representation of the B14 (pink) and B315 (blue) response elements (Muller et al., 2003), the brk 
transcription start site, and the insertion location of the brkXA mutant (Campbell and Tomlinson, 1999).  B315 
consists of two regions: 1) an enhancer (E) region, which alone drives reporter gene expression ubiquitously across 
the wing disc, and 2) the silencer (S) region, which, when combined with the E, drives reporter gene expression in a 
pattern very similar to B14 (Muller et al., 2003). 
 
 
 
Both the B14 and B315 response elements are in the vector pX27, which allows testing of 
the elements by examining the expression pattern of lacZ reporter utilized by this vector.  The 
B14 and B315 response elements driving the lacZ expression in the pX27 vector are identified as 
B14X and B315X, respectively.  I initially began my studies by repeating the X-gal staining 
published on B14 and B315, along with that of the P-element enhancer trap mutant brkXA which 
when heterozygous, as described in Chapter 2, drives lacZ in an identical expression gradient and 
pattern compared to endogenous brk.  These studies were undertaken to confirm our doubts that 
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the published spatial reporter gene expression actually differs from brk; however, the X-gal 
staining reaction in the published pictures may not have been allowed to proceed long enough to 
detect this type of expression. 
3.2.1 X-gal staining of B14X, B315X, and brkXA demonstrates that B14X & B315X fail to 
recapitulate endogenous brk expression 
While identifying graded X-gal staining is quite difficult when staining is observed at one time 
point, it is more obvious if staining is monitored both early when staining first appears as well as 
later.  If the staining exhibited is graded, then there is a medial shift in the expression domain of 
the staining in the later stained discs as compared to the discs stained for less time as staining 
becomes apparent in regions where expression is lower.  If there is little or no graded expression 
present, the two time points will appear to have similar staining patterns, with X-gal staining 
appearing to extend to the same medial region of the disc.  
X-gal staining B14X (two lines called B14X-A and B14X-B), B315X, and brkXA/+ wing 
imaginal discs for both 90 minutes as well as overnight at 37°C confirmed that the reporter gene 
staining in B14X-A, B14X-B, and B315X never extends as far into the mediolateral region of the 
A/P axis of the wing disc and is not graded like that of the brkXA-lacZ construct (Fig. 3-2).  brkXA 
exhibits graded X-gal staining as judged by the medial shift in expression from early to later 
staining time points (staining shifts from the white dashed lines in Fig. 3-2 to the red dashed 
lines).  B14X and B315X do not exhibit graded X-gal staining as they do not have a medial shift 
in expression from early to later staining time points (width of staining at 90 minutes and 
overnight are the same as judged by the white dashed lines in Fig. 3-2). 
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 Figure 3-2: X-gal staining of B14X, B315X, and brkXA demonstrates that B14X and B315X fail to recapitulate 
endogenous brk staining. 
X-gal staining at 90 minutes (top row) and overnight (bottom row) performed at 37ºC.  brkXA (first column) staining 
reveals staining extends more medially across the A/P axis of the wing imaginal disc following overnight staining 
(compare white dashed line and red dashed lines indicating the boundaries of staining).  Staining demonstrated by 
both lines of B14X (columns 2 and 3) and that of B315X (column 4) does not expand medially after overnight 
staining as indicated by the white dashed line identifying the boundaries of staining. 
 
 
 
3.2.2 Immunofluorescence confirms that B14X & B315X fail to recapitulate endogenous 
brk staining 
Because it is difficult to detect graded X-gal staining, studies were undertaken with anti-ßgal 
antibodies as antibody staining can clearly reveal graded expression that X-gal staining cannot. 
ßgal staining in brkXA heterozygotes previously demonstrated a graded expression pattern 
identical to that of staining with anti-brk antibodies (Chapter 2); therefore, staining with anti-ßgal 
(of brkXA) and anti-brk will be used interchangeably in the remainder of this document. To 
confirm that the expression patterns from B14X and B315X are not graded like that of brkXA, the 
 97 
ßgal produced from the reporter genes was visualized using an anti-ßgal antibody.  B14X, 
B315X, and brkXA heterozygotes were dissected, fixed, and third-instar wing imaginal discs were 
stained with anti-ßgal antibodies.  An intensity profile was constructed along the A/P axis close 
to the margin using NIH Object Image to compare the expression profiles of B14X, B315X, and 
brkXA/+ expression from comparably sized third-instar wing imaginal discs (Fig. 3-3).  B14X was 
found to drive reporter gene expression in a pattern that is not identical to brk expression; its 
expression does not extend as far medially toward the center of the disc as that of brkXA/+.  This 
appears to be largely due to the fact that the gradient in B14X is much more precipitous than the 
extended graded expression from brkXA.  B315X was also found to drive reporter gene expression 
a pattern that is not identical to brk expression; its expression appears to extend more medially 
toward the center of the disc than that of brkXA/+.  Curiously, in the anterior this appears to be 
because its expression is higher in the region where expression is graded, but the opposite is true 
in the posterior.  These observations confirmed our initial suspicions that neither the B14 nor 
B315 response elements appears to drive a reporter gene in the correct place/gradient as brk. 
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Figure 3-3: Immunofluorescence confirms that  B14X and B315X fail to recapitulate brk expression. 
Antibody staining B14X, B315X, and brkXA/heterozygotes with an anti-ßgal antibody.  While all three are different 
discs, everything possible was done to ensure that similar discs were utilized. (A) lacZ reporter gene expression.  
brkXA/+ expression has previously been demonstrated to be identical to staining with an anti-brk antibody (Chapter 
2).  Grey lines indicate the region utilized to generate the intensity profile in (B).  (B) Intensity profiles of B14X 
(red), brkXA (green), and B315X (blue) across the center of the wing imaginal discs, from left to right.  B14X appears 
to drive reporter gene expression in a pattern that extends less far medially than that of brk while B315X appears to 
drive reporter gene expression more medially than brk. 
 
 
 
3.3 VECTOR AND REPORTER GENE DIFFERENCES DO NOT EXPLAIN WHY 
B14 AND B315 DO NOT DRIVE REPORTER GENE EXPRESSION IDENTICALLY TO 
BRK 
Several possibilities could explain why B14 and B315 fail to drive reporter gene expression in a 
pattern identical to that of brk.  First, the pX27 vector may contain cryptic sequences that modify 
expression driven by B14.  Second, the nature of the promoter used to drive reporter gene 
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expression may be important; the pX27 vector used to test the B14X and B315X response 
element fragments uses a heterologous hsp70 minimal promoter.  There may be something 
specific to this promoter that interferes with its ability to drive a normal brk pattern, or there may 
be something unique about the endogenous brk promoter that is essential to drive the endogenous 
expression pattern.  Third, B14 may be missing additional essential cis-regulatory elements 
required to drive the normal pattern of brk expression.  These possibilities will be examined in 
the subsequent section.   
 To test the first and second possibilities, the B14 and/or B315 response element(s) were 
tested in different enhancer-testing vectors of which one utilized a different promoter (Table 3-
1). Also, upon examination of the hsp70 minimal promoter utilized by many vectors (including 
pX27), we found that putative Brk binding sites are present within the promoter.  These sites 
could recruit Brk to alter the reporter gene expression driven by the response elements.  To 
determine whether the vector and/or promoter was/were responsible for the inappropriate 
expression of the reporter from B14X and B315X, the B14 and B315 response elements were 
tested in vectors that (a) used a different promoter (C4PLZ), (b) did use a standard hsp70 
promoter but were constructed differently (pH-Pelican), or (c) which used an hsp70 promoter in 
which the Brk sites were mutated (pHSB); additionally, some of these vectors used (d) GFP or 
Gal4 (with UAS-GFP) as reporters to rule out possible artifact with using ßgal. All of the 
combinations of promoters, putative Brk binding sites present in the hsp70 promoter, and 
reporter genes are illustrated for the vectors utilized in this study in Table 3-1.  The construct 
designation letter added to the end of B14 or B315 corresponds to the vector utilized.  For 
example, B14Z is constructed in the C4PLZ vector whereas B14B only differs in that it is 
constructed in the pHSB vector. 
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 Table 3-1: Vectors utilized to study the affects of B14 and B315 in different vectors. 
Vector Construct Promoter Brk Sites in Promoter Reporter
Designation Present Mutated
C4PLZ Z transposase no no lacZ
pX27 X hsp70 yes no lacZ
pHPelican N hsp70 yes no lacZ
pHStinger R hsp70 yes no GFP
pHSB B hsp70 yes yes GFP
pHSGal4 G hsp70 yes yes Gal4 (GFP)  
 
 
 
3.3.1 The reporter gene can not explain the inability of B14 & B315 to drive reporter gene 
expression exactly recapitulating brk expression 
Initially, B315X was re-injected in order to generate more than one transgenic line in the same 
manner as described by Muller et al. (2003); expression was similar in both my transgenic lines 
as well as the Basler lab’s version of B315X (i.e. none were identical to brk) (compare Fig 3-4 A 
and E).  This experiment confirmed that the differences in expression were not due to the 
transgene insertion site, confirming that multiple inserts of B315X all have similar reporter gene 
expression, though none are identical to brk.  
The pH-Pelican utilizes a standard hsp70 promoter but the vector is constructed 
differently than pX27.  To rule out that B315X does not drive reporter gene expression in a brk 
pattern due to artifacts contained within its pX27 vector (testing possibility b), B315 was 
constructed in the pH-Pelican vector (B315N) driving lacZ expression (Fig. 3-4).  Expression of 
B315N was not identical to brk expression indicating that vector artifacts do not explain why 
B315 does not drive reporter gene expression in a brk gradient. 
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To rule out that the expression driven by B14X and B315X are not artifacts of using ßgal 
as a reporter gene (testing possibility d), both B14 and B315 were constructed in vectors utilizing 
GFP as a reporter.  These were compared to the lacZ expression of B14 and B315 as 
demonstrated with B315N, B315X, B14X, and B14Z, which all utilize lacZ reporters but are not 
expressed in patterns identical to brk (Fig. 3-4 and Fig. 3-5). Upon comparison of reporters 
utilizing lacZ to those utilizing GFP, like B315R (Fig. 3-4 D), we determined that the lacZ 
reporter is not responsible for the failure of the B14X and B315X reporters to recapitulate brk 
expression. Additionally, upon comparison of reporters utilizing lacZ to those utilizing Gal4 (and 
the UAS-Gal4 system to observe expression by crossing to UAS-GFP and visualizing GFP 
expression in the pattern in which the response element drove Gal4), like B14G (Fig. 3-5 D), it 
was observed that the type of reporter gene does not cause B14 to be expressed in a pattern 
identical to brk.  Therefore, the type of reporter gene utilized (GFP, lacZ, or Gal4) is not relevant 
to the reporter gene expression driven by B14 and B315.   
3.3.2 The use of the hsp70 promoter cannot explain the inability of B14 to recapitulate brk 
expression 
To determine if the hsp70 promoter used by the vector is the reason why B14X does not drive 
reporter gene expression in a brk pattern (testing possibility a), B14 was constructed in the 
C4PLZ vector (B14Z) which utilizes a transposase promoter and this reporter gene expression 
was compared to that of the B14 lines obtained from the Basler lab which utilize the hsp70 
promoter (Fig. 3-5).  The transposase promoter utilizes a TATA box type promoter as does 
hsp70 (Bier et al., 1989; Kaufman and Rio, 1991; O'Kane and Gehring, 1987).  The reporter gene 
 102 
expression driven from B14Z mirrored that of B14 indicating that B14’s spatial differences in 
expression are not due simply to the use of the hsp70 promoter (compare Fig. 3-5 A and C). 
3.3.3 The putative brk binding sites are not responsible for the inability of B14 & B315 to 
recapitulate brk expression 
To examine if the presence of putative Brk binding sites contained within the hsp70 promoter of 
the enhancer-bashing vectors utilized is the reason why B14 and B315 do not drive reporter gene 
expression in a brk pattern (testing possibility c), B14 and B315 were constructed in the pHSB 
vector where the putative Brk binding sites in the promoter are mutated (B14B and B315B).  
B14B expression was compared to that driven by B14X.  The B315R expression was compared 
to B315 in the same parent vector, pHStinger, whose putative Brk binding sites in the hsp70 
promoter are intact (B315R).  Upon examination of reporter gene expression, it was determined 
that removing putative Brk binding sites from the promoter does not alter reporter gene 
expression for either B14 or B315 (compare Fig. 3-5B and Fig. 3-4 B and D).  These constructs 
also do not have expression identical to that of brk.  Therefore, the presence of putative Brk 
binding sites in the hsp70 promoters of enhancer bashing vectors does not explain why the 
reporter gene expression driven by B14 and B315 is not identical to brk. 
Overall, by testing both B14 and B315 in a variety of enhancer-bashing vectors, it was 
determined that the type of promoter utilized by the vector, the presence of putative Brk binding 
sites in the promoter, and the type of reporter gene whose expression is driven by the response 
element are not reasons why reporter gene expression driven by B14 and B315 does not match 
that of brk.  Therefore, further studies were undertaken to determine if the endogenous promoter 
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is important or if additional regulatory sequence information is necessary to recapitulate a brk 
expression pattern. 
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Figure 3-4: Vector differences do not explain why B315 fails to recapitulate brk expression. 
B315, in various vector backbones, fails to recapitulate endogenous brk expression.  (Ai) Expression of B315X 
(anti-ßgal) differs from that endogenous brk as demonstrated by staining with an anti-brk antibody (Aii).  (Aiii) 
merge of (Ai-Aii). (Bi) Expression of B315B (anti-GFP) differs from that endogenous brk as demonstrated by 
staining with an anti-brk antibody (Bii).  (Biii) merge of (Bi-Bii). (Ci) Expression of B315N (anti-ßgal) differs from 
that endogenous brk as demonstrated by staining with an anti-brk antibody (Cii).  (Ciii) merge of (Ci-Cii). (Di) 
Expression of B315R (anti-GFP) differs from that endogenous brk as demonstrated by staining with an anti-brk 
antibody (Dii).  (Diii) merge of (Di-Dii). (Ei) Expression of B315X when re-injected (anti-ßgal) differs from that 
endogenous brk as demonstrated by staining with an anti-brk antibody (Eii).  (Eiii) merge of (Ei-Eii). 
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 Figure 3-5: Vector differences do not explain why B14 fails to recapitulate brk expression. 
B14, in various vector backbones, fails to recapitulate endogenous brk expression.  (Ai) Expression of B14X (anti-
ßgal) differs from that endogenous brk as demonstrated by staining with an anti-brk antibody (Aii).  (Aiii) merge of 
(Ai-Aii). (Bi) Expression of B14B (anti-GFP) differs from that endogenous brk as demonstrated by staining with an 
anti-brk antibody (Bii).  (Biii) merge of (Bi-Bii). (Ci) Expression of B14Z (anti-ßgal) differs from that endogenous 
brk as demonstrated by staining with an anti-brk antibody (Cii).  (Ciii) merge of (Ci-Cii). (Di) Expression of B14G 
(when crossed to UAS-GFP) differs from that endogenous brk as demonstrated by staining with an anti-brk antibody 
(Dii).  (Diii) merge of (Di-Dii). 
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3.4 B14 IS NOT THE MINIMAL RESPONSE ELEMENT NECESSARY TO CREATE 
THE BRK EXPRESSION PATTERN 
Because vector context was determined to not be relevant for the reporter gene expression driven 
by B14 and B315, I sought to determine if the minimal sequence necessary to create the graded 
brk expression gradient had been identified.  I decided to work for the duration of my thesis work 
with the B14 response element as it is larger than B315.  Because initial experiments suggested 
that B14 and B315 were not the only response element regions necessary to recapitulate brk 
expression, the larger B14 response element was used to determine what additional genomic 
sequences were necessary to recapitulate brk expression and rescue mutants, if necessary. Also, 
results described in Chapter 2 indicated that B315 is not expressed in embryos, presumably 
because it does not contain all response elements necessary for embryonic expression—this 
construct would not be expected to rescue brk mutants as it is not expressed embryonically. If 
additional sequences need to be added to recapitulate the brk expression pattern, it would be best 
to start with the larger response element fragment.  All of the reporter gene and rescue constructs 
created to test this are illustrated in Fig. 3-6.  Constructs utilized to test for brk mutant rescue 
contained a “W” at the end of the construct’s name indicating that it did not drive a reporter gene 
(without reporter), but rather drove the brk cDNA.  Vectors containing putative Brk sites within 
hsp70 promoters utilized mutated sites, where appropriate. 
 107 
  108 
Figure 3-6: Reporter and rescue constructs created. 
B14 is represented in pink in the first column.  The second column depicts the promoter and either the reporter or 
the rescue (brk cDNA) used.  The third column is a detailed magnification of the promoter region.  The fourth 
column is a description of the result achieved.  See text for detailed discussion of the constructs.  A “W” at the end 
of a construct’s name indicates it is utilized to test for brk mutant rescue. 
 
 
 
3.4.1 Creation of a recombinant Drosophila line to standardize gene expression/rescue 
studies 
I created a recombinant fly line to utilize in the gene expression and rescue studies.  The brkXA 
hypomorphic mutation and ombGal4 UASGFP were recombined onto the same chromosome.  
Wildtype third instar wing discs were then dissected and stained to reveal brk (brkXA-lacZ), sal 
(anti-sal), and omb expression (ombGal4 UASGFP) (Fig. 3-7 A) as well as Brk protein staining 
with an anti-brk antibody (Fig. 3-7 B).  All expression patterns were determined to recapitulate 
previous brk, omb, and sal expression patterns.  brkXA mutant wing discs from this line were then 
examined (Fig. 3-7 C). These animals do not survive past the third instar stage, have no evidence 
of Brk protein (as determined by a lack of detectable staining with an anti-brk antibody), have no 
gradient of expression from brkXA-lacZ enhancer trap (as described in detail in Chapter 2), and 
have greatly expanded expression of omb due to the absence of Brk which normally represses the 
expression of omb (as described in detail in Chapter 2). 
If B14 is truly the minimal response element fragment necessary to drive a reporter gene 
in a brk expression gradient, then the combination of B14 with a promoter to drive the brk cDNA 
should rescue a brk mutant.  As the utilization of two different heterologous promoters was 
determined above to not influence reporter gene expression, the rescue experiments were 
performed utilizing the hsp70 minimal promoter with the putative brk binding sites mutated 
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(from pHSB); this construct drives the brk cDNA as described above and is termed B1470brkW.  
As the brkXA chromosome carries the forked marker and my transgene carries the white marker, I 
could determine which males were rescued. 
No brkXA rescued male adult flies were recovered in trans by the B1470brkW construct.  
Upon examination of the mutant non-rescue larvae carrying the B1470brkW transgene, the 
larvae looked exactly like brkXA mutant animals (i.e. they exhibit large discs with the 
characteristic brkXA-lacZ staining pattern of no gradient of expression as well as expanded omb 
expression and no detectable Brk protein) (Fig. 3-7 D).  Due to the lack of rescue of the brkXA 
mutant with B1470brkW, it can be concluded that B14 is not the minimal response element 
fragment necessary to create a brk expression gradient; this result is consistent with the reporter 
gene assays described in the last section. 
 Additional confirmation that B14 is not the minimal response element necessary for brk 
expression came from studies utilizing the B14G construct.  This construct drives Gal4 in the 
B14 expression pattern (Table 3-1 and Fig. 3-4).  The B14G construct was crossed to UAS-brk 
and tested for its ability to rescue the brkXA mutant (data not shown).  B14G driving UAS-brk 
fails to rescue a brkXA mutant (data not shown) further confirming the results obtained by 
B1470brkW indicating that B14 is not the minimal response element necessary for brk 
expression. 
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Figure 3-7: B1470brkW fails to rescue a brkXA mutation. 
brkXA wildtype and mutant with failed B1470brkW rescue.  (A-B) brkXA heterozygous wing disc shows proper sal 
(anti-sal), omb (ombGal4UASGFP), and Brk (anti-brk, brkXA-lacZ) expression.  (C) brkXA mutant wing disc shows no 
Brk (evidenced by no staining detected with anti-brk) as well as expanded omb (ombGal4UASGFP) expression and 
characteristic mutant brkXA-lacZ expression.  (D) brkXA mutant is not rescued by B1470brkW, has no Brk (evidenced 
by no staining detected with anti-brk) as well as expanded omb (ombGal4UASGFP) expression and characteristic 
brkXA-lacZ expression. 
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3.5 B14 IN COMBINATION WITH A REGION INCLUDING THE ENDOGENOUS 
PROMOTER DRIVES REPORTER GENE EXPRESSION IN A BRK PATTERN 
The heterologous hsp70 and transposase promoters utilized in reporter gene assays contains a 
TATA box style core promoter whereas brk appears to utilize a DPE style promoter (reviewed 
by Smale and Kadonaga, 2003). It is possible that correct brk expression and mutant rescue can 
only be achieved when an endogenous DPE promoter type is utilized. 
To examine if utilizing a region including the endogenous promoter instead of a 
heterologous promoter is necessary for B14 to drive a reporter gene in a pattern exactly like brk, 
B14BP1P and B14BP2P were created by combining B14 with either the BP1 or BP2 fragment 
(without a heterologous promoter) and driving GFP reporter gene expression (Fig. 3-8).  
Both B14BP1P and B14BP2P drove GFP reporter gene expression in a pattern identical 
to that of brk. Therefore, adding a region near the start of brk transcription (including the 
endogenous promoter) to B14 restores reporter gene expression to a pattern identical to brk. 
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 Figure 3-8: B14BP1P and B14BP2P drive GFP in a pattern identical to brk. 
(A) Schematic of the genomic regions utilized to build constructs.  (B) B14BP1P expression is identical to staining 
with an anti-brk antibody.  (Bi) B14BP1P expression (anti-GFP).  (Bii) Brk expression (anti-brk).  (Biii) Merge 
panel of (Bi) and (Bii).   (C) B14BP2P expression is identical to staining with an anti-brk antibody.  (Ci) B14BP2P 
expression (anti-GFP).  (Cii) Brk expression (anti-brk).  (Ciii) Merge panel of (Ci) and (Cii). 
 
 
 
3.6 A REGION INCLUDING THE ENDOGENOUS PROMOTER CAN COMBINE 
WITH B14 TO RESCUE A BRKXA MUTANT 
To examine if the combination of B14 with BP1 or BP2 are the minimal response element 
fragments necessary to drive brk expression, I sought to determine if they rescued a brkXA 
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mutant.  B14BP1brkW and B14BP2brkW were created using B14 and either BP1 or BP2 driving 
the brk cDNA fragment and the constructs tested for their ability to rescue the 
brkXAombGal4UASGFP mutation (see Fig. 3-6). 
 The B14BP1brkW transgene successfully rescued the brkXA mutant to adulthood where it 
produced a perfectly formed fly with wings properly sized and patterned upon comparison to 
wildtype (Fig. 3-9).  Upon dissection and examination of third-instar wing discs from these 
rescued mutants, omb expression was normal, brkXA expression was graded like that of brk, and 
Brk obtained from the transgene alone was expressed in the correct pattern and gradient.  This 
result indicated that sequences contained within the BP1 response element are necessary to 
rescue a brk mutant. 
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 Figure 3-9: B14BP1brkW rescues brkXA mutants.  
B14 combined with BP1 contains the response elements necessary to properly drive brk expression.  (A) Schematic 
of the genomic regions utilized in the study.  The red lines represent putative (activating) Mad binding sites while 
the blue lines represent putative Brk binding sites. (B) brkXA mutant discs rescued by the B14BP1brkW transgene.  
Anti-brk staining (Brk contributed totally from the transgene) demonstrated proper graded brk expression; omb 
expression was properly placed, and brkXA-lacZ expression demonstrates a non-mutant pattern.  (D-E) Wildtype and 
brkXA mutant rescue wings photographed at the same size.  (D) Wildtype wing.  (E) brkXA mutant rescued with 
B14BP1brkW transgene was correctly sized and patterned. 
 115 
3.7 MAD ACTIVATION NEAR THE BRK ENDOGENOUS PROMOTER IS 
NECESSARY FOR GRADED BRK EXPRESSSION 
Because B14BP1brkW rescues the brkXA mutation, two possibilities exist as to why this construct 
could rescue while B1470brkW failed to rescue.  The first possibility is that the type of promoter 
utilized by the two constructs is important.  B1470brkW uses an hsp70 (TATA box) minimal 
promoter while brk contains no TATA box and uses DPE promoter elements.  brk rescue may 
not be possible if a promoter that is too strong or non-native is utilized.  The second possibility 
why B14BP1brkW rescues brkXA while B1470brkW fails to rescue is that sequences necessary 
for correct gradient placement and expression (and therefore necessary for rescue) are located 
within BP1 but outside of the promoter itself.  
3.7.1 brkXA drives graded expression without utilizing the brk endogenous promoter 
To examine if B14BP1brkW rescues the brkXA mutant due to the presence of the brk endogenous 
promoter, I examined reporter expression from two P-element enhancer trap insertions in brk that 
drove lacZ reporter gene expression (Campbell et al., 1999).  These P-elements were compared 
to Brk expression with an anti-brk antibody (Fig. 3-10).  While brkXA has graded expression that 
extends as far medially across the A/P axis of the wing disc as anti-brk, brkX47 does not.  brkX47 
expression is confined to more lateral regions of the wing disc. It should be noted that the brkXA 
and brkX47 enhancer traps drive lacZ expression utilizing hsp70 promoters in PZ elements.  
Because brkXA expression is identical to brk, it is difficult to support the proposal that the nature 
of the promoter utilized (hsp70 or endogenous brk) is important to generate graded expression.  
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Sequences distal to the promoter that are still positioned upstream of the promoter in brkXA but 
not in brkX47 are most likely the factors responsible for graded expression in brkXA and in brk. 
The sequences included in the region upstream of the insertion site of brkXA were 
examined.  Most of BP1 is included in this region, and the most striking sequence element 
includes a cluster of overlapping putative Mad and Brk binding sites termed MP (Fig. 3-10).  The 
Mad binding sites contained within this region are characteristic of the sites known to be utilized 
when pMad acted as a transcriptional activator with the typical GC consensus sequences 
(described in detail in Chapter 1), not the repressive sites that recruit the MMS repression 
complex. In addition to repressing as a member of the MMS complex, pMad can also directly 
activate Dpp-dependent transcription of genes; the decision of activation or repression by pMad 
is determined by the Mad protein binding sites contained within the regulatory regions of Dpp-
responsive genes where GC-rich binding sites that are not situated exactly five basepairs away 
from Med binding sites (thus not allowing for the subsequent recruitment of Shn) allow for 
activation of transcription (Certel et al., 2000; Kim et al., 1997). It was hypothesized that 
sequences included in BP1 contribute to its brk expression pattern and rescue when combined 
with B14 to drive Brk. This is consistent with the observation that if B14B would be 
transcriptionally activated by pMad, its expression would be predicted to shift medially (and thus 
be expressed more like brk).  brkX47 most likely drives reporter gene expression in a brk-like 
pattern because the B14 element can presumably act upstream or downstream, thereby regulating 
brkX47, but it may also be that the activating Mad sites need to be close to the promoter to be 
effective in generating graded expression. 
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 Figure 3-10: Expression and insertion sites of different brk enhancer traps. 
Insertion sites and expression of brkX47 and brkXA compared to anti-brk.  (A-B) Wing imaginal discs from flies 
carrying brk enhancer traps.  (A) brkXA (lacZ enhancer trap; ß-gal expression).  (B) brkX47 (lacZ enhancer trap; ß-gal 
expression).  Comparison of expression reveals that the limit of reporter gene expression in brkXA along the A/P axis 
(marked by the white dashed lines) is more medial than in brkX47 (marked by the yellow dashed lines).  (C) Staining 
of a wildtype animal with anti-brk is identical to that of brkXA (expressed as far medially as white dashed lines).  (D) 
Diagram of the brk genomic region showing the brk transcriptional unit, the B14 and BP1 response elements, and 
the enhancer trap insertion sites.  (E) Magnification of the region in D including BP1, the brkXA insertion, the 
endogenous brk promoter elements (DPE, Inr), and the brk transcription start site.  Mad binding sites are shown with 
red lines and Brk binding sites with blue lines.  The Inr (pink) and DPE (purple) promoter elements are depicted 
with boxes on the sequence. The P-element in brkXA is a PZ element with an hsp70 promoter oriented so that the 
lacZ gene is immediately downstream of the promoter and this Mad/Brk element. 
 
 
 
3.7.2 Mad binds MP in vitro in EMSA studies 
To test the hypothesis that activating Mad binds the MP response element to generate graded 
expression when combined with B14, the ability of pMad to bind the MP region was tested in 
vitro using electromobility shift assays (EMSAs).  A 40 basepair double-stranded probe was 
generated against the MP region as well as a probe with the putative Mad binding sites mutated 
to use in competition experiments.  Plasmids that expressed the MBP fusion protein alone or 
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conjugated to Mad were obtained, expressed in bacteria, and proteins purified for use (Gao et al., 
2005).  The Mad protein is known to consist of two Mad Homology domains (MH1 and MH2) 
joined by a linker region.  Other labs have never successfully purified the entire Mad protein as 
the MH2 domain has been shown to antagonize DNA binding (Xu et al., 2005).  Therefore, the 
fusion protein created, MBP-MadNL, contained the MH1 plus linker region and was previously 
described to be successful in EMSAs (Kim et al., 1997). 
To begin these experiments, it was confirmed that the negative control, MBP protein, 
does not bind the MP probe on EMSA; therefore, any binding observed with MBP-MadNL 
would presumably be due to the MadNL portion of the protein (Fig. 3-11). As a positive control 
to ensure that the purified fusion protein generated functions for EMSA experiments, the ability 
of MBP-MadNL to bind a UbxB probe was tested, as previously reported (Kirkpatrick et al., 
2001; Saller and Bienz, 2001).  This binding was competed away with excess cold wildtype 
UbxB probe; however, binding was not competed away with excess cold probe in which the Mad 
binding sites were mutated.  This experiment served to validate that MBP-MadNL functionally 
binds probes containing its binding sites on EMSAs as well as validating the nature of the point 
mutations in probes created for UbxB to eliminate the ability of Mad to recognize and bind its 
binding sites; these same point mutations were created in my MP probe. 
MBP-MadNL was next tested with the MP probe and was found to bind and generate a 
shifted complex.  This binding was competed away by adding excess cold MP probe; however, 
this binding was not competed away by adding excess cold mutant probe where the putative Mad 
binding sites were mutated, thus indicating that the MBP-MadNL protein binds the Mad binding 
sites in the MP response element in vitro.   
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 Figure 3-11: Mad binds MP on EMSAs. 
EMSA experiment where MBP alone fails to bind the MP probe, but MBP-MadNL protein binds the probe.  This 
binding is competed away with cold wildtype probe but is not competed away with cold mutant probe where the 
putative Mad binding sites are mutated.  MBP-MadNL also binds to the UbxB control probe while MBP alone does 
not (not shown).  This binding is competed away with cold wildtype control probe but is not competed away with 
cold mutant control probe where the putative Mad binding sites are mutated. 
 
 
 
3.7.3 B14MPB drives reporter gene expression in a perfect brk pattern 
If sequences contained within BP1 and also lying upstream of the insertion site of the brkXA 
enhancer trap are necessary in combination with B14 for perfect brk expression and brk mutant 
rescue, an obvious potential region to test is the MP cluster of activating Mad binding sites 
contained within BP1 (Fig. 3-10 E).  As discussed in detail earlier, pMad can both activate and 
repress transcription of target genes based on its binding site context.  Based on this information, 
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a possible hypothesis describes a situation where activation by pMad at the MP element is 
necessary in the mediolateral region of the wing disc to pull the expression of B14 more medial.  
This could explain why B14 is not expressed as far medially across the A/P axis as brk—B14 
does not contain this potential element that may be activated by pMad.  Activation by pMad 
could be required in the BP1 element to extend expression, generate the graded brk pattern, and 
allow subsequent rescue.   
To test this possibility, B14 was combined with the MP region (35 basepairs in length) 
and placed into the pHSB vector (creating B14MPB); this combination of response elements plus 
the hsp70 promoter (with brk binding sites mutated) drove GFP reporter gene expression (Fig. 3-
12).  B14MPB was able to drive reporter gene expression in a pattern identical to brk (Fig. 3-12).  
This result supported the notion that the MP response element contains information necessary for 
proper brk expression; in addition, this supported the hypothesis that the expression and rescue 
provided by B14BP1P and B14BP1brkW, respectively, is not due to their usage of the 
endogenous brk promoter as B14MPB does not use the endogenous promoter yet retains the 
ability to drive perfect brk-like expression.  It should also be noted that the levels of reporter 
gene expression driven by B14MPB were much higher than those driven by B14BP1P.  
Therefore, lower levels of reporter gene expression are not necessary to allow B14BP1P to drive 
brk-like expression as B14MPB drives high levels of expression like endogenous brk.  
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Figure 3-12: Reporter gene expression driven by B14MPB is identical to brk. 
(Ai) brk expression in B14MPB animals (anti-brk).  (Aii) GFP reporter gene expression from the B14MPB 
transgene (anti-GFP).  (Aiii) merge of (Ai) and (Aii). 
 
 
 
3.7.4 B14MP70brkW rescues a brkXA mutant 
Because B14MPB expression looks exactly like endogenous brk expression, we tested whether 
the MP response element is the only fragment necessary in combination with B14 to rescue the 
brkXA mutant; I created B14MP70brkW that utilizes the two response elements and an hsp70 
promoter to drive the brk cDNA and tested for its ability to rescue the brkXA mutation (Fig. 3-13). 
The B14MP70brkW construct, upon comparison to B1470brkW (which fails to rescue 
brkXA), only differs in that it contains the 35 basepair MP response element.  This small region 
allowed rescue of the brkXA mutant by B14MP70brkW (Fig. 3-13).  The rescue also confirmed 
that the type of promoter utilized (hsp70 or endogenous/DPE style) is not the determinant that 
prompts rescue of mutants—it is the sequence of the response elements that creates the brk 
expression gradient and subsequent rescue.  
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 Figure 3-13: B14MP70brkW rescues brkXA. 
(A) Third instar imaginal discs from brkXA mutant rescued with the B14MP70brkW transgene. Anti-brk staining 
demonstrates Brk in the correct expression gradient and omb expression is correctly placed while the brkXA-lacZ 
reporter demonstrates a wildtype expression pattern. (B) Adult brkXA mutant wing rescued with the B14MP70brkW 
transgene is of the proper size and patterning as wildtype wings. 
 
 
 
3.7.5 The Mad binding sites in MP are activating sites 
Because the B14BP1brkW and B14MP70brKW constructs contain additional basepairs of 
sequence between their B14 response element and promoter, two possible explanations exist for 
their brk mutant rescue while B1470brkW fails to rescue.  (1) The addition of the MP element 
between B14 and the promoter adds additional spacing necessary between the two elements for 
rescue, or (2) the MP element contains additional sequence information necessary for rescue.  
The first possibility is not true: B1470brkW contains 64 basepairs of DNA between its B14 and 
hsp70 promoter while B14MP70brkW contains 68 basepairs, including its MP element, between 
its B14 and hsp70 promoter elements.  This indicates that the addition of spacing between the 
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B14 and promoter elements does not cause B14BP1brkW and B14MP70brkW to rescue a brk 
mutant; the rescue is due to the sequences contained within the MP element.   
The addition of the 35 basepair MP response element is the factor that permits 
B14MP70brkW to rescue a brk mutant, presumably due to activation of the construct by pMad at 
MP.  To confirm that these sites are really activating Mad sites, I tested the sites in a reporter that 
was already known to contain activating Mad sites, the Vestigal quadrant enhancer (VgQ) (Fig. 
3-14) (Certel et al., 2000; Kim et al., 1997).  This enhancer was previously shown to contain two 
activating Mad sites that are essential for it to drive reporter gene expression in the wing pouch.  
The VgQ enhancer in our modified pHSB vector similarly drives GFP expression in the wing 
pouch; this expression is dependent upon the presence of the Mad sites because when they are 
removed in VgQnomadB, reporter gene expression is lost, indicating that expression of GFP is 
dependent upon pMad both binding and activating the construct (Fig. 3-14).   
To test the Mad binding sites contained within MP for their ability to recruit pMad and 
activate expression, the binding sites were cloned into the VgQ enhancer in place of its own 
activating Mad binding sites.  The resulting construct, VgQMPB, drove reporter gene expression 
in the central region of the wing disc like VgQB (Fig. 3-14).  This expression was determined to 
be dependent on the presence of the activating Mad sites, as demonstrated by the lack of reporter 
gene expression from the construct VgQnomadB.  This result indicates that the Mad binding 
sites in MP recruit activating pMad. 
To further confirm that the reporter gene expression seen in VgQMPB is dependent on 
pMad, pMad null (Mad1-2) clones were created and reporter gene expression from VgQMPB 
analyzed (Fig. 3-14).  In clones lacking pMad, reporter gene expression from VgQMPB was lost, 
indicating that its expression is dependent upon pMad binding to the Mad binding sites contained 
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in MP to activate expression of the construct and, thus, its reporter.  This result confirms the 
notion that activating pMad binds to the MP element and also supports the hypothesis that pMad 
binds to the MP element to activate brk expression (while pMad also represses brk expression 
through its actions at the silencer as a member of the MMS complex, Chapter 2). 
 
 
 
 
 
 
Figure 3-14: The Mad binding sites in MP function as activating Mad binding sites. 
(A) Schematic of the constructs created.  (B) VgQB expression is found in the central portion of the wing disc.  (C) 
Removal of the activating Mad binding sites from VgQB creates VgQnomadB and results in a loss or reporter gene 
expression.  (D) Addition of the MP cluster of Mad binding sites to VgQnomadB restores reporter gene expression.  
(E) Reporter gene expression in VgQMPB is lost in Mad12 null mutant clones (marked by a loss of ß-gal (red) 
expression).  (Ei) Mad clones are marked by a loss of ßgal staining (red).  (Eii) VgQMPB expression (anti-GFP, 
green) is absent from Mad mutant clones.  (Eiii) merge of (Ei) and (Eii). 
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3.8 THE MP RESPONSE ELEMENT HAS A REDUNDANT ELEMENT NEAR THE 
BRK ENDOGENOUS PROMOTER 
3.8.1 Other sequences in BP1 rescue a brkXA mutant 
If the activating Mad sites contained within the MP element are the portion of BP1 that is 
necessary upon combination with B14 to allow rescue, then removal of these sites should return 
GFP reporter gene expression to that demonstrated by B14B and should cause a loss of rescue.  
Alternatively, redundant elements (to MP) may exist within BP1 that would still allow for proper 
reporter gene expression and subsequent rescue. To demonstrate the necessity of activation by 
pMad at the MP response element (in combination with B14 for rescue), a GFP reporter 
construct, B14BP1MP, as well as a rescue construct, B14BP1MbrkW, were designed (Fig. 3-15).  
These constructs contain B14 and the BP1 endogenous promoter/response element with the 
cluster of activating Mad sites contained within the MP response element removed. 
When reporter gene expression from B14BP1MP was examined, it was determined to 
look identical to anti-brk staining (Fig. 3-15).  Additionally, B14BP1MbrkW was able to rescue 
a brkXA mutant to adulthood where its wings were perfectly sized and formed.  These results 
suggest that other redundant elements are contained in BP1 that would also allow for proper 
reporter gene expression and rescue if tested individually. 
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 Figure 3-15: BP1 without MP still rescues brkXA lethality. 
(A) Schematic of the genomic region included in the constructs. The red lines represent putative Mad binding sites 
while the blue lines represent putative Brk binding sites. (B) Reporter gene expression from B14BP1MP looks 
identical to anti-brk.  (C) B14BP1MbrkW allows rescue of the brkXA mutation.  Anti-brk staining looks normal, as 
does that of omb, while brkXA expression looks wildtype.  (D) A brkXA mutant adult wing rescued with 
B14BP1MbrkW is correctly sized and patterned when compared to wildtype. 
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3.8.2 The BPB element can substitute for the MP element and allow rescue of a brkXA 
mutant 
To examine the possibility that other elements redundant to MP exist within BP1, the BP1 
response element was first divided into two portions, BPA and BPB.  The BPA element contains 
83 basepairs of the BP1 element beginning at the MP element and extending to the end of BP1.  
The BPB element begins just after the MP element and extends for 50 basepairs to the end of the 
BP1 element (Fig. 3-16). The BPA element was designed to test the removal of the first 109 
basepairs of BP1.  The activating Mad binding sites contained within the BPA element include 
those located within the MP element, which was previously been tested on its own, plus one 
additional site (that is not included in MP).  This one additional activating Mad binding site is the 
only one included within BPB; the B14BPBbrkW construct thus tests the ability of this one 
activating Mad binding site to combine with B14 and rescue a brk mutant.  Because Mad binding 
sites are difficult to predict, it is possible that the BPB element contains more than one site. 
The B14BPAbrkW construct rescued a brk mutant, as predicted (Fig. 3-16). The B14BPBbrkW 
construct also rescued a brk mutant (Fig. 3-16).  These results suggest that the BPB element and 
the MP element are redundant in their abilities to recruit activating pMad to the brk response 
element region.  Additional redundant response elements to MP and BPB may exist that were not 
identified in this study. 
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 Figure 3-16: B14BPAbrkW and B14BPBbrkW rescue a brkXA mutant. 
(A) Schematic of the genomic region included in the constructs. The red lines represent putative Mad binding sites 
while the blue lines represent putative Brk binding sites. (B) B14BPAbrkW rescues the brkXA mutation.  Anti-brk 
staining looks normal as does that of omb while brkXA expression looks like wildtype. (C) B14BPBbrkW rescues the 
brkXA mutation.  Anti-brk staining looks normal as does that of omb while brkXA expression looks like wildtype.  (Di) 
A brkXA mutant adult wing rescued with B14BPAbrkW is correctly sized and patterned when compared to wildtype.  
(Dii) A brkXA mutant adult wing rescued with B14BPBbrkW is correctly sized and patterned when compared to 
wildtype. 
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3.8.3 B14BPB70brkW can rescue a brkXA mutant 
To test the hypothesis that the BPB element and the MP element are redundant in their abilities 
to recruit activating pMad to the brk response element region and activate transcription, 
B14BPB70brkW was created (Fig. 3-17); this construct, much like the B14MP70brkW construct, 
was designed to test the ability of B14, the BPB response element (which contains one activating 
Mad binding site), and the hsp70 promoter (with putative Brk binding sites mutated) to drive the 
brk cDNA and rescue a brk mutant.  If rescue occured, then the result would lead to the 
conclusion that BPB is a redundant element to MP.  It would also demonstrate that the brk rescue 
phenotype exhibited by B14BPB70brkW is due to its response element composition and not to 
the use of the endogenous brk promoter. 
The B14BPB70brkW construct rescued the brkXA mutation to adulthood, where normally 
sized and patterned wings developed compared to wildtype (Fig. 3-17). This result supported the 
notion that the BPB element is redundant to the MP element in its ability to recruit activating 
pMad to the brk response element region.  This also demonstrated that rescue of the brk mutant 
by B14BPBbrkW is due to its response elements, not its use of the endogenous brk promoter as 
B14BPB70brkW rescues a brk mutant utilizing a non-endogenous (hsp70) promoter.   
While my thesis focused my efforts on the ability of pMad to bind and activate at the MP 
response element, I performed one additional experiment on the BPB response element to test 
the ability of this region to recruit activating pMad and drive reporter gene expression in the 
VgQ enhancer study.  To this end, VgQBPBB was created; it contains the one putative activating 
Mad binding site contained within BPB in place of the activating Mad binding sites originally 
found in VgQB.  Upon assaying for reporter gene expression, none was detected (Fig. 3-17).  
This was unexpected, but it is possible that one activating Mad binding site, while sufficient to 
 130 
rescue the brkXA mutant, is not sufficient in the VgQ enhancer experiment.  The VgQB construct 
has two activating Mad binding sites (see Fig. 3-14), and it is possible that the one site contained 
within BPB is not sufficient to drive reporter gene expression in this assay; more than one may 
be necessary. 
 
 
 
 
Figure 3-17: B14BPB70brkW rescues brkXA but VgQBPBB demonstrates no reporter gene expression. 
(A) brkXA mutant rescued with B14BPB70brkW transgene was correctly sized and patterned.  (B) VgQBPBB drove 
no expression in the wing disc (photographed at same levels as Fig. 3-14 B-D) (anti-GFP). 
 
 
 
3.9 DISCUSSION 
3.9.1 Reporter constructs and recapitulating the expression patterns of endogenous genes 
The brk gene is expressed in lateral to medial gradients along the A/P axis of the wing imaginal 
disc.  Although previous experiments demonstrated that this pattern of expression is established 
by Dpp signaling repressing brk expression through a Mad/Med/Shn complex, the experiments 
described in Chapter 2 clearly demonstrated that Brk negative autoregulation is essential to 
establish the normal pattern of brk expression.  The experiments in this chapter have addressed 
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whether these inputs are sufficient to establish the normal pattern of brk expression and have 
demonstrated that they are not; an additional input necessary for proper brk expression is 
activation of brk by pMad/Med. 
The experiments conducted in this chapter stemmed from our initial observations of the 
pattern of reporter gene expression driven by the B14 response element, an element that was 
originally stated to drive expression in a pattern identical to that of endogenous brk.  However, as 
shown above, this is incorrect—although B14-driven expression superficially resembles that of 
endogenous brk, upon closer inspection, expression does not extend as far medially as that of 
Brk protein.  This is a common failing of many studies using reporter constructs as researchers 
often overlook slight differences between reporter gene expression and that of the endogenous 
gene, probably surmising that a minor element is missing from the regulatory sequences in the 
reporter constructs they are using, but that it is not important because their study has revealed an 
important element necessary for the control of the expression of a particular gene.  This is the 
case for the previous brk study in which the key element under study was the silencer element to 
which pMad/Med/Shn bind. 
However, in regard to brk, it is essential to understand how the exact pattern of 
expression is established because the pattern of gene expression in the wing is dependent upon 
precise levels of Brk protein: if the gradient profile would be modified in any way, then the 
development of the wing would be totally disrupted because the pattern of expression of genes 
such as sal and omb, which control positioning of structures like wing veins, would be altered.  
Consequently, the fact that the B14 response element does not drive reporter gene expression in a 
pattern identical to that of brk can not be ignored and, as demonstrated by the experiments in this 
chapter, the devil is in the details. 
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3.9.2 B14 and B315 response elements 
Upon examination of the reporter gene expression driven by the B14 and B315 response 
elements in different vectors with different enhancers and reporters, it was determined that the 
reporter gene used as well as the type of promoter utilized by the vector (or presence of putative 
brk binding sites within that promoter) does not explain why neither response element drives 
reporter gene expression exactly like brk.   
B14 and B315 also do not have the same expression patterns as each other when tested 
with multiple promoters and reporter genes.  One possible explanation as to why reporter gene 
expression driven by the B14 and B315 response elements are different could be that the silencer 
and enhancer portions of B315 are too close to one another (Small et al., 1992).  Additionally, I 
was able to identify that B14 contains at least two more Dpp-responsive silencer elements in 
addition to the one (contained in B315) previously described (Pyrowolakis et al., 2004).  It is 
likely that these elements also contribute to the differences in reporter gene expression patterns 
driven by B14 and B315. 
B14 was refuted as the minimal response element necessary to create brk expression as it 
fails, upon combination with an hsp70 promoter, to drive a brk cDNA to rescue a brk mutant. 
3.9.3 BP1, an additional regulatory element located immediately upstream of the 
promoter 
The failure of B14 to drive reporter gene expression in a precise brk pattern and to rescue a brk 
mutant when used to drive Brk suggests that an additional regulatory element is absent from the 
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B1470brkW construct.  This is the BP1 response element.  BP1 is necessary, in combination with 
B14, to drive a brk cDNA and rescue a brk mutant.  This rescue is promoter independent.  
3.9.3.1 Additional constructs will confirm that no Brk protein is produced by B1470brkW 
when it fails to rescue brkXA mutants 
The B14B construct, as well as B14 in all response element testing vectors tested (Fig. 3-4), 
predicted that B1470brkW would drive Brk protein in the lateral regions of the wing disc; the 
B1470brkW non-rescue discs, however, contain no detectable Brk protein (Fig. 3-7 D).  The 
construct was confirmed to be cloned correctly.  Therefore, several possible explanations exist 
for this observation: (1) The anti-brk antibody is not of a good enough quality to recognize a 
small amount of Brk protein.  (2) The reporter construct responds differently to Brk than the 
endogenous gene in that B1470brkW construct is more sensitive to autoregulation so that 
essentially the brk in the transgene is keeping its own levels down to undetectable levels. To 
examine these possibilities, two additional constructs are currently being generated: 
B1470brkHAW and B1470F124HAW (Fig. 3-6).   
B1470brkHAW is exactly the same as B1470brkW except that the brk cDNA contains a 
C-terminal HA tag.  The HA tag does not interfere with rescue (B14BP1brkHAW, created by 
GC, rescues brkXA (personal observation)).  The B1470brkHAW construct is expected to not 
rescue brkXA (as B1470brkW did not) and will be examined for staining with an anti-HA 
antibody in order to rule out the possibility that low levels of Brk protein are driven by 
B1470brkW that are just undetectable by the anti-brk antibodies, although this would be 
unexpected and it is predicted that HA expression will also be undetected.   
B1470F124HAW will contain the brkF124 point mutation in the recognition helix of the 
DNA binding domain previously identified from an EMS screen to produce Brk with little or no 
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activity as brkF124 mutant clones in wing discs are indistinguishable from null allele clones 
(Winter and Campbell, 2004).  The B1470F124HAW construct is also expected not to rescue as 
it will produce a protein with little or no activity, but one that can be detected with an anti-HA 
antibody as well as the anti-brk antibody.  The ability of this protein to autoregulate will be 
examined by staining brkXA non-rescue discs with anti-brk and anti-HA.  If the B1470F124HAW 
construct is more sensitive to autoregulation (as predicted from the B1470brkW construct), then 
no protein expression is expected in brkXA/+ heterozygous animals as the endogenous Brk protein 
is expected to repress the transgene. In the brkXA mutant, expression is expected from the 
B1470F124HAW construct as no endogenous Brk protein will be present to autoregulate and, if 
our hypothesis is correct, it will be expected that staining with anti-brk and anti-HA will 
demonstrate expression in only the lateral regions of the wing disc. 
3.9.4 pMad binds sequences in MP and positively regulates expression 
The BP1 response element contains putative activating Mad binding sites. The cluster of putative 
activating Mad binding sites contained within BP1, known as the MP response element, binds 
pMad protein in vitro and possesses the ability to be combined with B14, an hsp70 promoter, and 
the brk cDNA to rescue a brk mutant (B14MP70brkW) (Fig. 3-13).  Furthermore, the sites are 
activating Mad sites.  Similarly, it was previously demonstrated that the Mad binding sites within 
the VgQ enhancer were also activating.  To test the function of MP, the MP response element 
was substituted in place of the activating Mad binding sites within the VgQ enhancer and it was 
demonstrated that the activating Mad binding sites contained within the MP response element 
could drive reporter gene expression that is dependent on pMad and could also recapitulate 
VgQB expression.  This result confirmed that activation by pMad, in addition to the repression 
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by pMad at the silencer element as previously noted and discussed in Chapter 2, are necessary to 
generate the correct brk expression pattern/gradient.   
3.9.5 The BPB element also appears to positively regulate expression 
The MP response element can be removed from BP1 without disrupting rescue; this result 
identified a response element, BPB, which acts redundantly to MP and can also be combined 
with B14, an hsp70 promoter, and the brk cDNA (B14BPB70brkW) to rescue a brk mutant.  
While BPB, and presumably its activating Mad binding site, retains the ability to rescue a brk 
mutant, BPB is not able to drive reporter gene expression in the VgQ enhancer.  This may be due 
to the fact that BPB contains one activating Mad binding site.  This one site may be sufficient in 
the context of brk mutant rescue but may not be sufficient to drive reporter gene expression in 
the VgQ enhancer experiment as the VgQB construct reporter gene expression was activated by 
two Mad binding sites.  Further experiments to assess this hypothesis would include placing 
multiple BPB response elements in the VgQ enhancer and assessing their ability to activate 
reporter gene expression, removing one of the two activating Mad binding sites from the VgQ 
enhancer and assessing its ability to active expression when only one site is present, and EMSA 
experiments to determine if pMad binds to BPB in vitro as it does to MP.   
 Additionally, a synthetic construct could be created where the activating Mad binding 
sites contained within the VgQ enhancer are added to the B1470brkW construct.  If this new 
construct allows rescue of a brk mutant, it would confirm that the rescue demonstrated by 
B14BP1brkW, B14MPbrkW, B14BPAbrkW, and B14BPBbrkW is due to activation by pMad. 
Activating Mad binding sites are difficult to identify; to test if the one Mad binding site 
contained within BPB is the factor that permits rescue of a brk mutant, a construct could be 
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generated where that Mad binding site is removed from BPB and the ability of the construct to 
rescue a brk mutant evaluated.  While the construct is predicted to not rescue, if it would, this 
result would suggest that other cryptic activating Mad binding sites are contained within BPB.  
 The one activating Mad binding site contained within BPB is located very close to the 
brk transcriptional start site raising the possibility that it may not be functional in vivo due to the 
masking of the DNA sequences necessary for the recruitment of basal transcription factors or due 
to the masking of its binding site by the binding of the basal transcriptional machinery.  TFIID is 
the factor that binds to the Inr and DPE elements of DPE-driven promoters like brk; DNase I 
footprinting analyses have been conducted and the region of DNA contacted by TFIID is not 
predicted to mask the single activating Mad binding site contained within the BPB response 
element, indicating that it could still be functional (Smale and Kadonaga, 2003).  Additionally, 
the B14BPBbrkW construct utilizes only this one activating Mad binding site within its 
endogenous promoter to rescue a brk mutant, indicating that the Mad binding site must be active 
while still not inhibiting the binding of the basal transcriptional machinery.  The identification of 
the BPB element may actually suggest that MP and BPB direct short-range activation that may 
be required for transcription of brk.    
3.9.6 Redundancy in response elements 
The redundancy in response elements (e.g. MP and BPB) possessed by brk is not unusual—brk 
itself contains multiple Dpp-responsive silencer elements; most likely they are utilized either 
combinatorially or to direct repression of expression at various times/places throughout 
development (Pyrowolakis et al., 2004).  Multiple Brk binding sites are present within the zen 
promoter and function in a redundant manner (Rushlow et al., 2001).  Recent data from the 
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Rahul Warrior lab suggests that brk contains multiple “B14-like” response elements, each 
containing a Dpp-responsive silencer element, which can all individually drive reporter gene 
expression in a pattern similar to brk (Yao et al., 2008).  Additionally, kruppel expression in the 
central domain of the embryo is directed by two adjacent response elements that each can 
function independently to drive the correct pattern of kruppel expression (Hoch et al., 1990).   
It is redundancy that appears to allow brkXA-lacZ expression to be identical to brk 
expression in a wildtype/ heterozygote situation—while BPB (with its one activating Mad 
binding site) is not influencing brkXA expression (as BPB is downstream of the enhancer trap 
insertion site and, therefore, likely not used by the enhancer trap to drive reporter gene 
expression), the MP element remains upstream of the brkXA insertion site and appears to direct 
lacZ expression mediolaterally. 
3.9.7 Counteracting the repressive forces 
The results of my experiments in this chapter have provided possibly the first example of both 
activation and repression of a gene (brk) by the same transcription factor (pMad) in the same cell 
via different regulatory elements. The activation of the BP1 response element by pMad is 
necessary to activate brk transcription in its graded mediolateral region where Brk also 
negatively autoregulates (as discussed in Chapter 2).  Without activation by pMad, brk 
expression is repressed to the lateral regions of the disc and has a very steep gradient due to 
repression by pMad and the MMS complex.  Activation by pMad is required at the BP1 element 
near the endogenous brk promoter to extend the steep brk expression profile into a more shallow, 
graded expression. 
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3.9.8 Why both activation and repression by pMad? 
Why are both activation and repression of brk expression by pMad necessary?  There are at least 
two possible reasons:  (1) Both activation and repression by pMad would be useful to act as a 
mechanism to stabilize the response of brk to Dpp and buffer against random fluctuations in 
pMad levels.  (2) pMad both activating and repressing brk could (and appears to) serve to modify 
the brk expression gradient.  With only repression of brk by pMad, the brk gradient is steep and 
confined more laterally (as demonstrated by reporter gene expression in B14B).  pMad activation 
(in addition to repression) serves to make the brk expression gradient more shallow and extended 
further medially. A shallow gradient is more useful for brk in that it allows for the generation of 
more separation of thresholds of responses spatially across the A/P axis; a steep expression 
gradient would not allow for many thresholds.  This spatial separation of thresholds of responses 
allows targets like sal and omb to respond more specifically to the amount of Brk present (Fig. 3-
18). 
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 Figure 3-18: Both repression and activation by pMad allow many thresholds of target gene responses. 
(A) When only repression by pMad contributes to the brk expression profile, the brk gradient is steep and confined 
to lateral regions.  Only a limited spatial separation of threshold responses to Brk concentration can be sensed by brk 
target genes.  (B) When repression and activation by pMad contribute to the brk expression profile, the brk gradient 
is shallower and extends further medially.  A shallow gradient allows for a clear spatial separation of threshold of 
responses sensed by brk target genes.  
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4.0  CONCLUSIONS AND FUTURE DIRECTIONS 
The goal of the research presented here was to understand how a brk expression gradient is 
established from a complementary gradient of BMP signaling.  Here, I have demonstrated that 
(1) Brk does not repress through binding standard sites and that it acts at the brk S element 
through interactions with members of the MMS complex to autoregulate, and (2) correct brk 
gradient profile and position requires not only sequences found in B14 but also a region near the 
endogenous promoter where pMad binds and activates expression.  This rescue adds support to 
the notion that the brk expression gradient must be properly placed to allow brk to influence 
spatial patterns of gene expression necessary for correct patterning.  
4.1 CAN A UNIFORM ACTIVATOR AND A GRADIENT OF REPRESSOR 
GENERATE A GRADED REPRESSIVE OUTPUT? 
Prior to my studies, it was thought that the brk repression gradient is the output established from 
two inputs: a uniformly expressed activator (the identity of which is still unknown) and a 
gradient of a repressor (pMad as a member of the MMS complex).  In theory, it may be thought 
that a proportional transcriptional response from a graded input (pMad repression gradient) 
would be generated quite easily (Fig. 4-1 A); however, very few examples exist in the literature 
of an input repression gradient resulting in an inverse expression gradient (most examples of 
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input repression gradients generate threshold output responses) indicating that utilizing a 
repression gradient to generate an inverse expression gradient may be quite difficult or has not 
yet been explored in great detail due to its high degree of complexity. 
The reporter gene expression pattern of the brkXA mutant is an example of an expression 
pattern generated by only two inputs: a pMad/MMS complex repression gradient as well as 
ubiquitous activation by the activator (Fig. 4-1 B).  This mutant exhibits a threshold output of 
expression, not a graded expression output; there is not a proportional response of brk expression 
to the graded MMS input, rather, brk expression switches from completely off to completely on 
at a specific level of pMad.  This supports the hypothesis that it may be difficult to generate an 
inverse output expression gradient output from an input repression gradient.  Additionally, many 
gap genes important for early Drosophila embryonic development are repression gradients; 
however, their outputs are threshold responses, not graded responses.  This observation again 
supports the hypothesis that activation by the activator and graded repression by pMad/MMS 
complex are unable to generate a graded brk output on their own as no extended region of 
expression levels that can be sensed by the two inputs exists; the decision of whether or not brk 
is expressed is a simple threshold response: on or off. 
I would like to propose that for the brk gene (and probably for other genes as well), if 
only a single activator input and a single repressor input exits, it is difficult to establish a 
situation where there are intermediate levels of output expression; expression is either off or it is 
on at full levels.  In the case of brk expression, I believe that Brk negative autoregulation serves 
several purposes, as discussed in the next section, but the most important purpose of Brk 
negative autoregulation is that it is required to generate a graded repression output through its 
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interactions with pMad thereby modulating the activity of the MMS complex (Fig. 4-1 C).  This 
permits the generation of intermediate levels of expression, as will be discussed in detail below. 
 
 
 
 
Figure 4-1: Model for the establishment of graded brk expression. 
(A) Predicted expression model resulting from ubiquitously expressed activator and graded repressor inputs.  (B) brk 
expression resulting from ubiquitously expressed activator and graded repressor inputs is not graded, rather a 
threshold response is achieved; brk expression is either on or off.  (C) Brk negative autoregulation as a third input 
allows graded brk output expression due to the establishment of a feedback loop. 
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4.2 WHY DOES BRK NEGATIVELY AUTOREGULATE? 
There are at least three reasons why brk negatively autoregulates, as discussed in Moser and 
Campbell, 2005: first, to stabilize the brk expression gradient, second, to increase the sensitivity 
of cells to Dpp, and third, to ensure that the response to pMad is graded and not all-or-none.  
 First, Brk negative autoregulation may act as a feedback mechanism to ensure that the 
brk expression gradient is stable.  This would buffer against random fluctuations in brk levels 
and, importantly, against gross changes in levels that would be found, for example, in brk mutant 
heterozygotes compared to wildtype animals. 
Second, as already noted, pMad levels appear to be the same in the presence or absence 
of Brk, but in the mediolateral region, cells lacking Brk are unable to repress brk.  Consequently, 
if brk expression is used as a read-out of BMP signaling, these cells now fail to respond to the 
low levels of Dpp present in this region.  When Brk is present, these cells can now repress brk 
and this effectively allows cells to respond to these low levels of Dpp to which they cannot 
respond in the absence of Brk.  Thus, Brk negative autoregulation may act as a novel mechanism 
to extend the range of Dpp signaling in this tissue.   
Third, and most importantly, Brk negative autoregulation appears to be necessary in order 
to establish graded expression of brk from the pMad gradient. It is essential that there is not a 
simple threshold response of brk to pMad, but that the response is continuous from low to high.  
In the absence of Brk there is a threshold response, i.e. below a certain concentration of pMad 
there is no effect upon brk expression, but slightly higher levels result in complete repression, as 
demonstrated by the brkXA mutant: lacZ expression is either on or off.  However, Brk negatively 
autoregulates by interacting with the MMS complex at the brk S.  This repression from Brk 
changes the MMS activity gradient to non-constant, extending/modulating the activity of the 
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MMS complex and altering the two threshold responses described above into a series of 
equilibrium responses (to repression by Brk/MMS and activation by the activator) to ultimately 
create the brk expression pattern.  It is possible that the activator induces brk expression thereby 
increasing the activity of the MMS complex because more Brk protein can bind to it.  Brk 
protein binding to the MMS complex modulates the activity/effective range of the MMS 
complex laterally, but the amount of MMS complex is also decreasing laterally as pMad is 
expressed in a medial to lateral gradient.  Therefore, the brk expression pattern is an equilibrium 
response to the amount of each input present at each position in the gradient. There is not a 
single repressive input of the MMS complex only; the input repression utilizes Brk to contribute 
to the overall pattern of brk output expression.   
4.3 THE MECHANISM OF BRK AUTOREGULATION DIFFERS FROM THAT 
USED FOR TARGET GENE REPRESSION 
Brk possesses a DNA-binding domain that it uses to interact directly with the cis-regulatory 
response elements of a number of Dpp target genes to repress their expression (Kirkpatrick et al., 
2001; Rushlow et al., 2001; Saller and Bienz, 2001; Sivasankaran et al., 2000; Zhang et al., 
2001). Target gene repression by Brk requires this DNA-binding domain plus a repression 
domain/motif (to which it recruits co-repressors) in order for Brk to act as a transcriptional 
repressor of its target genes such as sal and omb (Winter and Campbell, 2004).   
Brk does not function in its typical transcriptional repressor role when it is autoregulating 
its own expression.  Negative autoregulation by Brk appears to function by Brk not binding to its 
binding sites on DNA but rather by interacting with pMad and promoting the activity of the 
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MMS repressive complex.  Other examples exist describing transcription factors that bind other 
complexes of proteins instead of their own binding sites.  The Teashirt (Tsh) protein functions as 
a transcriptional repressor of UbxB in the embryonic midgut by acting through a response 
element in UbxB by promoting the activity of another repressive complex, not by binding to the 
element; in this case, Tsh interacts with Brk, which binds its own binding sites directly on the 
UbxB response element (Saller et al., 2002).  It may be important for the function of Brk in 
autoregulation that it behaves in this previously un-described (for Brk), non-traditional manner—
most likely, the two forms of repression exhibited by Brk (binding its binding sites and recruiting 
co-repressors versus modulating the activity of another repressive complex) are different and the 
form of repression utilized is specific to the function Brk is performing.  Experiments to test this 
hypothesis will be described below. 
4.4 DEFINING THE CORRECT SLOPE AND POSITION OF THE BRK GRADIENT 
REQUIRES ACTIVATION BY MAD 
The studies I have performed indicate that both transcriptional activation and repression by 
pMad are necessary to generate the brk expression profile.  pMad activation at the BP1 element 
is necessary for proper graded brk expression.  Is it important that the activating Mad binding 
sites contained within BP1 (like those found in MP and BPB) are near the promoter?  The 
localization of the sites suggests that they act over a short range, possibly to recruit basal 
transcriptional machinery or to recruit co-factors important for opening the chromatin to allow 
the transcriptional machinery access to initiate transcription.  Although this has not yet been 
determined, potential experiments to test this hypothesis are described below. 
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How does pMad both activate and repress the same gene in the same cells at the same 
time?  And why does the repressive power of pMad in the MMS complex win over the activating 
power of the activator in the medial portions of the disc and not in the mediolateral regions? At 
least two possible explanations exist: (1) There is a difference in the number or affinity of pMad 
binding sites between the S and BP1.  The repressive sites may be high response targets meaning 
that they respond to high amounts of pMad while the activating sites contained within BP1 may 
be low response targets that respond only to low amounts of pMad.  Thus, the repressive power 
of pMad may be stronger than its activating power indicating that when the repressive sites at the 
S are occupied, they over-come any activation by pMad bound at activating sites.  These 
repressive sites preferentially loose pMad binding when pMad levels begin to decrease 
mediolaterally such that more pMad is bound at the activating sites in this region of the wing 
disc.  (2) Alternatively, the activating pMad binding sites at BP1 near the endogenous brk 
promoter may not be accessible when pMad is bound at repressive sites at the brk S in the medial 
region of the wing disc.  In order for the activating sites at BP1 to be functional, they may need 
the brk activator to initiate transcription mediolaterally for the chromatin to be opened enough 
for these binding sites to be available for pMad binding.  This possibility would help explain 
why the activating pMad binding sites contained within BP1 are located so close to the brk 
promoter.   Regardless of the mechanism of action, this type of response would not be possible if 
pMad was exerting both transcriptional activation and repression at the same response element.   
pMad is not the only example of a transcription factor that can act as both a 
transcriptional activator and a transcriptional repressor of the same gene: Tcf/Lef and Su(H), as 
described above, can both activate and repress their target genes (Barolo et al., 2002; Brantjes et 
al., 2001).  However, this activation and repression differs dramatically from that which I am 
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describing for the actions of pMad on Brk.  Tcf/Lef and Su(H) activate and repress transcription 
through interactions at the same response element  of their target genes.  The decision to activate 
or repress is controlled by the partners with which these transcription factors bind at the response 
element.  Conversely, pMad functions to activate and repress the transcription of Brk at the same 
time by binding to two different response elements.   This may be key to understanding how 
graded brk expression is achieved: if pMad were bound to the same response element, 
transcriptional activation may never occur because it appears that pMad is much more active as a 
transcriptional repressor.  The ability of pMad to activate and repress at separate sequence 
elements within the same cell to control the same gene appears to allow both transcriptional 
activities (activation and repression) to be present at the same time in order to regulate the 
expression of brk.   
4.5 MUTLIPLE RESPONSE ELEMENTS ARE NECESSARY TO CREATE THE 
BRK EXPRESSION PATTERN 
I have demonstrated that repressive and activating forces at multiple response elements are 
necessary for proper brk expression.  Without all the inputs, brk expression is not graded and is 
not located in the correct position.  It is not unusual that the brk response element would be 
derived of so many separate response element units; genes important in development often 
contain response elements with separate specificity (S portion of B14, MP, BPB) and signal 
amplification (enhancer portion of B14) portions (Arnosti, 2003). Alternatively, response 
elements like MP and BPB may also be serving in certain contexts for signal amplification; they 
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appear to be required for brk expression to be activated in mediolateral regions of the wing disc 
as demonstrated by the studies of reporter and rescue constructs with and without BP1.   
It is predicted that each separate response element of brk can independently affect gene 
expression.  Some of the response element units appear to recruit complexes of proteins (e.g. the 
silencer) while others appear to function as single or small groups of binding sites to direct 
function (e.g. MP or BPB).  While it appears for brk that each response element is independently 
undergoing interactions with its binding proteins to influence transcription, the total end–product 
of transcription necessary to generate the complex brk pattern of expression during development 
probably requires the activity of all the response elements functioning combinatorially (Arnosti, 
2003; Arnosti and Kulkarni, 2005).   
4.6 MODEL OF BRK AUTOREGULATION AND GRADIENT FORMATION IN 
THE DROSOPHILA WING 
Based on the research described above, we have generated a model to describe the mechanism by 
which the brk expression gradient is established (Fig. 4-2).  Our model proposes that there are 
four primary inputs necessary for brk gradient formation:  (1) A yet-unknown activator binds to 
sequences in the enhancer portion of B14 to drive expression throughout the wing pouch.  (2) A 
MMS repression complex binds to the S, with pMad becoming limiting the further from the Dpp 
source, repressing the expression of brk to lateral regions of the wing disc.  With just these two 
inputs alone, a competition exists between activation by the activator and repression by the MMS 
complex. (3) Brk negatively autoregulates by interacting with the MMS complex at the brk S.  
(4) Activation by Mad occurs at elements contained within the BP1 response element near the 
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endogenous brk promoter.  The combination of all these inputs results in the full recapitulation of 
brk expression.    
 
 
 
 
 
Figure 4-2: Model for the generation of the brk expression gradient. 
LEFT: The data presented in this thesis supports a model that suggests there are four primary inputs necessary to 
generate graded brk expression: (1) A unidentified activator binds to sequences in the enhancer, (2) A 
pMad/Med/Shn repression complex binds to the silencer with pMad levels becoming limiting further from the Dpp 
source, (3) Brk negatively autoregulates, probably by interacting with the MMS complex at the S, (4) Additional 
activating elements present close to the promoter recruit pMad as an activator.  RIGHT: The brk expression pattern 
is described graphically and schematically on wing imaginal discs for each of the represented sets of inputs. 
 
 
 
4.7 FUTURE EXPERIMENTS TO STUDY BRK AUTOREGULATION AND 
GRADIENT FORMATION 
4.7.1 Interactions between Brk and pMad 
Immunoprecipitation experiments indicated Brk binds to pMad and MBP-PD experiments 
indicated Brk interacts directly with pMad and Med in the absence of DNA.  Other transcription 
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factors that interact with pMad do so via discrete domains.  To be confident that interactions 
between Brk and pMad are specific, we would expect to identify such a discrete pMad 
interaction domain in Brk by conducting MBP-pull down experiments to further narrow down 
which portion of Brk is necessary for this interaction.  N-terminal deletions of Brk have been 
created and could be tested for their ability to interact with Mad and Med as C-terminal 
truncations do not disrupt complex formation. 
Additionally, to identify the region or domain/motif of Brk necessary for autoregulation, 
studies could be conducted in embryos where modified forms of Brk containing different 
domain/motifs would be driven with enG4 and B14 expression evaluated.  Modified forms of Brk 
unable to repress B14 would help to narrow down the domain/motif necessary for Brk 
autoregulation. 
4.7.2 Interactions of Brk at the silencer 
4.7.2.1 EMSA studies 
Preliminary studies suggested that the N-terminal region of Brk may bind weakly to an EMSA 
probe covering the brk S, but we were unsure if this binding was physiologically relevant as the 
Brk protein utilized contained only the DNA binding domain (data not shown). The Brk DNA 
binding domain was not evaluated for its ability to bind weakly to random sequences of DNA 
that did not contain a cognate Brk site.  Additionally, MBP-MadNL and the N-terminal region of 
Brk could not simultaneously bind to the S (data not shown).  To determine if full-length Brk 
could bind the brk S in EMSA studies, in vitro translated full-length Brk protein could be tested 
on EMSA.  Similar experiments using full-length Brk could test the ability of Brk to 
simultaneously bind the S with MBP-MadNL.   
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The existence of the MMS complex was originally revealed by using S2 cells transfected 
with constructs encoding tagged forms of Mad, Med, and Shn as well as a constitutively active 
form of Tkv, utilized to upregulate BMP signaling (Muller et al., 2003; Pyrowolakis et al., 2004).  
In EMSAs, proteins from cells transfected with these constructs could shift the S element and 
specificity was demonstrated with supershifts using antibodies against the tags (Pyrowolakis et 
al., 2004).  To determine if Brk binds together with the MMS construct to the S, these 
experiments could be repeated with co-transfection of a construct encoding a tagged Brk protein.  
If Brk binds together with the MMS complex, it would result in a shifted band with a slower 
mobility than that of the MMS complex alone; the band should also supershift with an antibody 
against Brk or its tag. 
4.7.2.2 ChIP experiments 
Because the ChIP experiments described in Chapter 2 utilizing embryo extracts failed to indicate 
an enrichment of Brk at UbxB or the brk S, these experiments could be attempted utilizing wing 
imaginal disc tissue.  Driving a tagged Brk protein in half of the tissue utilized in the generation 
of chromatin (with enG4) will significantly enrich the population of cells in which Brk is 
autoregulating.  Additionally, ChIPs in discs are advantageous as our lab has conducted detailed 
studies on sal and omb, two Brk targets in the wing that could be used as positive controls (GC, 
unpublished results).  If ChIP experiments are successful in demonstrating that Brk is found at 
the brk S, this would help to rule out the possibility that Brk autoregulates by regulating the 
activity of an unknown activator of an unknown repressor of Brk.   
If these studies with imaginal discs were successful, ChIP experiments that could be 
conducted in the future that would include IPs utilizing antibodies against the myc-tagged Mad 
protein.  These experiments would indicate which regions of the brk regulatory elements are 
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bound by pMad.  We would expect to find pMad at the S element as well as at the activating 
Mad binding sites contained within the BP1 element.  pMad may also be found at other Mad 
binding sites present in the brk regulatory region.  Depending on the specificity of the region Brk 
was determined to bind, interactions between pMad and Brk could be supported by comparing 
ChIP results if they indicate that both proteins interacted at the same region, particularly the S 
element.   
ChIP experiments could also be conducted in embryos where UAS-Dad was driven in 
addition to UAS-Brk.  My studies already indicated that UAS-Dad (utilized to reduce the levels 
of pMad) caused Brk to no longer autoregulate the B14 response element indicating that 
autoregulation by Brk is dependent on pMad.   If Brk was demonstrated by ChIP to interact at 
the S, then a ChIP experiment in these embryos could be utilized to demonstrate where (or if) 
Brk binds in the absence of pMad.  It would be predicted that if pMad and Brk interact together 
at the S to allow Brk to autoregulate, driving UAS-Dad in embryos should cause Brk to no 
longer be found at the S. 
4.7.3 Method of Brk negative autoregulation 
To determine if Brk could autoregulate by binding its own binding sites rather than interacting 
with the MMS complex, a form of Brk could be generated that cannot interact with the MMS 
complex.  This could be determined by MBP-pull down experiments.  This protein would then 
be used to replace the endogenous form of Brk.  The ability of the modified Brk to rescue the 
brkXA mutant would then be evaluated.  If rescue was still possible, this would indicate that Brk 
could autoregulate without its interactions at the MMS complex, presumably by binding its own 
binding sites contained within its regulatory regions. 
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4.7.4 Studies contrasting the activity of pMad at the S and BP1 elements 
To determine what causes pMad to both activate and repress brk through the BP1 and S 
elements, as described above, EMSA studies could be conducted to determine how many pMad 
protein molecules are bound to both the S and MP elements.  Presumably, more than one pMad 
binds to the BP1 element.  EMSA studies could also be conducted to determine if the binding 
sites at the S are higher affinity Mad binding sites than those contained at the MP element to 
shed light on the mechanisms utilized by pMad to activate and repress at the same time in the 
same cells. 
4.7.5 Studies to determine how pMad activates transcription 
To begin to address the hypothesis that pMad activates at the BP1 element by promoting the 
chromatin modification or the recruitment of the basal transcriptional machinery, ChIP studies 
could be performed on Drosophila S2 cells transfected with a construct similar to the VgQMPB 
construct.  This S2 cell construct would be transcriptionally activated in response to pMad.  ChIP 
would be performed on cells transfected with this construct using antibodies that detect 
chromatin modification (specifically against acetylated histones that promote transcriptional 
activation) and antibodies that detect members of the basal transcriptional machinery.  This 
experiment would indicate what proteins are recruited to pMad when it activates transcription. 
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4.8 GRADIENTS ARE USED THROUGHOUT DEVELOPMENT TO PATTERN 
ORGANISMS 
BMPs and other TGF-ßs act as morphogens in many developmental systems (Chen and Schier, 
2001; McDowell and Gurdon, 1999) and, although a direct vertebrate homolog of Brk has not 
been identified, the results described here pose a number of questions about how BMP/TGF-ß 
signaling functions to regulate gene expression.  For example, are analogous transcriptional 
mechanisms required to boost the response of cells to low levels of external signaling molecules?  
Also, in regard to Smad activity, are transcriptional responses to Smads more likely to be largely 
all-or-none as with brk expression in the absence of Brk so that special mechanisms are required 
to modulate this to a more graded response when required? 
The studies I have performed have added two additional layers to the information known 
about the establishment of the brk expression gradient.  While it was previously thought that one 
positive input (activation by a yet un-identified activator) and one negative input (repression by 
the MMS complex on the S) created graded brk expression, my studies demonstrated that an 
additional negative and positive influence were necessary: negative autoregulation by Brk and 
activation by Mad at a previously un-identified element.  This information greatly contributed to 
the understanding of how a brk expression gradient is established in the correct location so that it 
can properly generate spatial patterns of gene expression. 
The research I have conducted will be useful and applicable to other gradients of factors 
established in response to morphogen gradients.  Gradients of transcription factors play essential 
roles in virtually all developmental systems.  In addition to brk and the other Drosophila 
examples I have described, gradients of transcription factors pattern vertebrates where examples 
include a gradient of Pax6 that appears to be negatively autoregulated and is important for 
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corticogenesis, a gradient of thyroid hormone that is responsible for establishing graded cone 
opsin expression in the developing mouse retina, and an inverse expression gradient of Irx5 to 
graded potassium channel expression where Irx5 recruits a co-repressor, m-Bop, to repress 
potassium channel expression in mouse cardiac ventricular repolarization (Costantini et al., 
2005; Flanagan, 2006; Manuel et al., 2007; Roberts et al., 2006).  Understanding how these 
gradients are established and how they are used to establish spatial patterns of gene expression is 
essential to understanding how these developmental systems operate.  The generation of the brk 
expression gradient and the use of the Brk protein gradient to define limits of gene expression 
provides an excellent model system to examine the basic mechanisms involved in these 
processes and should provide novel insights into how other transcription factor gradients are 
established and utilized. 
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5.0  METHODS 
5.1 FLY STRAINS UTILIZED FOR STUDIES 
w1118 (w[1118]),  w;∆2-3 (w[*]; ry[506]P(ry[+t7.2]=Delta2-3)99B), brkM68, brkXA, brkX47, 
brkF124, UAS-3PF3-HA (Dmel\brkScer\UAS.T:Ivir\HA1), tkvQD (tkvQD.Act5C), B14X (Ecol\lacZbrk.B14), 
B315X (Ecol\lacZbrk.B315), dppE-brkS (Ecol\lacZdpp.DB271), ombG4 (biomb1-GAL4), UASGFP 
(avic\GFPScerFRT.RnorCD2:Tub84B), enG4 (Scer\GAL4en-e16E), hs-GFP (avic\GFPhs.T:HsapMYC), hs-flp 
(P(hsFLP)22), FRT18 ((P(ry[+t7.2]=neoFRT)18), Ubiq-mycmad (MadUbi-p63E.T:Hsap\MYC), UAS-
Dad (DadScer\UAS.cTa), Mad1-2 (w[*]; Mad[1-2] P(ry[+t7.2]=neoFRT)40A/CyO), Med2 (ru[1] h[1] 
P(ry[+t7.2]=neoFRT)82B sr[1] e[s] Med[2]/TM3, Sb[1]) 
5.2 GENERATION OF REPORTER CONSTRUCTS 
5.2.1 Reporter constructs created to test B14 and B315 
Constructs created to test the regulatory regions of brk were cloned into GFP or lacZ reporter 
vectors.  pH-Stinger, pStinger, and pH-Pelican vectors are as described (Barolo et al., 2000).  
pHSB is a modified version of the pH-Stinger vector in which the two Brk binding sites in the 
hsp70 promoter have been mutated by inverse PCR (Campbell, unpublished).  pHSG4 is a 
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modified version of pHSB where Gal4 replaces GFP (Campbell, unpublished).  C4PLZ is a lacZ 
reporter enhancer-testing vector as described (Wharton and Crews, 1993).  pX27 is a lacZ 
reporter enhancer-testing vector as described (Segalat et al., 1994).  pUAST is an over-
expression vector as described (Brand, 1993). 
All transgenic lines were generated in the following manner: plasmid DNA (final 
concentration 0.8µg/µL) containing the transgene were injected into the posterior of w1118 or 
w;2-3 embryos.  Injected embryos were incubated at 18C in humidity chambers until larvae 
emerged from vitelline membranes.  Larvae were collected and placed in food vials at 25C until 
adults emerged.  Each adult G0 fly was mated to three w1118 flies of the opposite sex and the F1 
generation from each vial was screened for flies containing w+ eye color indicative of 
transformation. 
5.2.1.1 B14 enhancer-testing constructs 
B14B was created by cloning the 6.8 kb EcoRV fragment of lambda genomic clone 347 
(Campbell and Tomlinson, 1999) into the EcoRV sites of pBluescript to create 347RVS.  The 
AvrII/NotI fragment from 347RVS was cloned into the AvrII/NotI sites of pBluescript to create 
B14S.  The Asp718/SacII fragment of B14S was cloned into the Asp718/SacII sites of pHSB to 
create B14B.  B14Z was created by cloning the Asp718/NotI fragment of B14S into the 
Asp718/NotI sites of C4PLZ.  B14G was created by cloning the Asp718/SacII fragment of B14S 
into the Asp718/SacII sites of pHSG4. 
5.2.1.2 B14 with deletions of putative Brk binding sites 
B14BB was created by first cloning the XbaI fragment of lambda genomic clone x4795 
(Campbell and Tomlinson, 1999) into the XbaI site of pBluescript creating 347B.  The 
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Asp718/BglII fragment of 347B was then cloned into the Asp718/BamHI sites of pBluescript 
creating 347ABgS.  Inverse PCR was performed on 347ABgS using primers Brk7A and 
Brk7B (primer sequences reported in Table 5-1).  The PCR product was digested with BsiWI 
(restriction site provided by primers) and ligated to create 347BaBgS.  The AvrII/PmeI 
fragment of 347BaBgS was cloned into the SpeI/PmeI sites of B14S to create B14BS.  The 
Asp718/SacII fragment of B14BS was cloned into the Asp718/SacII sites of pHSB creating 
B14BB.  B142BB was created by initially performing inverse PCR on B14S using primers 
Brk14A and Brk14B.  The PCR product was digested with AgeI (restriction site provided by 
primers) and ligated to create B142BS.  The Asp718/SacII fragment of B142BS was cloned 
into the Asp718/SacII sites of pHSB creating B142BB.  B142M15B was created by initially 
performing inverse PCR on B142BS using primers brk15MA and brk15MB.   The PCR 
product was digested with AfeI (restriction site provided by primers) and ligated to create 
B142M15S.  The Asp718/SacII fragment of B142M15S was cloned into Asp718/SacII 
digested pHSB creating B142M15B. 
5.2.1.3 B315 enhancer-testing constructs 
B315X was obtained from Bruno Muller (Muller et al., 2003).  B315B was created by first 
cloning the Asp718/XbaI fragment of B315X into the Asp718/XbaI sites of pBluescript to create 
B315S.  The Asp718/SacII fragment of B315S was then cloned into the Asp718/SacII sites of 
pHSB to create B315B.  B315R was created by cloning the Asp718/SacII fragment of B315S 
into the Asp718/SacII sites of pH-Stinger.  B315N was created by cloning the Asp718/SacII 
fragment of B315S into the Asp718/SacII sites of pH-Pelican.   
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5.2.1.4 B315 with mutations of putative Brk binding sites 
B315M15B was created by initially performing inverse PCR on B315S with brk14MA and 
brk15MB.  The PCR product was digested with AfeI (restriction site provided by primers) and 
ligated to create B315M15S.  The Asp718/SacII fragment of B315M15S was cloned into the 
Asp718/SacII sites of pHSB to create B315M15B.  B315M15X was created by cloning the 
Asp718/XbaI fragment of B315M15S into the Asp718/XbaI sites of B315X.  
5.2.2 Reporter constructs created to test regions near the endogenous promoter of brk in 
the fly 
B14BP1P was created by initially performing PCR on 347RVS template DNA with primers 
B14F2 and B14R1.  The PCR product was digested with AvrII and cloned into the XbaI site of 
pStinger to create B14P.  PCR was then performed on lambda genomic clone 366 (Campbell and 
Tomlinson, 1999) template DNA with primers BP1F1 and BP1R1.  The PCR product was 
digested with Asp718/BsiWI and cloned into the Asp718 site of B14P creating B14BP1P.  
B14BP2P was created by performing PCR on 366 template DNA with primers BP2F2 and 
BP1R1.  The PCR product was digested with Asp718/BsiWI and cloned into the Asp718 site of 
B14P creating B14BP2P.  B14BP1MP was created by initially performing PCR on 366 template 
DNA with primers BP1F1 and BP1R1.  The PCR product was digested with Asp718/BsiWI and 
cloned into the Asp718/BsiWI sites of the pLitmus29 vector to create BP1L.  Inverse PCR was 
then performed on BP1L using PCR primers brkMPF2 and brkMPR2.  The PCR product was 
digested with AgeI (restriction site provided by primers) and ligated to create BP1ML.  The 
Asp718/BsiWI fragment of BP1ML was cloned into the Asp718 site of B14P creating 
B14BP1MP.   
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B14BPAP was created by initially performing PCR on BP1L template DNA with primers 
brkMPF4b and pLitseqR.  The PCR product was digested with Asp718/BglII and cloned into the 
Asp718/BglII sites of pLitmus29 to create BPAL.  The Asp718/BsiWI fragment of BPAL was 
then cloned into the Asp718 site of B14P creating B14BPAP.  B14BPBP was created by initially 
performing PCR on BP1L template DNA with primers brkMPF3 and pLitseqR.  The PCR 
product was digested with Asp718/BglII and cloned into the Asp718/BglII sites of pLitmus29 to 
create BPBL.  The Asp718/BsiWI fragment of BPBL was then cloned into the Asp718 site of 
B14P creating B14BPBP.  B14MPB was created by initially annealing oligos brkMPds1 and 
brkMPds2 and cloning into the BamHI site of pHSB to create MPB.  The Asp718/SacII fragment 
of B14S was then cloned into the Asp718/SacII sites of MPB to create B14MPB. 
5.2.3 Reporter constructs created to test for activation by Mad 
To create VgQB, VgQS (also known as VgQBsk) was obtained from the Carroll Lab.  The 
Asp718/SacII fragment of VgQS was cloned into the Asp718/SacII sites of pHSB creating 
VgQB.  VgQnomadB was created by initially performing inverse PCR on VgQS with primers 
VgQF1 and VgQR1.  The PCR product was digested with BamHI (restriction site provided by 
primers) and ligated to create VgQnomadS.  The Asp718/SacII fragment of VgQnomadS was 
cloned into the Asp718/SacII sites of pHSB to create VgQnomadB.  To create VgQMPB, 
annealed oligos brkMPds1 and brkMPds2 were cloned into the BamHI site of VgQnoMadS to 
create VgQMPS.  The Asp718/SacII fragment of VgQMPS was cloned into the Asp718/SacII 
sites of pHSB to create VgQMPB.  To create VgQBPBB, annealed oligos BPB2dsF and 
BPB2dsR were cloned into the BamHI site of VgQnoMadS to create VgQBPBS.  The 
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Asp718/SacII fragment of VgQBPBS was cloned into the Asp718/SacII sites of pHSB to create 
VgQBPBB. 
5.2.4 Miscellaneous reporter constructs created 
B216X was created by Asp718/SpeI digestion of B315X.  The product was Klenow treated and 
re-ligated to create B216X.  HA3PF3HAU was created by initially performing PCR on template 
DNA Flu3PRX (Winter and Campbell, 2004) with primers FluF and FluR.  The PCR product 
was digested with Asp718/XhoI and cloned into the Asp718/XhoI sites of pUAST to create 
FluU.  PCR was then performed on template DNA brk3PF2 (Winter and Campbell, 2004) with 
primers 3PFAspF and M13R.  The PCR product was digested with Asp718/XbaI and cloned into 
the Asp718/XbaI sites of FluU to create HA3PF3HAU.  Flag3PF3HAU was created by initially 
performing PCR on template vector DNA pCMV-3FLAG-1a (Sigma-Aldrich) with primers 
FlagF and FlagR.  The PCR product was digested with Asp718/XhoI and cloned into the 
Asp718/XhoI sites of pUAST to create FlagU.  PCR was then performed on template DNA 
brk3PF2 with primers 3PFAspF and M13R.  The PCR product was digested with Asp718/XbaI 
and cloned into the Asp718/XbaI sites of FlagU to create Flag3PF3HAU.    
5.3 GENERATION OF RESUCE CONSTRUCTS 
B1470brkW was created by initially performing PCR on template DNA pHSB with primers 
pHSBA1 and pHSBA2.  The PCR product was digested with KpnI/BsiWI and cloned into the 
KpnI/BsiWI sites of pLitmus29 creating hsp70L.  The KpnI/BsiWI fragment of hsp70L as well 
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as the BsiWI/XbaI fragment of lambda genomic clone 366 (Campbell and Tomlinson, 1999) 
were cloned into the KpnI/XbaI sites of pLitmus29 creating hsp70brkL.  The KpnI/XbaI 
fragment of hs70brkL was then cloned into the KpnI/SpeI sites of B14BP1P creating 
B1470brkW.  B14BP1brkW was created by cloning the XbaI fragment of 366 into the XbaI/SpeI 
sites of B14BP1P.  B14BP2brkW was created by cloning the XbaI fragment of 366 into the 
XbaI/SpeI sites of B14BP2P.  B14BP1MbrkW was created by cloning the XbaI fragment of 366 
into the XbaI/SpeI sites of B14BP1MP.   
B14BPAbrkW was created by cloning the XbaI fragment of 366 into the XbaI/SpeI sites 
of B14BPAP.  B14BPBbrkW was created by cloning the XbaI fragment of 366 into the 
XbaI/SpeI sites of B14BPBP.  B14MP70brkW was created by initially cloning the XhoI/XbaI 
fragment of hsp70brkL into the XhoI/SpeI sites of MPB creating MP70brkW.  PCR was then 
performed on B14S template DNA with primers B14FAsc and B14RAsp.  The PCR product was 
digested with Asp718/AscI and cloned into Asp718/AscI cut MP70brkW to create 
B14MP70brkW.  B14BPB70brkW was created by initially performing PCR on BP1L template 
DNA with primers BPBBamF and BPBBamR.  The PCR product was digested with BamHI and 
cloned into the BamHI site of pBluescript creating BPBS.  The Asp718/BamHI fragment from 
BPBS was then cloned into the Asp718/BamHI sites of pHSB creating BPBB.  The XhoI/XbaI 
fragment of hsp70brkL was then cloned into the XhoI/SpeI sites of BPBB creating BPB70brkW. 
PCR was then performed on B14S template DNA with primers B14FAsc and B14RAsp.  The 
PCR product was digested with Asp718/AscI and cloned into Asp718/AscI cut BPB70brkW to 
create B14BPB70brkW. 
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 Table 5-1: Primers used to generate transgenic lines. 
Primer Name 5'-Sequence-3'
3PFAspF gatcggtaccATGGATAGCAGCAGCGAACAG
B14F2 AGGTCGCACCACAAAGGG
B14FAsc gatcggcgcgccCCTAGGGAGACCTAAAACTACAG
B14R1 gatccctaggCGGCCGCACACTCATGTC
B14RAsp gatcggtaccTACGGCCGCACACTCATGTCG
BP1F1 gatcggtaccCTGCACGCACACGAACAC
BP1R1 ATGTCTGCGTGCTGTTGC
BP2F2 gatcggtaccTGTAGCGCAGCCAGAAAC
BPB2dsF gatcAACTAGAACGCCGAGGGCAGAACAATTGTGTTTTGGATTCCTTGCCGTGC
BPB2dsR gatcGCACGGCAAGGAATCCAAAACACAATTGTTCTGCCCTCGGCGTTCTAGTT
BPBBamF gatcggatccGGCGAGGCAGTCTAGAAC
BPBBamR gatcggatccGCACGGCAAGGAATCCAAAAC
brk15MA gatcgatcagcgctTAATGGATAGTTCTTCTC
brk15MB gatcgatcagcgctTGAGTTCGCTTCGGTTCG
brkMPds1 gatcGTCGACGGCGGCGCCGGCAGCGACGCCGGCCGAGGC
brkMPds2 gatcGCCTCGGCCGGCGTCGCTGCCGGCGCCGCCGTCGAC
brkMPF2 gatcaccggtGGCGAGGCAGTCTAGAAC
brkMPF3 atgcggtaccGGCGAGGCAGTCTAGAAC
brkMPF4b atgcggtaccGTCGACGGCGGCGCCGGCAGCGAC
brkMPR2 gatcaccggtTGCGGTTCACTCTGAAAT
Brk14A gatcaccggtAACAGGTACTCGAGGAAC
Brk14B gatcaccggtGTCGACGCCTGCTAACTA
Brk7A gatccgtacgAACAGGTACTCGAGGAAC
Brk7B gatccgtacgCAAAAGAGCTGTAGCCAG
FlagF gatcctcgagGCCGCCACCATGGATTACAAG
FlagR gatcggtaccCGCCCGGGCTTTATCGTCATC
FluF gatcctcgagATGGCTGGGAATATCTACCCAT
FluR gatcggtaccTCCTGCGTAGTCCGGGACGTC
M13R GGAAACAGCTATGACCATG
pHSBA1 GCATGCTGCAGCAGATCTG
pHSBA2 gatccgtacgCTCTAGCGCGTACCCTAG
pLitseqR TGGCGAAAGGGGGATGTG
VgQF1 atgcggatccTTGGCGAGTGTGCCA
VgQR1 atgcggatccCCAAGCACAAACATT
 
 164 
5.4 CLONAL ANALYSIS AND EMBRYONIC ECTOPIC EXPRESSION STUDIES 
Homozygous mutant clones were generated in wing imaginal discs by hs-flp/FRT-induced 
mitotic recombination.  Clones were generated in the second or early third instar of larvae by 
heat shock for 60 minutes at 37C. 
Ectopic expression of UAS-3PF3-HA was performed by crossing to the Gal-4 expression 
lines en-Gal4 and en-Gal4UAS-GFP; both drive expression in the stripes in the embryo. 
5.5 IMMUNOSTAINING AND X-GAL STAINING  
Dissection and staining of wing imaginal discs was carried-out by standard techniques. The 
following primary antibodies were used: anti-Sal (rabbit, 1:50) (Kuhnlein et al., 1997); anti-gal 
(rabbit, 1:2000 Cappell) and (mouse, 1:200 Promega); anti-HA (mouse, 1:1000 Covance); anti-
GFP (rabbit, 1:1000 Torrey Pines); anti-brkR3 (rat, 1:200) (Campbell and Tomlinson, 1999).  
Secondary antibodies included Alexa 594 (rabbit), Alexa 488 (rabbit, mouse, rat), Alexa 568 
(mouse minX) (Molecular Probes), Cy3 (rat minX), and Cy5 (rabbit, mouse minX, rat minX) 
(Jackson Immuno Research).  Discs containing lacZ reporters were stained along side one 
another following a standard protocol and wings from adult flies were mounted in GMM.   
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5.6 ELECTROMOBILITY SHIFT ASSAYS 
5.6.1 Probe preparation 
Equal molar ratios of complementary oligos (Table 5-2) were mixed and annealed by heating to 
90C and slowly cooling to RT to a final concentration of 50pmol/uL.  Probes were radiolabeled 
by Klenow extension of 3’ ends using -32P dCTP and unincorporated nucleotides were removed 
using Bio-Rad Micro Bio-Spin P30 gel spin columns.  
5.6.2 EMSA reactions 
Reactions were performed by incubating bacterially expressed, purified fusion proteins (as 
described in 5.9) with 10,000cpm 32P-labeled probe in 10uL reactions in Mad Binding Buffer (all 
buffer recipes are in appendix A).  For competition experiments, 50X, 100X, or 300X of 
unlabeled probe was added to the reaction.  Reactions were incubated for 30 minutes at room-
temperature.  The entire reaction was separated on a non-denaturing 4% polyacrylamide gel 
following standard protocol.  The gels were dried and exposed to autoradiographic film.   
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Table 5-2: EMSA probe sequences. 
 
 
Primer Name 5'-Sequence-3'
brkMPF atgGTCGACGGCGGCGCCGGCAGCGACGCCGGCCGAGGC
brkMPR atgGCCTCGGCCGGCGTCGCTGCCGGCGCCGCCGTCGAC
brkMPM7MadF atgGTCGACAGCAGCGACAGCAGCGACACAGTCAGAGGCCAT
brkMPM7MadR atgATGGCCTCTGACTGTGTCGCTGCTGTCGCTGCTGTCGAC
UbxBF gacTCTGGACTGGCGTCAGCGCCGGCGCTTCCAGCT
UbxBR GGCAGCTGGAAGCGCCGGCGCTGACGCCAGTCCAGA
UbxBM2F atgTCTGGACTGATGTCAATAGTACTGCTTCATAT
UbxBM2R atgATATGAAGCAGTACTATTGACATCAGTCCAGA
 
 
5.7 WESTERN BLOTS 
All Western blot procedures were performed in a similar manner using standard procedures 
(Sambrook, 2001).  Proteins were separated on SDS-polyacrylamide gels along with Precision 
Plus Kaleidoscope protein standard markers (Bio-Rad) and transferred to Immobilon-P PVDF 
membranes (Millipore) for immunoblotting.  Immobilon-P PVDF membranes were pre-wet in 
methanol and soaked in 1X Anode Buffer.  Gels were soaked for 30 minutes in 1X Cathode 
Buffer prior to transfer.  Proteins were transferred to the membrane using a Trans-Blot SD Semi-
Dry Electrophoretic Transfer Cell at constant amperage for 30 minutes as suggested by the 
manufacturer (Bio-Rad).  Membranes were blocked in 1X PBS, pH 7.4 with 5% non-fat dry milk 
overnight at 4C. 
Detection of immunocomplexes was completed essentially as described in the 
manufacturer’s protocol for the ECL Western detection reagent (Amersham).  Blots were 
incubated in 1X TBST, 1% BSA, and primary antibody for one hour at room-temperature with 
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rocking followed by three five minute washes using 1X TBST.  Blots were then incubated in 1X 
TBST, 5% non-fat dry milk, and secondary antibody for 45 minutes with rocking followed by 
three five minutes rinses using 1X TBST.  After washing, immunocomplexes were detected 
using the ECL Western blotting kit (Amersham) and exposed to film.  Following imaging, if 
desired, blots were striped using 1X Western Strip Buffer for one hour at 50C then rinsed five 
times with 1X TBST and blocked as previously described before probing with a different 
antibody. 
The primary antibodies used for Western blotting are as follows: anti-HA (1:500, rabbit, 
Santa Cruz Biotechnology); anti-HA (1:200, mouse, Santa Cruz Biotechnology); anti-BrkR3 
(1:1200, rat); anti-mycHRP (1:400, mouse, Santa Cruz Biotechnology).  HRP-conjugated 
secondary antibodies for Western blotting were used at the following concentrations: anti-rat 
(1:5,000 Jackson Immuno Research); anti-rabbit (1:10,000 Jackson Immuno Research); anti-
mouse (1:18,000 Jackson Immuno Research). 
5.8 CO-IMMUNOPRECIPITATIONS 
5.8.1 Embryo lysate preparation 
Embryo collections were 0-20 hours at 25C for W1118 or  genotypes.  
Embryos were de-chorionated in 50% bleach for three minutes, rinsed well, and transferred into 
Eppendorf tubes containing cold 1X RIPA Lysis Buffer with protease inhibitors.  Embryos were 
homogenized with a pestle and the supernatant analyzed for the concentration of total protein as 
determined by Bradford analysis, according to standard procedure (Bio-Rad).   
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5.8.2 Immunoprecipitation reactions 
Reactions were performed in 500L volumes in 1X IP Buffer.  Typically, 25L of embryo lysate 
was used in each reaction with 1g of commercial antibody or 2L of anti-brkR3 antibody.  The 
antibody/embryo lysate/buffer solution was mixed for 4 hours at 4C with rocking after which 
20µL of 50% slurry of Protein A/G PLUS Agarose (Santa Cruz Biotechnology) was added to 
each reaction.  The reactions were incubated overnight at 4C with rocking.  To isolate the 
immunocomplexes, the resin was washed four times with 1mL of IP buffer for two minutes.  The 
resin was then re-suspended in 50µL of 2XSB, boiled for five minutes, cooled, and debris 
pelleted before loading on an SDS-polyacrylamide gel and subjecting to Western blot. 
5.9 GENERATION OF FUSION PROTEINS  
5.9.1 Generation of MBP fusion proteins Mad and Med 
Initially, small-scale expression and purification of the MBP-fusion proteins was conducted in 
order to test for solubility.  MBP, MBP-MadNL, and MBP-MedNL (gifts from Allen Laughon) 
were expressed on a large-scale essentially as described in Molecular Cloning (Sambrook, 2001).  
Plasmids were transformed into BL21 cells using standard procedures and grown on 2XYT 
plates with 60µg/mL carbecillin.  Single colonies were grown in 5mL of 2XYT with 60µg/mL 
ampicillin for approximately 8 hours at 37C; the entire culture was then diluted 1:10 and grown 
for 16 hours at 37C.  The cultures were again diluted 1:20 in media with 60µg/mL ampicillin 
and grown at 37C for 60 minutes and then RT until the ODA600 readings were between 0.6 and 
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0.8. The fusion proteins were induced with 0.2mM IPTG and the cultures grown for three hours 
at RT.  Cultures were chilled on ice and centrifuged at 5000 g for 10 minutes at 4C and pellets 
resuspended in 20mL 1X Column Loading Buffer (1X CLB) before freezing at -20C overnight.   
 The cells were thawed and sonicated on ice for 8 minutes (50% pulse, 2.5 power) and 
centrifuged at 10,000 g for 20 minutes.  The supernatant was incubated with 3mL amylose resin 
(pre-washed in 1X CLB) and mixed for 30 minutes.  The resin was gently pelleted and washed 
four times with 10 volumes 1X CLB.   Protein was eluted in 6mL 1X CLB with 10mM maltose 
and dialyzed against four changes of Mad Dialysis Buffer.  The concentration was then 
determined by Bradford analysis and aliquots frozen at -80C.  
5.10 MBP-PULL DOWN ASSAYS  
5.10.1 Radiolabeled protein construct generation 
Luciferase was provided by the TNT in vitro transcription/translation rabbit reticulocyte lysate 
system kit (Promega).  ZenAR was provided by the Rushlow Lab (Rushlow et al., 2001).  3PFT 
was created by initially performing PCR on template DNA brk3PF2 (Winter and Campbell, 
2004) with primers brkGFBGL and T3 (primer sequences in Table 5-3).  The product was 
digested with BglII /NotI and cloned into the BamHI/NotI sites of vector pET-21a.   
FluT was created by performing PCR on brk3PRX (Winter and Campbell, 2004) 
template DNA using primers M13F and M13R.  The PCR product was digested with EcoRI/NotI 
and cloned into the EcoRI/NotI sites of vector pET-21a.  To create Stop1T, PCR was performed 
on brk3PF2 with primers brkGFBGL and Stop1RI.  The PCR product was digested with 
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BglII/EcoRI and cloned into the BamHI/EcoRI sites of FluT to create Stop1T.  Stop2T and 
Stop3T were created as described for Stop1T except using forward primer brkGFBGL and 
reverse primers Stop2RI and Stop3RI, respectively. 
RH2DT was created by first performing inverse PCR on brk3PF2 with primers brkA10a 
and brkA11a.  The PCR product was digested with AgeI (restriction site provided by primers) 
and ligated to create brkRHDS.  PCR was then performed using brkRHDS as a template and 
brkGFBGL and M13R as primers.  The PCR product was digested with BglII/NotI and cloned 
into the BamHI/NotI sites of pET-21a creating RH2DT.  
NTAT was created by performing PCR on template DNA 3PF2 with primers Stop1RI 
and brkNT1BglF.  The PCR product was digested with BglII/EcoRI and cloned into the 
BamHI/EcoRI sites of FluT to create NTAT.  NTBT and NTCT were created as described for 
NTAT except that Stop1RI was used as the forward PCR primer and brkNT2BglF and 
brkNT3BglF were used as the reverse primers, respectively. 
 
 
 
Table 5-3: Primers used to create in vitro translated protein. 
Primer Name 5'-Sequence-3'
brkA10a gatcaccggtGTTGTATTTCCTGGCCGT
brkA11a gatcaccggtGAGTCAAATTTGCGATCA
brkGFBGL AGTCagatctATGGATAGCAGCAGCGAA
brkNT1BglF agtcagatctGGCAGCCCCAAAATGGGAAG
brkNT2BglF agtcagatctAATCAGCAACAGCAGCAG
brkNT3BglF agtcagatctGGCATGGTTCCACACCCC
M13F gtaaaacgacggccagt
M13R GGAAACAGCTATGACCATG
Stop1RI atgcgaattcGGCTGGTGTGGCAACCGC
Stop2RI atgcgaattcCAGCTTGTGCTCCTCCGG
Stop3RI atgcgaattcTTTGCTGGAGCTGCAGTT
T3 ATTAACCCTCACTAAAGGGA  
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5.10.2 In vitro transcription/translation reactions 
The coupled TNT in vitro transcription/translation rabbit reticulocyte lysate system (Promega) 
was used in the presence of 35S-methionine to generate both full-length and truncated 
radiolabeled Brk fusion proteins following the manufacturer’s protocol using 1µg of plasmid 
DNA in a 50µL final reaction volume. 
5.10.3 Immunoprecipitations 
Immunoprecipitation experiments utilizing radiolabeled in vitro translated proteins were 
performed as described in section 5.8.2 substituting 20µL in vitro translated protein for the 
embryonic lysate and with no pre-absorption. 
5.10.4 Pull-down assays 
Pull-down reactions were performed essentially as described (Rushlow et al., 2001).  Briefly, 
20µL of radiolabeled in vitro translated fusion protein was pre-absorbed on amylose resin (New 
England Biologicals) for 45 minutes on ice.  The pre-absorbed protein was then mixed with 
200µL DNAP Buffer and 250ng MBP, MBP-MadNL, or MBP-MedNL (as described above) and 
incubated at 37C for 60 minutes.  Following incubation, 20µL of 50% slurry of amylose resin in 
1X DNAP Buffer was added and the reactions incubated for 60 minutes at RT on a nutator.  
Resin was washed five times with 1mL DNAP Buffer and the pellet re-suspended in 60µL 
2XSB.  The samples were boiled for five minutes and 15µL of supernatant run on SDS-
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polyacrylamide gels alongside 10% input radiolabeled protein.  The gels were fixed, dried, and 
exposed to film following standard procedures. 
5.11 GENERATION AND PURIFICAITON OF ANTIBODIES 
GST-Pro6 antigen was previously purified in the lab and subsequently used for antibody 
production.  The fusion protein was injected into three rats and three guinea pigs.  The animals 
were boosted at days 21, 42, and 63 followed by a terminal bleed on day 73. 
5.11.1 Preparation of affinity column containing GST 
GST was coupled to CNBr-Sepharose 4B (cat# 17-0430-01, Amersham) as described by the 
manufacturer.  Approximately 10 mg (4 mL) of the protein, dialyzed in 1X Coupling buffer 
(Appendix A), was mixed with the prepared resin and incubated overnight with rocking at 4°C.  
The mixture was centrifuged at 1500 g for 4 minutes, and the supernatant discarded.  The CNBr 
resin was washed twice in 10 bed volumes of 1X Coupling buffer before the active groups on the 
resin were blocked with 10 bed volumes 1X Active group blocking buffer (0.1M Tris-HCl, pH 8) 
at room-temperature for 3 hours with rocking.  The resin was then washed twice in 10 bed 
volumes of 1X Coupling buffer, and transferred to a gravity-flow column (Novagen).  The 
column drained completely to pack with a final bed volume of 2.5mL and contained 
approximately 10mg of antigen.   
To remove all loosely bound antigen, the column was washed through the following 
series of buffers, checking that the pH of the last few drops of eluate reached the pH values of 
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the respective buffers (all listed in Appendix A): (1) 10 bed volumes of 1X Coupling buffer (pH 
8.3), (2) 10 bed volumes of Low pH elute buffer (pH 2.5), (3) 10 bed volumes of 1X Coupling 
buffer (pH 8.3), (4) 10 bed volumes of High pH elute buffer (pH 11.5), (5) 10 bed volumes of 1X 
Coupling buffer (pH 8.3).  The five washes were then repeated to ensure that all loosely bound 
proteins were removed.   
5.11.2 Removal of anti-GST antibodies from antisera 
Approximately 3mL of the anti-brkGP10 antisera was diluted 1:3 in 0.1 M Tris-HCl, pH 8, and 
filtered through a 0.22 m filter disc before loading onto the affinity purification CNBr-coupled 
column.  To eliminate GST-specific antibodies the antisera was loaded onto a CNBr-GST 
column. The entire eluate from this column was collected. 
5.11.3 Final antibody purification 
For final antibody purification, a Protein A Sepharose column was prepared following 
manufacturer directions (Amersham). Briefly, the Protein A Sepharose was expanded in 
deionized water, washed for 3 washes of 10 mL 1 mM HCl, with 10 minutes rocking followed 
by centrifugation at 5000 g for 5 minutes.  The Protein A Sepharose resin was loaded onto a 
gravity-flow column (Novagen) and allowed to drain completely, packing the column with a 
final bed volume of 1.5 mL Protein A Sepharose resin.  The column was washed with 10 bed 
volumes 1X PBS, pH 7.4 (Appendix A) to equilibrate the column.   
To concentrate the antibody, the eluates obtained above were loaded onto the Protein A 
Sepharose column.  The column was washed with 10 bed volumes of 1X PBS buffer and the pH 
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of the last few drops of the wash buffer was checked to have reached pH 7.4.  The antibodies 
were eluted by washing with 5 volumes low pH elute buffer, pH 2.5.  The eluate was collected in 
0.5mL fractions into microfuge tubes containing 100L of 1 M Tris, pH 8.  Upon completion, 
the pH of the eluate was checked to be sure it was approximately pH 7.5.   
The fractions that contained the antibodies were determined by spot testing each fraction 
for the presence of protein. The antibodies were centrifuged at 1500 g for 5 minutes and the 
supernatant was dialyzed against 1X PBS, pH 7.4, for 4 hours at 4°C, then dialyzed twice 
overnight against 1X PBS, pH 7.4 at 4°C.  Upon completing dialysis, the dialyzed antibody was 
stored in 1X PBS, pH 7.4 with 1% BSA added as a stabilizer.  Antibodies were sterile filtered 
through a 0.22 m filter disc, aliquoted, and the purified antibodies were stored at 4°C and -
80°C. 
5.12 CHROMATIN IMMUNOPRECIPITATIONS 
5.12.1 Chromatin preparation 
All buffers for ChIP are described in Appendix B.  Overnight collections of embryos of the 
genotype  were collected on plates and dechorionated for three minutes in 
a solution of 50% bleach.  They were washed well with distilled water and 0.5g of embryos was 
transferred into a 50mL Falcon tube.  The embryos were washed with 50mL PBT, and then 
cross-linked by adding 10mL Cross-linking Solution, 649µL 37% formaldehyde (Fisher 
Scientific), and 30mL n-Heptane.  The embryos were vigorously shaken for 15 minutes.  After 
crosslinking, the embryos were resuspended in 30mL PBT/Glycine Solution.  The embryos were 
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washed in PBT and from this point on, processed at 4ºC.  The embryos were resuspended in ice-
cold PBT+PIs and dounced 20X with a loose pestle in a Wheaton homogenizer before spinning 1 
minute at 400g.  The supernatant was saved and spun again at 1100g for 10 minutes.  The pellet 
was resuspended in 15mL ice-cold Cell Lysis Buffer+PIs and dounced 20X with a tight pestle in 
a Wheaton homogenizer.  The nuclei were pelleted by centrifugation at 2000g and resuspended 
in 1mL ice-cold Nuclear Lysis Buffer+PIs.  To two 50mL Falcon tubes, 2mL ice-cold Nuclear 
Lysis Buffer+PIs and 0.3g acid-washed 212-300 micron glass beads (Sigma) were added.  After 
20 minutes, the re-suspended nuclei was split and added to this mixture for sonication.  
Sonication was carried out to produce chromatin fragments with an average size of 500bp.  Each 
batch of chromatin was sonicated 15 times with 25 seconds on, 25 seconds off at power 5.  The 
glass beads were pelleted by centrifugation at 5000g and the supernatant transferred to microfuge 
tubes where any remaining glass beads were pelleted.  The supernatant (containing fixed sheared 
chromatin) was then pooled, 200µL aliquots were generated, and the chromatin flash frozen and 
stored at -80C.   
5.12.2 Immunoprecipitation 
Chromatin was thawed on ice and reactions conducted at 4ºC.  Varied amounts of chromatin 
(20µL-400µL) were tested in IP reactions by combining the appropriate amount of chromatin in 
400µL minimal reactions with IP Dilution Buffer+PIs.  Chromatin was pre-absorbed by 
incubating with 50µL 50% Protein A/G PLUS Agarose (Santa Cruz) for 4 hours.  Reactions 
were then conducted following condition A or B as follows: 
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A: Pre-absorbed chromatin was mixed with varied amounts of antibody (0.5µL-10µL) 
overnight with rotation.  50µL of a 50% slurry of Protein A/G Plus Agarose (Santa Cruz) pre-
absorbed with BSA and Salmon Sperm DNA was then added to the IP for 3 hours with rotation. 
B: Varied amounts of antibody were mixed with 50µL of a 50% slurry of Protein A/G 
Plus Agarose (Santa Cruz) pre-absorbed with BSA and Salmon Sperm DNA for 4 hours with 
rotation.  The resin was washed well with IP Dilution Buffer+PIs.  Pre-absorbed chromatin was 
then added to the reaction in 400µL minimal reaction volumes and rotated overnight. 
The chromatin/antibody/resin complex was pelleted and washed 2 times for 5 minutes 
with 1mL IP Dilution Buffer, 2 times for 5 minutes with 1mL High Salt Wash Buffer, four times 
for 5 minutes with 1mL Wash Buffer, and two times for 5 minutes with 1mL TE Wash Buffer.  
The reactions were then brought to room temperature and the resin re-suspended in 150µL IP 
Elution Buffer, rotated for 15 minutes, and the supernatant saved to a clean tube.  This elution 
was repeated one more time.   
The appropriate amount of input chromatin was brought up to 300µL with Nuclear Lysis 
buffer.  The input and eluted chromatin were then treated with 3µL of 5mg/mL RNaseA for 30 
minutes at 37ºC.  Proteins were removed by adding 6µL of 50mg/mL ProteinaseK to each 
reaction and incubated 90-120 minutes at 45ºC.  The crosslinking was then reversed by 
incubation at 65ºC overnight.  The immuno-complexes were then purified using the QIAquick 
PCR purification kit (Qiagen) and eluted in 50µL Buffer EB (Qiagen). 
5.12.3 PCR analysis 
PCR was carried out using Platinum Taq DNA polymerase (Invitrogen).  Reaction conditions 
and cycling parameters were optimized for each primer pair.  25L reactions were utilized and 
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half of each reaction was run on a 2% TBE gel, stained with ethidium bromide, and imaged on a 
Kodak Image Station 440CF.    
 
 
 
Table 5-4: Primers used in ChIP analysis. 
Primer Name 5'-Sequence-3'
brkSF1 GGGAAGAATTGAATGAGTTGTGGTAAC
brkSR1 ACAAGCGAGAGACAGAGAGCGAGCGGGC
DNApolF4 GAATCGGAGGACATTAGTAGGTTGC
DNApolR4 GCAGTGGTTTCTTTCCATCGTAGTG
UbxBF1 ACCATCTAACAGGTGCCGAGC
UbxBR1 GCCACTTACGCAGCTAATAAAGCAG
UbxBF5 AATGCCGAAAGACACAGCCG
UbxBR5 ATGCCATCCGTATGCGTGCG  
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APPENDIX A 
GENERAL BUFFER RECIPES 
Mad Binding Buffer: 
50mM KCl 
20mM HEPES, pH 7.6 
1mM DTT 
1mM EDTA 
50µg/mL poly[d(A-T)] 
4% Ficoll  
0.25mg/mL BSA 
 
1X PBS, pH 7.4: 
10mM Na2HPO4O 
2mM KH2PO4O 
137mM NaCl 
2.7mM KCl 
 
1X Anode Buffer, pH 9.6: 
60mM Tris 
40mM CAPS 
15% Methanol 
 
1X Cathode Buffer, pH 9.6: 
60mM Tris 
40mM CAPS 
 
1X TBST, pH 7.5: 
20mM Tris-HCl, pH 7.5 
150mM NaCl 
0.05% Tween-20 
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1X Western Strip Buffer: 
62.5mM Tris-HCl, pH 6.8 
100mM 2--mercaptoethanol 
2% SDS 
 
1X RIPA Lysis Buffer: 
150mM NaCl 
1% NP-40 
0.5% Sodium deoxycholate 
0.1% SDS 
50mM Tris, pH 8.0 
1mM PMSF 
2g/mL Aprotinin 
1g/mL Leupeptin 
0.7g/mL Pepstatin 
 
1X IP Buffer: 
150mM NaCl 
0.5% NP-40 
5mM EDTA, pH 8.0 
50mM Tris, pH 7.5 
2ug/mL Leupeptin 
1ug/mL Pepstatin A 
 
2XSB: 
100mM Tris, pH 6.8 
20% glycerol 
4% SDS 
0.01% Bromophenol Blue 
200mM DTT 
 
Mad Dialysis Buffer: 
50mM KCl 
20mM HEPES, pH 7.6 
1mM DTT 
1mM EDTA 
 
1X CLB: 
20mM Tris, pH 7.5 
0.2M NaCl 
1mM EDTA 
1mM DTT 
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1X DNAP Buffer: 
80mM NaCl 
35mM KCl 
5mM MgCl2 
25mM Tris, pH 7.5 
10% glycerol 
0.1% NP-40 
1mM DTT 
 
1X Coupling Buffer: 
0.1M NaHCO3, pH 8.3 
0.5M NaCl 
1mM EDTA, pH 8.0 
 
Low pH Elute Buffer, pH 2.5: 
0.1M glycine, pH 2.5 
20mM NaCl 
 
High pH Elute Buffer, pH 11.5: 
20mM Tris-HCl, pH 11.5 
0.5M NaCl 
1mM EDTA, pH 8.0 
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APPENDIX B 
CHROMATIN IP BUFFER RECIPES 
Protease Inhibitor Concentrations: 
3.3µg/mL Aprotinin 
10µg/mL Leupeptin 
4µg/mL Pepstatin 
1mM AEBSF or PMSF 
 
10X PBS, pH 7.4: 
80g Sodium chloride 
2g Potassium chloride 
14.4g Disodium hydrogen orthophosphate 
2.4g Sodium dihydrogen orthophosphate 
 
PBT: 
1X PBS  
1% Triton-X100 
 
PBT/Glycine Solution: 
4.69g Glycine 
5mL 10% Triton-X100 
50mL 10X PBS 
dH2O to 500mL 
 
Crosslinking Solution: 
50mM HEPES pH 8.0 
1mM EDTA 
0.5mM EGTA 
100mM NaCl 
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Cell Lysis Buffer: 
5mM HEPES pH 8.0 
85mM KCl 
0.5% NP-40 
 
 
Nuclear Lysis Buffer: 
50mM Tris pH 8.0 
10mM EDTA 
1% SDS 
 
IP Dilution Buffer: 
0.01% SDS 
1.1% Triton X-100 
1.2mM EDTA 
16.7mM Tris pH 8.0 
167mM NaCl 
 
High Salt Wash Buffer: 
0.1% SDS 
1% Triton X-100 
2mM EDTA 
20mM Tris pH 8.0 
500mM NaCl 
 
Wash Buffer: 
100mM Tris pH 8.0 
500mM LiCl 
1% NP-40 
1% Sodium Deoxycholate 
 
TE Wash Buffer: 
10mM Tris pH 8.0 
1mM EDTA 
 
Elution Buffer: 
1% SDS 
0.1M NaHCO3 
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